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Abstract
Chronic diseases are a major concern in terms of prevalence and disability in
a progressively aging population. Osteoarthritis (OA) is a chronic condition
that affects 15% of the population with up to 50% over the age of 65 years
having radiological evidence of OA. Self-management (SM) is increasingly
being utilized as a strategy to enable people to manage their chronic
condition. There is conjecture as to the effectiveness of SM for arthritis with
systematic reviews and meta-analyses citing only small, if any, benefits in
terms of pain and functional improvements.
A disease specific SM education program for OA knee, known as the OAK
Program, delivered by health professionals, was tested in a Quality
Assurance study and found to show improvements in pain, function and
quality of life.  Recent evidence suggests there is increased mortality
associated with OA of the knee, with a further increased risk for those with
OA of the knee and restricted activity.  With the improvements demonstrated
in the Quality Assurance study, it was necessary to test this Program under a
more rigorous study design.
In this doctoral research the OAK Program was compared to a control group
in a randomised controlled trial (RCT) (Study 1). The aim of Study 1 was to
determine whether people with osteoarthritis of the knee completing the OAK
Program report improved quality of life, knee function and decreased pain
compared with those managed conventionally.
One hundred and forty-six people with OA of the knee were randomised into
either a control group or the OAK (Program) group. The OAK Program is a
six-week intervention, with follow-up to six-months. The no-intervention/usual
medical management control group had assessments at the same time-
points as the OAK group: pre-intervention, post-intervention (8-weeks) and at
six-months.  The results of this RCT showed improvements in pain, physical
function and quality of life in the OAK group when compared to a control
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group, with improvements maintained to six-months. These positive findings
added weight to the effectiveness of the OAK Program, and the next part of
this doctoral research was to compare it with another self-management
model.
The Arthritis Self-Management Program (ASMP) is the most accepted self-
management model for arthritis but it has not demonstrated improvements in
pain and function to any significant degree. It is generic in content and
utilises lay leaders therefore the comparison with the OAK Program that is
disease specific and uses health professionals would give information useful
to determine the most effective self-management model for osteoarthritis.
In Study 2, the OAK Program was compared in a RCT to Stanford
University’s Arthritis Self-management Program (ASMP), a generic arthritis
SM program facilitated by lay leaders (Study 2) with follow-up continuing to
twelve-months. The aim of Study 2 was to test whether a greater proportion
of people with osteoarthritis of the knee completing the OAK Program report
clinically meaningful improvements in pain, knee function and quality of life,
compared to those completing the ASMP.
One hundred and eighty people with OA of the knee were randomised into
either the OAK group or the ASMP group. Participants and assessors were
blind to group allocation. Study 2 methods were the same as Study1 with the
exception of an extended follow-up period to 12-months.
Primary outcomes for both studies included pain, physical function and
quality of life as determined by the proportion of minimal clinically important
improvements and responder criteria achieved by participants in each group.
Group by time differences using an ANOVA analysis were also computed for
each variable.
Study 1 demonstrated significant in improvements in pain, physical function
and quality of life compared to the usual medical management control group.
The advantage of participating in the program was maintained for the six-
vmonth follow-up period when, for ethical reasons the control group was
offered the self-management program.
In Study 2 both groups received a self-management intervention and both
groups demonstrated significant improvements in most primary outcome
measures. The OAK Program participants however had greater
improvements in pain and function compared to the ASMP group in the short
term. The advantage of participating in the OAK Program was maintained
through to the 12-month follow-up in VAS pain, and WOMAC and SF-36
Physical Function domains, but other outcomes became non-significant.
Physical function and pain decreased in the OAK group in both Study 1 and
2. This is unique to the OAK Program, as other arthritis SM programs have
not demonstrated significant improvements in either pain or function. These
findings are important, as pain and function are predictors of disability. The
improvements in these measures suggest a functional improvement and in
the context of the recent evidence of increased mortality associated with a
decline in functional ability this is particularly relevant.
The inclusion of specific information on pain relief and exercise for people
with OA of the knee in the OAK Program is likely to have an association with
the improvements demonstrated in pain and function. This specific
information is beyond the scope of lay leaders and it may be that a disease
specific SM program for people with OA of the knee is more effective than a
heterogeneous generic SM program for arthritis. However, since the
mechanisms involved with successful SM are not clear, there may be other
factors that play a role in the process since both the control group and ASMP
group also achieved improvements.
The OAK Program demonstrated significant improvements in primary
outcomes in both Study 1 and Study 2. The ASMP group also showed
improvements in these outcome measures however none were significant
compared to the OAK group.
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The results of these studies demonstrate that the OAK Program is an
effective SM program for people with OA knee, however Study 2 does not
definitively determine which SM program is most effective therefore further
research is required.
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1CHAPTER 1
Introduction.
Among an ageing population, the prevalence of chronic disease will increase
resulting in a major impact on health care costs (Woolf 2001). Osteoarthritis
(OA) of the knee is a prevalent chronic condition and one of the most
common causes of musculoskeletal disability (Abramson and Attur 2009).
Complementary to conventional medical care, self-management  (SM) is a
primary care intervention that is considered to be beneficial in the
management of people with chronic illness (Abramson and Attur 2009). The
term SM is described as
“…any formalized patient education programme aimed at providing the
patient with the information and skills necessary to manage their condition
within the parameters of the medical regime.” - The Expert Patient Approach,
p22.
(Department of Health 2001)
and
“…are based on developing the confidence and motivation control over life
with a chronic condition”- The Expert Patient Approach, p6.
(Department of Health 2001)
Unlike traditional patient education programs, SM programs aim to achieve
more than providing information to increase knowledge.  They also aim to
change health behaviour and health status, (Lorig 2002) and are designed to
assist people to manage their condition (between physicians visits), by
teaching them how to cope with their symptoms, including the physical  and
psychological consequences of living with a chronic disease.
In recent years SM has become an accepted intervention in the management
of chronic illness. Developed countries have increasingly incorporated SM
into their health budgets as a means of addressing the prevalence of chronic
illness in a progressively aging community (Bury, Newbould et al. 2005). The
application of SM for people with arthritis originated in the 1980’s (Lorig and
Gonzalez 1992), and has become increasingly popular, particularly since the
advent of the Bone and Joint Decade.
2The recognition of arthritis as a major health burden by the World Health
Organization (Woolf and Pfleger 2003) resulted in the period from 2000 to
2010 being acclaimed as the Bone and Joint Decade (BJD). The aims of the
BJD (Tsou and Chng 2002) were:
1. To raise awareness of the growing burden of musculoskeletal
disorders on society.
2. To empower people to participate in their own care.
3. To promote cost-effective prevention and treatment.
4. To advance understanding of musculoskeletal disorders through
research and so improve prevention and treatment.
Despite its prevalence and the associated disability burden, in Australia
arthritis only became a national health priority in 2002.  Arthritis is now
acknowledged as being third only to cardiovascular and psychological
conditions in its prevalence in this country (Knox, Harrison et al. 2008).
SM is considered to be an effective strategy in the treatment of arthritis
(Chodosh, Morton et al. 2005). Although generally thought to be cost-
effective there is little evidence to support this suggestion. Some contrary
evidence suggests that this is actually not the case with respect to either
health or social care costs (Patel, Buszewicz et al. 2009). Despite the lack of
evidence, Australia and the UK have incorporated SM into national health
care initiatives (Jordan and Osborne 2007) and in the USA, one large health
care organization has incorporated SM into their funding program (Nolte,
Elsworth et al. 2007).
Across the chronic disease spectrum various models of SM, either disease
specific or generic, have been employed.  These models include individual,
group-based, postal and internet programs (Warsi, Wang et al. 2004). Face-
to-face interaction with health professionals is one important component of
some programs, especially where medication compliance is necessary. In
other versions, trained lay leaders deliver more generic programs, often
based on information that is pre-scripted to guarantee uniformity.
3The application of SM has been shown to be more effective for people with
hypertension, diabetes and asthma than those programs designed for people
with arthritis (Chodosh, Morton et al. 2005; Griffiths, Foster et al. 2007;
Jordan and Osborne 2007; Nolte, Elsworth et al. 2007). In fact, there is little
robust evidence to support the value of the application of SM in arthritis.
Furthermore, there is lack of consensus regarding the most effective type of
SM program and the most successful means of program delivery for this
condition.
In a meta-analysis of chronic disease SM programs, Chodosh, Morton et al
(2005) identified the difficulties in isolating the factors that result in greater
efficacy of SM programs.  This appears to be due to discrepancies among
the different disease states and differing components included in SM
programs (Chodosh, Morton et al. 2005).
Chodosh, Morton et al (2005) then suggested (based on the literature and
with the addition of expert opinion), that there were five possible components
of successful SM strategies. Thus patients who receive interventions tailored
to their specific needs and circumstances are likely to derive more benefit
than those receiving interventions that are generic.  Equally, in a group
setting patients are more likely to benefit being with others affected by the
same condition than from an intervention provided in some other setting.
Feedback is also important since patients are more likely to derive benefit
from a cycle of intervention followed by some form of individual review with
the provider of the intervention than from interventions where no such review
exists. In addition a psychological emphasis would be valuable since patients
are more likely to derive benefit from a psychological intervention than from
interventions where there is no psychological component. Further, patients
who receive interventions directly from their medical providers (physicians or
primary care providers) and identified as medical care, are more likely to
derive benefit than those who receive interventions from nonmedical
providers (Chodosh, Morton et al. 2005).
4For arthritis, as for other forms of chronic diseases, it is difficult to determine
the most effective model of SM.  This difficulty arises because of the
discordance between programs, study designs and outcome measures used
in SM trials and reported in the literature. Outcome Measures in Rheumatoid
Arthritis Clinical Trials - OA Research Society International (OMERACT-
OARSI) has proposed a simplified set of responder criteria to address this
issue (Pham, van der Heijde et al. 2004). These criteria were the combined
opinions of academic researchers and representatives of both health agency
and pharmaceutical companies. The proposed criteria covered three
domains: pain, function and patient’s global assessment. For each of these
domains a response is defined by both an absolute change and a relative
change (per cent) in the variable.  Six scenarios were evaluated (A, B, C, D,
E, F) – three considered pain as the first response variable and three
considered pain and/or function (Pham, van der Heijde et al. 2004). The
treatment effect was similar in all six scenarios however scenario D, (which
has been used to report the responder analysis in both trials reported in this
thesis) had higher sensitivity and specificity than the other scenarios for hip
OA and was chosen by the expert panel to represent the OMERACT-OARSI
set of responder criteria (Pham, van der Heijde et al. 2004).
The criteria used for Scenario D is: An improvement of ≥50% and an
absolute change of ≥20 points on a 100 point scale in pain or function, OR an
improvement of at least two of the following: An improvement of ≥20% and
an absolute change of ≥10 in two of pain, function and global health.
Despite the introduction of these criteria, there is still a paucity of robust trials
with which to make evidence based decisions on the most effective SM
program for people with arthritis.
Most commonly, the Stanford University Arthritis SM Program (ASMP) has
been the industry standard for arthritis, however there is no unequivocal
evidence to support the widespread use of the ASMP. Systematic reviews
(Warsi, LaValley et al. 2003; Newman, Steed et al. 2004; Warsi, Wang et al.
2004; Newbould, Taylor et al. 2006) of SM interventions for various chronic
5diseases have reported a trend towards a small benefit from arthritis
programs, with the majority being the ASMP or derivatives of the ASMP.  The
results of these reviews however, have been found to be largely insignificant
and some suggestion of publication bias has been described (Warsi, Wang
et al. 2004; Chodosh, Morton et al. 2005).  Most trials reported short-term
changes only, with few trials following participants beyond six months.
Several limitations of the ASMP have been identified. These include the
generic content of the program that is necessary because it is facilitated by
lay leaders; the fact that participants with any type of musculoskeletal
condition are included in the same group and the fact that the drop-out rate
associated with the ASMP appears to be high. (Warsi, Wang et al. 2004;
Chodosh, Morton et al. 2005). In contrast, successful SM programs for such
disorders as asthma, diabetes and hypertension generally use health
professionals for program facilitation. Such programs have the added
advantage that they also include specific information on clinical disease
management, assist the participants to correct erroneous health beliefs and
offer structured exercise within the SM program (Griffiths, Foster et al. 2007).
One study (Cohen, van Houten Sauter et al. 1986) has made a comparison
between programs facilitated by lay leaders and health professional leaders.
The study compared 34 people in a lay-led group with 34 people in a group
led by health professionals, with 32 controls. Assessments were done at
baseline and again at 4 months. Improvements in exercise knowledge and
practice were demonstrated in both groups, compared with their baseline
values with authors concluding that there was little difference between the
groups led by lay leaders or health professionals. However the study design
required all leaders both lay and health professionals, to deliver the same
scripted program.  Thus the knowledge and skills of the health professionals
may not have been optimally utilised, providing the potential for a flawed
outcome (Cohen, van Houten Sauter et al. 1986).
The major benefit of lay leaders is that they have the capacity to be role
models as they often have musculoskeletal conditions themselves (Lorig and
6Holman 2003).  Health professionals with their knowledge and skills can also
have a powerful influence as models for the groups’ members (Taylor and
Bury 2007). Modelling has the potential to transmit knowledge and skills to
which people may aspire, particularly if the information is perceived to be
important and relevant (Bandura 1977).
As well as the discussion created by the difference in group leadership, there
is also speculation about the mechanisms that contribute to successful SM.
There is little concrete evidence to support any particular aspect of these
programs with the exception of medication compliance (Chodosh, Morton et
al. 2005). Chronic illnesses that encompass pain, such as arthritis, are more
complex than those that are predominantly medication focused, for example
hypertension. Though all chronic disease management requires behaviour
modification and coping strategies if they are to be effective, arthritis SM
interventions also need to include medication compliance (Newman, Steed et
al. 2004).
The literature suggests that SM may not be effective across all chronic
diseases (Jordan and Osborne 2007; Nolte, Elsworth et al. 2007) and that
further investigation could help clarify whether SM programs for arthritis are
beneficial and worthwhile (Warsi, LaValley et al. 2003; Newman, Steed et al.
2004; Chodosh, Morton et al. 2005; Nolte, Elsworth et al. 2007). Weingarten,
Henning et al (2002) in their meta-analysis of chronic disease management
programs comment on the diversity of programs and suggest that to
determine the effectiveness and costs, evaluations need to compare different
types of interventions (Weingarten, Henning et al. 2002). It has been
suggested that disease specific programs delivered by health professionals
are an essential component of successful SM (Jordan and Osborne 2007;
Taylor and Bury 2007). One program developed by Arthritis Western
Australia represents a disease specific SM program for people with OA of the
knee.  It is known as the OAK Program and specifically employs health
professionals for program facilitation.  This program was tested in a quality
assurance (QA) study that demonstrated improvements for patients in pain,
function and quality of life (Coleman, Briffa et al. 2008a).  A description of this
7study is included in the Appendix.  The results of the QA study were
encouraging and it was decided to test the OAK Program further in two
stages using a rigorous study design, a randomised controlled trial (RCT).
Aims of the thesis
The specific aims developed for the studies that constituted this thesis were:
1.  To determine whether a disease specific SM program designed for
delivery by health professionals (namely the OAK Program) would improve
pain, function, and quality of life in individuals with OA of the knee.
2.  To test the OAK Program further by comparing it with the industry
standard for arthritis SM, the ASMP.
To fulfil these aims, two RCTs were designed.  In the first (Study 1) changes
in response to the OAK Program were compared with responses in a
comparable control group that had no SM intervention. In the second study,
responses to the OAK Program were compared with responses to the ASMP
in a group of people with arthritis of the knee.
Study 1:
Hypothesis
To determine whether a disease specific SM program for people with
osteoarthritis of the knee (the OAK program), implemented by health
professionals, would achieve and maintain clinically meaningful
improvements in health related outcomes compared with a control group.
This study was registered with the Australia and New Zealand Clinical Trial
Registry, number: 12607000080426. Curtin University of Technology, Human
Research Ethics Committee approved this study (HR141).
Study 2:
Hypothesis
A greater proportion of people with OA of the knee that complete the OAK
Program will achieve a minimal clinically important difference in pain, function
8and quality of life, at eight weeks, six and twelve months compared to those
who complete the ASMP.
This study was registered with the Australia and New Zealand Clinical Trial
Registry, number: 1260700001460. Curtin University of Technology, Human
Research Ethics Committee approved this study (HR12).
Ethical considerations
Both Studies 1 and 2 were conducted at Arthritis WA, a community setting
that is close to public transport and has available infrastructure for study
management and co-ordination. Copies of consent forms, participant study
information, doctors study information, SF-36 and WOMAC licenses, case
report forms, assessment forms, Curtin University ethics approval, for both
studies are included in the Appendix.  Arthritis WA has a licence from
Stanford University to conduct the ASMP and it is also licensed to train lay
leaders for facilitation of the ASMP.
Study information was stored according to National Health and Research
Council guidelines (Australian Government 2009) in hard copy in a locked
filing cabinet, and electronically on one password protected computer that
was available only to the study co-ordinator. Patient demographics were
stored separately from all data and case report forms (CRFs) contained no
identifying information. CRFs were identified by participants’ initials and study
number only. The codes for these were stored on the password-protected
computer. At completion of the study, this information will be archived in a
secure location for 7 years and will then be destroyed.
Prior to commencing enrolment for Studies 1 and 2, ethical approval was
obtained from the Human Research Ethics Committee, Curtin University of
Technology. Arthritis WA also gave approval for the studies, and the OA
Knee Advisory Committee that had guided the QA study was invited to
continue in that capacity with the OAK Program in the next two phases of the
study.
9Advisory Committee
In keeping with usual policy at Arthritis WA, an Advisory Committee was
established to contribute to progress development and subsequent
evaluation of the OAK Program. The Advisory Committee consisted of two
rheumatologists, a geriatrician/rheumatologist, and an associate professor in
physiotherapy. The members of the Advisory Committee met on average
every 2-3 months initially and twice yearly thereafter unless there were
complicating issues. Updates, abstracts, and correspondence were sent to
members of the Advisory Committee via email between meetings.
The Advisory Committee contributed to the selection of outcome measures
used to measure changes in pain, quality of life, muscle strength, physical
function and range of motion in the knee. They also advised on a range of
areas involved in the study design, for example identifying an acceptable
method of diagnoses for OA of the knee; inclusion and exclusion criteria;
randomisation procedure; assessment time-points and procedures.
The next chapter will review the literature relevant to the issues associated
with OA of the knee and the use of SM as a management technique for
people with this disability.
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CHAPTER 2
Literature Review
Chronic disease can be seen as evolving along a continuum. A disease-free
state undergoes an asymptomatic biological change, progresses to clinical
illness and, depending on severity, can continue on to impairment and
disability.  The continuum can include the development of complications and
disability in some cases (National Public Health Partnership 2001). Most
health care initiatives are directed initially towards prevention, however, once
the condition has developed then the approach of choice becomes curative
at the various points along the continuum.
Osteoarthritis
This review is about one such chronic condition, OA, and approaches to
management that involve the individual understanding and taking
responsibility for their own disease.  Initially, the disease process and
prevalence, the risk factors associated with it, and the associated aetiology
and diagnosis will be examined, with particular emphasis on OA of the knee,
since it is the focus of this thesis.  Following this, the ideas that have led to
the development of SM approaches of interest to the present work will be
presented.  Finally, a particular SM program for OA of the knee will be
examined in the studies that form the basis of this thesis.
It is recognised that some causal agents affect more than one chronic
condition (Guh, Zhang et al. 2009). Guh, Zhang et al (2009), in their meta-
analysis of co-morbidities relating to obesity, use obesity as an example of
this since it can be attributed, in part, to a number of different co-morbidities.
Such co-morbidities include cancer (kidney, colorectal, prostate, ovarian,
uterine/endometrial, esophageal, pancreatic, and postmenopausal breast),
type II diabetes, cardiovascular disease risk (hypertension, coronary artery
disease, congestive heart failure, pulmonary embolism, stroke), gallbladder
disease, chronic back pain, OA, asthma, and diabetes (Guh, Zhang et al.
2009). Public health initiatives that target one health problem, such as
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obesity, may in fact be affecting multiple chronic illnesses. It is estimated by
the Australian Bureau of Statistics for those over the age of 65 years, that the
majority will have three or more chronic conditions (Caughey, Vitry et al.
2008; Australian Bureau of Statistics 2009). When people have two or more
chronic conditions, their quality of life is likely to be significantly reduced,
which may result in more frequent visits to general practitioners and an
increase in health expenditure (National Public Health Partnership 2001).
In 2007, Access Economics prepared a report for Arthritis Australia on the
impact of musculoskeletal conditions (Access Economics 2007). The report
indicates that musculoskeletal conditions are the second most costly national
health priority, behind cardiovascular disease, and more Australians are
diagnosed with arthritis than any other national health priority condition. This
same report highlights a number of facts about arthritis including that it is
more prevalent in women (19.9%) than men (17%) and that 62% of all
people with arthritis are of working age (15-64 years). Arthritis connected
productivity costs and absenteeism account for $7.6 billion per year (Access
Economics 2007) thus in terms of disability burden, arthritis is second only to
depression. The report indicates that the total financial costs for arthritis in
2007 were estimated to be $23.9 billion a sum that equates to approximately
$1,100 per Australian.
Further information presented in this same report (Access Economics 2007)
described OA as the most common form of arthritis accounting for 46% of
those with a diagnosis of arthritis affecting 10% of the population. Dieppe and
Lohmander (2005) suggest it is also more common in women than men over
65 years of age and the prevalence of OA of the knee is similarly greater in
women than men. Forty per cent of the population will have OA by the age of
65 (Access Economics 2007), and it is the third leading cause of life years
lost to disability (DALYS) (March and Bagga 2004).
Caughey, Vitry et al (2008) conducted a systematic review of chronic
diseases focusing on six Australian national health priority conditions
(arthritis, asthma, cancer, cardiovascular disease, diabetes mellitus and
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mental health problems). Twenty-five studies were included in the review
with the aim of reporting the prevalence of co-morbidities.  The findings
suggest that one in two people presenting to their GP with a chronic illness
will also have arthritis (Caughey, Vitry et al. 2008). In addition, people with
OA suffer from co-morbidities that have an adverse effect on physical
function more frequently than the general population (Kadam and Croft
2007). The combination of OA plus another chronic illness has more serious
effects on health status than the sum of the two conditions alone (Kadam and
Croft 2007). Moreover those people with a chronic illness such as OA who
have additional co-morbidities are more likely to be prescribed medication for
each condition that may result in polypharmacy with the associated risk of
unwanted medication interactions and adverse effects (Caughey, Vitry et al.
2008; Dawes 2010).
There is no single identified cause of OA, however several risk factors have
been identified.  These include age, heredity factors, sports injuries,
occupational risk factors, obesity, and biomechanical factors (Australian
Institute of Health and Welfare 2005).
Age is the most significant risk factor having the highest correlation with OA
(Abramson and Attur 2009). Age seems to increase the risk of developing
OA, and more women than men are affected after the age of 50 years. It
occurs more often in the hip in men, but more commonly in the hand, knee
and feet in women (Jordan, Kington et al. 2000). With advancing age, factors
including weight gain, decreased proprioception, muscle weakness and gait
abnormalities contribute to increasing stress on joints.
There appears to be a genetic predisposition for OA (Jordan, Kington et al.
2000; Leveille 2004), however the precise link with the genetic contribution to
the pathogenesis of OA is difficult to determine and it is probable that
multiple genetic factors influence disease severity (Felson 2009). One study
of 130 identical and 120 non-identical female twins, aged between 48-70
years, demonstrated a clear genetic link in women with OA involving the
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hand and/or knee, however the genes involved have yet to be identified
(Spector, Cicuttini et al. 1996).
In a review of the development of the scientific understanding of arthritis
Abramson and Attur (2009) report that some genes involved with disease risk
in OA have been located, however the genetic components may differ
between specific joints and also between sex and race. They also point out
that since OA is so prevalent in the population it is difficult to analyse the
precise genetic contribution to the incidence and severity of OA (Abramson
and Attur 2009). Valdes, Doherty et al (2007) compared the genes of 603
people with OA with 596 age-matched controls without OA and concluded
that there is a complex interaction between genetic variants that can predict
the risk of OA (Valdes, Doherty et al. 2007). In addition to the genetic
component, mechanical and metabolic risk factors can initiate and
perpetuate the biomechanical changes that result in OA (Abramson and Attur
2009).   For example, body mass index, knee pain, medial tibial bone area
are all influenced by genetics (Jones, Ding et al. 2003). It may be that in
those with a genetic predisposition to OA, the disease is triggered by an
injury resulting in OA of that injured joint (Jordan, Kington et al. 2000). Some
elite athletes such as soccer or football players are predisposed to
developing OA (Lane 1996), but for those who undertake recreational
physical activity there is little evidence to show that they are at any greater
risk of developing OA (Conaghan 2002; Sharma, Kapoor et al. 2006).
Sports injury involving menisci or tendon rupture in youth will increase the
relative risk of developing OA. In Sweden in 1989, 219 young soccer players
with anterior cruciate injuries were followed for 14 years (mean age at 14
year follow-up was 38 years). At this follow-up 154 remained in the study and
122 consented to having an X-Ray, of these 78% had radiograph evidence of
OA (von Porat, Roos et al. 2004). Lohmander et al (2004) followed 106
female soccer players, with anterior cruciate injury due to soccer, mean age
at assessment was 31 years.  At the 12 year follow-up 103 females
consented to X-Rays and of these 42% had radiographic OA (Lohmander,
Ostenberg et al. 2004). In a review of joint injury in young adults, Roos
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(2005) states that in practical terms 50% of people who suffer injury to the
menisci or tendons in their 20’s will experience knee pain and functional
limitations resulting in lifestyle restrictions around 14 years after the initial
injury.
Occupational risk seems to have a relationship with OA. Although cartilage
requires a certain amount of loading to stay healthy (Sharma, Kapoor et al.
2006), excessive bending and loading may contribute to the risk of
developing OA (Conaghan 2002) and biomechanical abnormalities may
cause uneven loading and exacerbate the pain associated with OA
(Conaghan 2002; Sharma, Kapoor et al. 2006). Occupational risk factors are
fairly well known in men, but most studies do not include women at home
who are subject to domestic and childminding activities (Sharma, Kapoor et
al. 2006) so the impact of occupation on women may be underestimated.
Ethnicity may be a contributing factor, but there are conflicting theories
regarding ethnic risk factors. African American males are more likely to
develop OA of the hip than their Caucasian counterparts, and their X-Rays
show more severe involvement. The OA is often bilateral and is associated
with greater disability than that found in Caucasian males (Jordan, Kington et
al. 2000).
Obesity has a direct association with OA (Creamer, Lethbridge-Cejku et al.
1997; Sowers 2001; Nevitt 2002), pain, and disability (Okoro, Hootman et al.
2004). Those with OA who are overweight are likely to show increased
disease progression on X-Ray and the risk is increased fourfold in women,
especially for the knee (Pascual 2003) and to a lesser extent for the hip
(Jordan, Kington et al. 2000). The risk for OA knee is increased by 15% for
every additional increment of BMI above 27 (Sowers 2001) with 50% of
middle-aged women with OA in one knee progressing to bilateral OA of the
knee within two years (Nevitt 2002). Obesity is the number one preventable
cause of OA knee in women and second in men after trauma (Nevitt 2002). It
is generally accepted that weight loss will result in an improvement in pain
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and disease progression for those with a diagnosis of OA (Focht, Rejeski et
al. 2005).
The forces acting on the knee are 3-6 times body weight during normal
activities of daily living (Huang, Chen et al. 2000) therefore the heavier the
weight the greater the load the knees endure. Obesity associated with
biomechanical abnormalities such as joint malalignments are thought to have
a combined effect on the progression of OA. Obesity alone exacerbates OA,
but the effect is more pronounced in the presence of valgus or varus
deformity of the knees (Sharma, Lou et al. 2000). The distribution of load is
more critical where there is a varus deformity and the effect of increasing
BMI will be more pronounced on the varus knee (Sharma, Kapoor et al.
2006). This suggests that the loading effect of a BMI of 30 will be greater on
a varus knee than on a normally aligned knee.  Thus walking for those with
OA and noticeable varus will tend to create the conditions for a fourfold
increase in medial OA progression (Felson 2005; Sharma, Kapoor et al.
2006).
With advancing age, BMI gradually increases up to about the sixtieth year
when it then starts to gradually decline (Elia 2001). About the same time
there is an increase of adipose tissue in the omentum, visceral fat increases,
fat is redistributed into muscle (Zamboni, Mazzali et al. 2005), and there is
loss of lean muscle mass and changes in metabolism, all of which lead to
changes in body shape and weight. Such changes occur at a time of gradual
decrease in physical activity (Elia 2001).  This decline in energy turnover
(energy intake versus output - in the form of physical activity) is likely to be
accentuated in those with chronic diseases (Elia 2001).
There is a strong association with disability in those with OA as BMI
increases (Okoro, Hootman et al. 2004). This is worrying as there is a world
trend in western countries for an increasing prevalence of obesity, which will
potentially result in an increase in the prevalence of disability.
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Postural alignment of the hip, knee and ankle influence load distribution and
that in turn has an effect on the structure of the OA knee and the resulting
functional outcome (Sharma 2003; Abramson and Attur 2009). As indicated
previously, it is thought that varus and or valgus malalignment may be both a
cause of OA knee and a result of it (Sharma 2003). Varus and valgus
malalignment increase the medial and lateral load in the knee and are  strong
predictors of structural and functional deterioration (Sharma, Song et al.
2001; Fransen and McConnell 2008). Malalignment also strongly predicts
joint space narrowing on X-Ray, loss of cartilage on MRI (Felson 2009) and
bone marrow lesions that are also predictive of disease progression
(Abramson and Attur 2009).
Aetiology of Osteoarthritis
For many years it was thought that OA was a consequence of “wear and
tear” and thus part of the aging process.  The view was that the “wear and
tear” had a destructive impact on cartilage. Currently, OA is considered to be
the result of a number of different conditions that cause both biological and
mechanical destabilization of the joint (Abramson and Attur 2009). It involves
all the tissues of the joint and may be initiated by a variety of factors including
genetic, developmental, metabolic and traumatic (Abramson and Attur 2009).
Osteoarthritis resulting from this combination of factors is characterized by
morphologic, biochemical, molecular and biomechanical changes that result
in tenderness, joint pain, loss of range of movement, crepitus, effusion, and
inflammation (Creamer, Lethbridge-Cejku et al. 1997; Sharma, Kapoor et al.
2006).
It is suggested that the primary cause of OA may be the disruption of the
subchondral bone (Felson and Neogi 2004) with increased stiffness that
transmits more load to the overerlying cartilage (Bobinac, Spanjol et al.
2003). It is understood that the cartilage relies on the condition of the
underlying subchondral bone for its integrity (Creamer, Lethbridge-Cejku et
al. 1997; Hunter and Conaghan 2006). Articular cartilage has two main
functions – it absorbs impact by deforming under load, and it provides a
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smooth surface for joint movement.  If subchondral bone becomes too stiff, it
is no longer effective as a shock absorber and this in turn affects the
cartilage (Creamer, Lethbridge-Cejku et al. 1997).
Cartilage defects and the volume of subchondral bone are thought to be
associated with OA (Ding, Cicuttini et al. 2005) especially in those who are
obese. In people with OA, increased bone turnover in the arthritic joint,
decreased bone mineral content and stiffness, and a decrease in trabecular
bone have been observed in subchondral bone structure when compared
with normal bone, suggesting that bone metabolism may play a role in the
progression of OA (Wluka, Forbes et al. 2006).
Oestrogen has an effect on the tissues associated with OA of the knee (bone
cells, chondrocytes and synoviocytes) interacting with collagen synthesis,
bone stiffness and inflammation (Sowers, McConnell et al. 2006). Decreasing
oestrogen levels at menopause also appear to influence the occurrence of
OA. The incidence of the disease dramatically increases around menopause
(Sniekers, Weinans et al. 2008), suggesting that oestrogen possibly has
some protective effect. At 50 years of age, the ratio of the incidence OA in
females to males is 10:1 with the onset of symptoms occurring
perimenopausally or within 5 years of menopause (Roman-Blas, CastaÒeda
et al. 2009).
A further consequence of menopause is sarcopenia, or age related muscle
loss which is characterised by progressive loss of skeletal muscle fibres and
lean muscle mass (Leveille 2004) and its replacement by fat and connective
tissue (Hamerman 1997). Sarcopenia is thought to be a combination of
hormonal and immunological changes that occur with advancing age
(Poehlman, Toth et al. 1995). Cytokines that cause inflammation may also
play a role in the loss of muscle and its relationship with disability (Leveille
2004). It is associated with Vitamin D and oestrogen in women and
testosterone and physical activity in men (Leveille 2004). It appears the loss
occurs in fast twitch, or type 2 muscle fibres and aerobic type exercise is not
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effective in reducing this loss. Resistance, or strength training is required to
maintain or increase muscle mass and strength (Hamerman 1997).
There is a gradual decline in quadriceps strength associated with OA
(Suetta, Aagaard et al. 2007). Whether quadriceps weakness precedes the
development of OA or is a consequence of OA is not clear (Lewek, Rudolph
et al. 2004). Sensorimotor dysfunction is associated with the loss of function
and the evolving disability associated with quadriceps weakness, impaired
proprioception and impaired neuromuscular protective reflexes (Hurley
2003). It is suggested that in some cases quadriceps weakness precedes
pain and evidence of joint damage on X-Ray (O'Reilly, Jones et al. 1998).
Furthermore, the combination of muscle sensorimotor dysfunction, impaired
articular sensory input and impaired neuromuscular protective reflexes and
shock absorption capacity may be responsible for excessive, rapid, jarring to
joint loading during gait (Hurley 2003).
Studies of the association between ROM and limitation in physical activities
are scarce (Steultjens 2000). There is a natural decline in ROM with
advancing age, however the extent of the decline is not well documented
(Roach and Miles 1991). As with muscle weakness, ROM is also affected by
OA. Periarticular connective tissue becomes fibrotic, contracted or shortened
when the joint is inactive or immobilized due to the pain of OA, resulting in a
decline in ROM (Huang, Yang et al. 2005). In addition the muscles around
the knee may become shortened further adding to loss of range. After a
relatively short period of time – as little as 3 weeks, the muscles start to
become contracted causing instability of the joint (Huang, Yang et al. 2005).
The combination of instability, musculoskeletal impairments such as lower
limb weakness and a decline in ROM are related to function and disability,
thus lower extremity ROM, and lower limb muscle force are often predictors
of functional ability (Beissner, Collins et al. 2000; Steultjens 2000).
Inflammation may play a role in OA, and C-reactive protein has been found
to be raised in some people with OA (Conaghan 2002), however, sensitive
assays are required for accurate measurement of this phenomenon. The
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extent to which inflammation contributes to OA remains controversial and
there is still much that is not understood in relation to the overall cause of
OA.
Pain and Osteoarthritis
Pain, a topic that comprises a moderate proportion of the OAK program
(central to the studies that make up this thesis) is one of the most common
topics of discussion amongst those participants of the OAK studies; hence it
is discussed here at some length.  Pain is a symptom of OA that is often
reported and is usually the reason that people seek medical attention
(Conaghan 2002; Felson 2005). X-Ray imaging shows poor correlation
between pain and structural damage (Dieppe and Lohmander 2005),
however recent studies using MRI have shown that the site of pain correlates
with bone oedema and synovial hypertrophy (Conaghan 2002; Felson 2005).
Other associations with pain include knee effusions, synovial thickening, and
lesions such as tendonitis and bursitis.
One study using a non-anaesthetised subject undergoing arthroscopy of both
knees revealed interesting facts about pain within the knee joint. Although
the data were obtained from only one subject, both knees were subjected to
arthroscopy and the sensations were the same in both knees (Dye, Vaupel et
al. 1998). The most sensitive areas were identified as the ligament insertion
sites, synovium and patella fat pad. When probed, the patella was not found
to be sensitive, however the insertion of fluid into the patella caused great
pain which suggests that the pain associated with OA may be caused by an
increase in bone pressure (Felson 2005).
Although the process of pain sensation is not fully understood, it is thought
that pain in OA is the result of both local and central factors (Dieppe and
Lohmander 2005). There are two types of neurones responsible for the
sensation of pain. One neurone produces only nociception (pain) and the
other responds to both mild and acute pressure (Felson 2005). In addition, it
is thought that there is also disruption to the central nervous system
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perception of pain sensitivity (Kosek and Ordeberg 2000). Inflammation
influences the input from these neurons causing increased stimulation. The
increased stimulation has the effect of causing hypersensitivity, that is a
stimulus that was not previously painful becomes so, and the receptor field
enlarges so that there is a greater area to be stimulated (Kosek and
Ordeberg 2000; Felson 2005) resulting in a lower threshold for pain.
Cartilage does not contain pain fibres, but they are present in surrounding
structures such as ligaments, synovium, joint capsule, bone and bone
marrow and part of the meniscus (Dieppe and Lohmander 2005). Bone
marrow lesions are thought to be a strong predictor of OA progression
(Felson 2005; Hunter and Conaghan 2006) and bone marrow oedema is
associated with joints most likely to be painful. This association is not clearly
understood, however, using MRI there is evidence of osteonecrosis,
excessive fibrosis and extensive bony remodelling which may provide an
explanation for the prevalence of malalignment and bone marrow lesions
(Felson 2005).
As the disease progresses pain will occur frequently at night (Kosinski,
Janagap et al. 2007), and will become more chronic as the condition
deteriorates. Stiffness is a common symptom and may limit the initiation of
movement in the affected joint (Dieppe and Lohmander 2005). Eventually the
movement within the joint will become restricted until ROM is decreased
significantly, which may cause disability and impact on activities of daily living
such as walking or climbing stairs (Fransen and McConnell 2008).
There is a lack of information associating pain with the decline of function.
Two studies are of interest – the MAK study (Sharma, Song et al. 2001)
which recruited 237 people with primary knee OA and investigated the role of
malalignment and its  effect on pain and function; and the OASIS study
(Vignon, Valat et al. 2006) – a systematic literature review that aimed to
determine recommendations for certain activities for people with OA knee or
hip. Both studies found an association between pain and function, but the
results were not statistically significant when adjusted for SE interaction
22
(Sharma, Kapoor et al. 2006). In a systematic review describing the course of
deterioration, pain and function in OA, van Dijk, Deeker et al (2006) looked at
18 studies with long–term follow up of 3 years. The van Dijk, Deeker et al
(2006) team reported that most studies of the progression of OA focus on
radiological changes (where signs of radiological deterioration are common,
but the association between function and these changes is contradictory)
rather than on functional deterioration.  This is despite the fact that there is
limited evidence for the association between worsening pain and function
over time due to the lack of high quality studies (van Dijk, Deeker et al.
2006).
Van Dijk, Veenhof et al (2010) further examined the prognosis of limitations
in activities in OA of the knee or hip in a 3-year cohort study that aimed to
describe the course of limitations in activities of those people with OA knee
and hip with respect to function, co-morbidity and cognitive function (van Dijk,
Veenhof et al. 2010). Their findings suggested that on an individual (but not
group) level, prognostic factors for worsening function included an increase
in pain, reduced muscle strength, reduced ROM, and an increased number
of co-morbidities (van Dijk, Veenhof et al. 2010).
Diagnosis of Osteoarthritis
A clinical diagnosis of OA may be made based on the history of symptoms
and the association of pain that occurs with activities involving the effected
joint (Jordan, Kington et al. 2000). X-Rays are often used to establish a
diagnosis and monitor disease progression, however it is known that clinical
changes do not always correlate with changes on X-Ray (Dieppe,
Cushnaghan et al. 1997) and changes on X-Ray do not always reflect those
related to pain.
The Kellgren and Lawrence (1957) grading system suggests that X-Rays
should be read by the same observer or preferably by two observers in
consultation. This system is most commonly used to gauge OA using the
presence of osteophytes and the degree of joint space narrowing as markers
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of disease severity (Hunter and Conaghan 2006; Sharma, Kapoor et al.
2006). Joint space narrowing is due to loss of cartilage, and the presence of
osteophytes and joint space narrowing are typical findings on X-Ray,
however, some patients with established OA do not show progressive
changes on X-Ray over time.  In addition, the relationship among
osteophytes, joint space narrowing, pain and function is not proven, though it
is stronger with osteophytes than joint space narrowing. Knee pain has an
association with joint space narrowing which advances more rapidly in the
presence of pain (Hunter and Conaghan 2006).
Since the progression of OA is variable from person to person, X-Ray may
not be the most satisfactory method of gauging disease progression.
Magnetic resonance imaging (MRI) is more sensitive than X-Ray as it allows
the visualisation of soft tissue, subchondral bone and cartilage, including any
defects that may be present. It is used increasingly in the diagnosis of OA
(Ding, Cicuttini et al. 2005; Felson 2005; Hunter and Conaghan 2006). MRI is
useful as the surrounding structures within the joint are important factors in
understanding the pathogenesis and disease progression and can viewed
easily using this imaging method.
Pain is often a useful marker, and with reliable measures such as the
Western Ontario McMaster OA index (WOMAC) (Bellamy 2005), pain,
stiffness and function can be assessed to monitor disease progression
(Jinks, Jordan et al. 2002).
The Knee
Of special interest to the current studies is OA of the knee.  That being the
case, it is essential to examine the anatomy of this joint in some detail.
Moore and Dalley (2006) describe the knee as the largest and one of the
most complex joints in the body (Moore and Dalley 2006). It is a synovial joint
that is required to perform a number of complex manoeuvres, and compared
with the hip joint is relatively unstable because it is not well protected by
surrounding muscles. It has a hinge-like movement that allows flexion and
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extension with a degree of internal and external rotation when in flexion
(Moore and Dalley 2006).
The knee is the junction of two bones (the femur and tibia), the ends of which
are not in contact with each other but are covered with hyaline cartilage and
contained within a joint capsule. Surrounding the capsule are ligaments and
muscles that perform a stabilising function (Moore and Dalley 2006).
Synovial fluid lies within the joint capsule and allows the two ends of the
bones to move without friction. It is a complex fluid that can be thought of as
tissue in which the matrix consists of a transudate of plasma supplemented
by hyaluronans (Arden and Cooper 2005).
The knee joint gets its stability from the structures surrounding it, including
the capsule, ligaments and active muscle control (Williams, Chmielewski et
al. 2001; Moore and Dalley 2006). These structures prevent separation of the
two bones ends. To give stability, the cartilage that forms the menisci has a
natural tendency to expand, acting as a spacer within the joint and bringing
the capsule and ligaments under tension. The meniscii also distribute stress
across the joint and provide shock absorption (Brindle, Nyland et al. 2001).
The two opposing forces of the cartilage trying to push the bones apart, and
the capsule, ligaments and muscle preventing it, maintain the stability of the
structure. If the cartilage loses its volume or thickness or the ligaments
become slack or the muscles weaken, the joint will become unstable which
may lead to a risk of developing OA (Woo, Debski et al. 1999).  Conversely,
these events can also be a consequence of OA (Arden and Cooper 2005).
The knees form an important element of the main weight bearing structure of
the body and carry the load of many daily activities such as walking,
standing, getting up and down from sitting, and climbing stairs therefore
injury or OA can significantly effect activities of daily living (Moore and Dalley
2006).
The knee is commonly involved in OA with a prevalence of 34% in people
aged 65 years or older (March and Bagga 2004; Access Economics 2007;
Kadam and Croft 2007). As outlined earlier, it involves the entire joint and
25
includes loss of cartilage that is associated with changes to underlying bone
(growth of osteophytes and sclerosing or thickening of the bone), changes in
the soft tissue within the joint - including the synovium, ligaments and
muscles (Jordan, Kington et al. 2000).
The presence of OA in the knee compromises the ability to get up from a
chair, climb stairs and walk (McCarthy, Mills et al. 2004) and has more
negative effects on these activities than any other condition (Jordan, Kington
et al. 2000). OA is more debilitating when it occurs in the weight bearing
joints as it has a greater impact on mobility (Moore and Dalley 2006). People
suffering from OA of the knee are likely to be less active resulting in further
reduced joint mobility, strength, fitness, balance, and general health (Brady
2003; Sharma, Kapoor et al. 2006).
Nuesch, Dieppe et al (2011) examined the mortality of OA knee and hip in a
population based cohort study of 1163 people with a 14-year follow-up. The
authors highlighted the fact that very little is known about the mortality
associated with OA, and found that people with OA knee are at a higher risk
of death when compared with the general population. These authors claim
that the most striking finding is that people with walking disability are at an
even higher risk of death than those people with OA who are more active.
The authors suggest the possibility of two pathways accounting for this
association. The first is that the cardiovascular co-morbidity along with the
association of pain results in less physical activity and a greater use of non-
steroidal anti-inflammatory drugs. The second pathway is an association with
chronic inflammation that may be causally involved with cardiovascular
related disease. The authors suggest that the aim of OA interventions should
be to encourage people with OA to participate in a level of activity that meets
with the World Heath Organization guidelines. Furthermore, the authors
suggest than an aggressive approach to encouraging physical activity even
with painful OA seems justified (Nuesch, Dieppe et al. 2011).
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Management of OA
Increased physical activity and weight loss are an important part of the
management of OA. Combined, they will not only benefit the condition but
will improve muscle bulk, strength, balance, endurance and will reduce the
number of falls in the older members of the population (Elia 2001).
Additionally, physical activity and weight loss may also prevent the threshold
of disability being reached which will help to maintain functionality (Elia
2001). In this section, the various approaches to the management of OA will
be considered.
Exercise appears in many guidelines for the treatment of OA (Brosseau,
Robinson et al. 2003; Hurley 2003; Focht, Rejeski et al. 2005; Sharma,
Kapoor et al. 2006). Although there is consensus on the benefits of exercise,
many published recommendations are not supported by evidence (Roddy,
Zhang et al. 2005). Areas in need of supportive evidence include the
contraindications for exercise, predictors of response to exercise, ways of
increasing adherence and promoting physical activity, the role of exercise
and muscle strength in slowing the progression of the disease and the best
method of delivering exercise as an intervention in subjects with hip or knee
OA (Brosseau, Robinson et al. 2003; Roddy, Zhang et al. 2005).
According to a Cochrane Collaboration published review of exercise
regimens for OA of the knee, evidence of reduced pain and improved
function as an outcome are reported (Fransen and McConnell 2008).
However, neither the type nor intensity of exercise can be recommended
based on this review because of the large variation in exercise content in the
thirty-two programs included (Fransen, McConnell et al. 2001).
Regular exercise not only strengthens muscles and improves flexibility, it
also promotes cardiovascular fitness, reduces fatigue, improves vitality and
social functioning, and has been shown to be effective in decreasing anxiety
and depression (Westby 2001). Regular exercise does not appear to have a
detrimental effect on disease progression (Westby 2001; Hurley 2003).  The
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combination of diet and exercise is more effective than dieting alone and also
results in improvements in pain and physical function (Creamer, Lethbridge-
Cejku et al. 1997; Evans and Cyr-Campbell 1997; Focht, Rejeski et al. 2005).
The recommendation of the American College of Sports Medicine is that
resistance exercise is an important component of any overall exercise
program and that strength training is the only effective way to limit the effects
of sarcopenia (Roubenoff and Castaneda 2001) in the elderly (Evans and
Cyr-Campbell 1997; Hurley and Roth 2000).  Age related decline in muscle is
not inevitable, and skeletal muscle will adapt to the demands placed on it.
The more sedentary the lifestyle, the weaker the muscle will become
(Doherty 2003). Thus it appears that physical activity is a critical factor in
maintaining the structure and function of skeletal muscle (Kirkendall and
Garrett 1998). A Cochrane Collaboration review of 121 resistance training
trials for older people which included 6700 participants, concluded that
resistance training had small but significant results that translated into
improved physical function resulting in improvements in the performance of
simple activities such as walking, climbing steps, or standing up from a chair
(Liu and Latham 2009).
Indeed, strength training is also important in relation to endurance capacity.
As people age and become inactive, it may be that they are no longer able to
exercise in an aerobic capacity to the extent required to balance energy input
with output such that they can maintain a healthy weight and promote muscle
strength (Kirkendall and Garrett 1998).
Resistance type exercise not only increases muscle mass, but also has an
effect on energy balance in elderly people (Kirkendall and Garrett 1998).
People who participate in resistance training require 15% more energy to
maintain their body weight as a result of an increase in metabolic rate (Evans
and Cyr-Campbell 1997). Resistance type exercise is essential when elderly
people are trying to lose weight as it is the only form of exercise that will
preserve lean muscle mass (Doherty 2003). Since weight reduction is
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frequently included in guidelines in the treatment of OA (American College of
Rheumatology 2000), this fact should be carefully considered.
For older persons, performing resistance exercise two or three times per
week has been shown to reduce physical disability and improve function in
areas such as balance, gait, rising from a chair and climbing stairs (Liu and
Latham 2009). Resistance exercises have a large positive effect on muscle
strength, on aerobic capacity and on the reduction of pain in older people
with OA (Latham, Anderson et al. 2003).
Aerobic exercise has been recommended for the management of many
chronic diseases, arthritis being no exception. Both high and low impact
aerobic exercise are suggested as the intensity of exercise for the treatment
of OA does not appear to be significant (Brosseau, Robinson et al. 2003).
Walking results in the largest improvements in pain and physical activity,
depression improves with aerobic dancing, and disease activity improves
most with aquatic exercise (Bartels, Lund et al. 2007) while aerobic capacity
appears to improve with most forms of exercise but is greatest with cycling
(Westby 2001).  Thus it is suggested that an exercise regimen that includes a
variety of different aerobic activities would be optimal (Brosseau, Robinson et
al. 2003).
In a review of soft-tissue aging and musculoskeletal function, Buckwalter,
Woo et al (1993) describe age related changes to tendons and ligaments
that, like muscles, also undergo deterioration contributing to frailty and
disability (Buckwalter, Woo et al. 1993). These structures become stiff
resulting in a decrease in ROM and a subsequent decrease in functional
ability (Buckwalter, Woo et al. 1993). As tendons and ligaments become
fibrous with age, there is a decline in the mechanical properties of strength,
stiffness and their ability to withstand stresses (Nordin, Lorenz et al. 2001).
Flexibility exercises improve the mobility of contractile and non contractile
tissues such as ligaments and tendons (Cafiero and Maritz 2003).
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Feland and Myrer (2001) studied the effects of 3 different stretching routines
on 62 elderly subjects (mean age 84 years). They commented that most
studies have been focused on younger subjects with little literature available
on the effects of stretching on older subjects (Feland, Myrer et al. 2001).
Their findings suggested that stretching maintained for 60 seconds and
repeated four times per day for six weeks can result in a greater rate of
improvement in ROM in older people (Feland, Myrer et al. 2001). Although
stretches maintained for shorter durations also improved flexibility, the
benefits of holding the stretch for longer periods have been shown to be
greater (Feland, Myrer et al. 2001; Cafiero and Maritz 2003). Furthermore,
for the benefits of improved ROM to be maintained, stretching must be
continued over time.
Exercise in water is often recommended as a treatment for people with OA.
While short term benefits have been identified, no long term effects have
been proven (Bartels, Lund et al. 2007). The water is thought to relieve pain,
relax muscles and provide an environment where the effect of gravity on
joints is reduced. The resistance provided by water requires effort, so ROM
and to some degree, strengthening exercises may be performed in water.
Comparisons of land based exercise and exercise in water, have
demonstrated that both result in improvements in quadriceps strength,
walking speed and distance (Foley, Halbert et al. 2003; Silva, Valim et al.
2008). Hydrotherapy is useful as a form of aerobic exercise for people with
OA as the buoyancy of the water reduces joint loading, allowing increased
intensity of exercise. Hydrotherapy also has the added benefits of heating the
affected joint with pool temperatures being around 33 degrees Celsius. It is
thought that the soothing effect of the warm water relaxes muscles and
encourages a greater range of joint movement (Becker 2009).
Since OA is a condition that varies significantly in severity, exercise needs to
be individually prescribed according to age, extent of joint involvement and
co-morbidities (Roddy, Zhang et al. 2005). Exercise “dosage” is a factor of
frequency, intensity and duration and is also dependent on the individual’s
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level of exertion.  In addition, since exercise needs to be adhered to over the
long term for benefits to be maintained, it usually requires some kind of
supervision or monitoring (Fransen, McConnell et al. 2001).
Long-term adherence to exercise programs is difficult to achieve (Roddy,
Zhang et al. 2005). Perhaps this is because many of the exercise programs
do not mimic common lifestyle settings since they are often conducted in
tertiary health settings using sophisticated equipment and expert supervision
(Thomas, Muir et al. 2002). The attrition rate in such situations is linked to the
intensity of the exercise program, that is the higher the intensity the greater
the drop out rate, particularly in the long-term (Cox, Burke et al. 2003). It may
be that to encourage participants’ long term adherence, exercise programs
may need to be initially designed to be simple, easy to implement and
practical and of a lower intensity (Brosseau, Robinson et al. 2003; Marks and
Allegrante 2005). Explanations of the rationale for exercise, demonstrations,
and strategies to improve SE are necessary to encourage people to
participate in habitual exercise, with regular follow-up being necessary to
motivate people to continue long term (Hurley 2003; Marks and Allegrante
2005).
It is difficult to compare exercise regimens since there is a large degree of
variability between outcome measures, assessment techniques, frequency,
intensity and duration reported (Westby 2001). When determining significant
improvements in study populations, for those people who have mild to
moderate disease, the lack of severity of their OA makes it difficult to
demonstrate improvements. Commonly used outcome measures that use
self-reported pain and physical function questionnaires may exhibit a “ceiling
response”, and potential benefits in terms of increasing endurance capacity
will not be reflected in the results (Fransen, McConnell et al. 2001).
Balance
Falls occur in 30% of the population over the age of 65 years, and of these
20% will require hospitalisation (Gillespie, Gillespie et al. 2003). Many of
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those people who fall will not regain their former function and will become
disabled (Gillespie, Gillespie et al. 2003; Hill and Schwarz 2004).  In
Australia, the incidence of falling is considered to be serious enough to
warrant it being classified under the injury prevention national priority area
(Hill and Schwarz 2004). Given that balance is often compromised in people
with OA, the risk of falling represents a significant problem (Hinman, Bennell
et al. 2002). Quadriceps weakness, impaired proprioception along with the
other deficits associated with aging increase the risk of falls in those with OA
(Hinman, Bennell et al. 2002).
Balance requires that the centre of gravity remain within the limits of stability
within the base of support (Yim-Chiplis and Talbot 2000). Most activities of
daily living will require a combination of dynamic, static and reactionary
balance (Berg 1989). For example, standing on one leg will require good
static balance (maintaining the centre of gravity within the base of support
during standing or sitting) (Wooley, Czaja et al. 1997) and dynamic balance
(maintaining the centre of gravity within the base of support while moving)
(Wooley, Czaja et al. 1997). Reactive balance is a response to an external
disturbance and anticipatory balance is a reaction to an expected
disturbance (a bus slowing down to stop) (Yim-Chiplis and Talbot 2000).
The central nervous system is continuously involved in balance. The
cerebellum coordinates limb motion, postural sway, upright posture during
walking, generates the rhythmic motion and coordination involved in flexor
and extensor muscle activation, and is involved in reactionary and
anticipatory balance control (Morton and Bastian 2004). Sensory and motor
neurons are continually adapting and adjusting to sensory input.   It is widely
reported that strength training and exercise, including specific balance
exercises are beneficial for balance and falls prevention strategies (Gardner,
Robertson et al. 2000; Carter, Khan et al. 2001; Gardner, Buchner et al.
2001; Robertson, Devlin et al. 2001; Day, Fildes et al. 2002; Gillespie,
Gillespie et al. 2003; Liu-Ambrose 2004).
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Thermotherapy
Non-pharmacological treatment of OA often includes thermotherapy, usually
in the form of heat or ice packs applied to the affected area. In a review of
the physiological basis of cryotherapy and thermotherapy, Nadler et al (2004)
describes heat as relieving pain by relaxing muscles and improving
circulation to the area (Nadler, Weingand et al. 2004). Cold is thought to
reduce pain by promoting vasoconstriction thus blocking nerve endings
(Nadler, Weingand et al. 2004). Both methods of pain relief are easily utilised
in a home situation.
There is little solid evidence demonstrating that either heat or cold are
effective treatments for OA because of the difficulty associated with
conducting blinded trials, the small sample sizes and differing study designs
of the published studies (Brosseau, Yonge et al. 2003). Despite this the use
of thermotherapy and ice in particular is included in the OMERACT-OARSI
recommendations for the management of OA hip and knee (Zhang,
Moskowitz et al. 2008).
Ice appears to be more effective in relieving the symptoms of OA as well as
achieving a reduction in swelling, and a significant improvement in range of
motion and function (Brosseau, Yonge et al. 2003).The effect on pain is less
clear, although the combination of ice and massage has been shown to have
a significant effect on pain (Zhang, Moskowitz et al. 2008). Cold application
needs to be carefully monitored in order to avoid a rebound vasodilation
(Brosseau, Yonge et al. 2003). No significant improvements when using heat
packs have been reported.
Summary
OA is the most common form of arthritis. OA affecting the knee and is
considered to be a combination of different factors that result in both
biological and mechanical destabilization of the joint (Abramson and Attur
2009). It involves the entire joint and surrounding muscles ligaments and
cartilage within the joint capsule. It is thought that subchondral bone
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disruption causes increased stiffness that results in cartilage defects over
time (Felson and Neogi 2004) and is characterized by morphologic,
biochemical, molecular and biomechanical changes that produce symptoms
of tenderness, joint pain, loss of range of movement, crepitus, effusion, and
inflammation (Creamer, Lethbridge-Cejku et al. 1997; Sharma, Kapoor et al.
2006).
The most common joint affected is the knee (Access Economics 2007). OA
of the knees can be debilitating as the knees are load bearing joints that are
involved in many daily activities such as walking, standing, getting up and
down from sitting, and climbing stairs. Therefore OA of the knee can
significantly affect activities of daily living (Moore and Dalley 2006). This is an
important consideration because of the recent evidence demonstrating that
the mortality associated with OA knee is higher than that of the general
population and those people with OA knee who have walking disability are at
an even greater risk of early death than their more active counterparts with
OA (Nuesch, Dieppe et al. 2011).
Risk factors include: age, heredity factors, sports injuries, occupational risk
factors, obesity, and biomechanical factors (Australian Institute of Health and
Welfare 2005).
Diagnosis is by clinical symptoms, X-Ray, or MRI. X-rays provide information
mainly on bones with poor definition of cartilage and surrounding tissue
whereas MRI is capable of visualizing all structures within the joint.
Pain is a central feature of OA and is usually the reason that people seek
medical attention (Conaghan 2002; Felson 2005). Occurring frequently at
night (Kosinski, Janagap et al. 2007), it will become more chronic as the
condition deteriorates. Stiffness is also a common symptom limiting the
initiation of movement in the affected joint (Dieppe and Lohmander 2005)
and in some instances range of movement is decreased significantly, which
may cause disability and limit activities of daily living such as walking or
climbing stairs (Fransen and McConnell 2008).
34
Exercise and weight loss appear in many of the treatment guidelines for OA
(Brosseau, Robinson et al. 2003; Hurley 2003; Focht, Rejeski et al. 2005;
Sharma, Kapoor et al. 2006), with recommendations that aerobic, resistance,
flexibility and balance exercises be incorporated into an exercise regimen
(Hurley and Walsh 2009; Liu and Latham 2009). Resistance exercise is also
beneficial for age related muscle loss and the associated decline in balance
(Hinman, Bennell et al. 2002). Water based exercise is considered to be an
appropriate form of exercise for OA since the buoyancy of the water reduces
joint loading, allowing increased intensity of exercise and the soothing effect
of the warm water relaxes muscles and encourages a greater range of joint
movement (Becker 2009).  It is difficult to prescribe a precise exercise
regimen as there is a large degree of variability between outcome measures,
assessment techniques, frequency, intensity and duration, making
comparisons difficult in studies of exercise and OA (Westby 2001).
In the next section one approach to the management of OA, namely SM,
which has become increasingly important as a result of the work of Lorig and
Gonzalez (1992) will be examined.  The concept of SM is a major component
of this thesis.
Self-Management
SM consists of a number of different components and is considered to be
beneficial in the management of OA. Since it is an integral part of the OAK
program, both the theoretical framework and the individual elements that
constitute SM will be presented in some detail. Although the components of
SM vary depending on the chronic disease to which it is applied, those
discussed here are considered particularly relevant to OA.
Barlow (2002 p178) describes SM as the
“…individuals ability to manage the symptoms, treatment, physical
and psychosocial consequences and life-style changes inherent in
living with a chronic condition”
(Barlow, Wright et al. 2002), p178.
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In the 1980’s Kate Lorig and colleagues at Stanford University developed the
first SM program with a knowledge-based focus that was thought to result in
behaviour change (Lorig and Gonzalez 1992). However, once it became
apparent that education alone did not result in behavioural changes
(Newman, Mulligan et al. 2001) Albert Bandura’s Social Cognitive Theory
(Bandura 2001) was incorporated into the constructs of the Stanford SM
model.   The model was structured to enhance behavioural changes by the
use of goal setting, group interaction, modelling, and social persuasion (Lorig
and Holman 2003).  The program became known as the Arthritis Self
Management Program (ASMP).
As SM programs have evolved, the emphases within the programs have
developed differences depending on the chronic illness to which they are
directed.  The inclusion of an education component is important where the
chronic illness involves the use of medications (Newman, Steed et al. 2004;
Warsi, Wang et al. 2004; Chodosh, Morton et al. 2005). Self-management
interventions for OA that aim to teach patients how to manage their
symptoms and how to moderate day-to-day activities to suit their needs with
respect to their state of health, usually incorporate a considerable education
content (Pajares 1996). With arthritis SM, pain management is a priority,
along with physical and psychological functioning (Newman, Steed et al.
2004). The combination of SM and education compliments medical care and
is thought to enhance the overall management of OA (Von Korff 1997).
Health education, which is just one component of SM has a prolonged
benefit (up to 4 years) in reducing the pain of OA, and this result has been
replicated in a number of independent samples (Lorig, Sobel et al. 2001).
Research suggests that improvements of 20% in OA symptoms over and
above that attributable to medical management alone, can be achieved using
patient education interventions (Pajares 1996; Ettinger, Burns et al. 1997).
Despite the positive reports, SM programs have limitations.
These limitations are generally agreed to be attributable to several factors
mainly related to the lack of a strong research base for the use of SM.  Much
of the published data is based on post hoc mail outs to determine
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improvement (Lorig, Mazonson et al. 1993). Most do not have randomised
controlled study designs or have methodological problems (Lorig, Sobel et al.
1999; Barlow, Turner et al. 2000).  Additionally, volunteers recruited for SM
programs may themselves be motivated to succeed, and therefore may not
represent the general population (Taylor and Bury 2007).  Most importantly,
the precise mechanism related to any success of SM is not entirely
understood (Newman, Mulligan et al. 2001; Bodenheimer, Lorig et al. 2002).
In addition, there have been few papers published on the long-term effects of
SM (to 12 months). Barlow, Turner et al (1998) reported that people having
completed the ASMP in the UK experienced improvements at 12 months,
however, this was not a randomised controlled trial (Barlow, Turner et al.
1998). In fact, only three RCTs have followed patients’ long term progress
and each of these had mixed groups of rheumatoid arthritis and OA while
only two involved the use of the ASMP (Bodenheimer, Lorig et al. 2002;
Newman, Steed et al. 2004).  Thus it is difficult to suggest that SM for people
with arthritis has established benefits, even though SM programs, particularly
the ASMP are widely supported.
The OAK program, central to this present work, utilizes Bandura’s social
learning theory (Bandura 2001) which has a central concept of self-efficacy
and cognitive behavioural therapy (CBT) based on clinical psychology
approaches (Newman, Mulligan et al. 2001; Newman, Steed et al. 2004)
including self-talk, relaxation, guided imagery, and visualisation in its
theoretical framework.
In order for behaviour to change, several elements need to be present.
Initially, there must be a strong desire to perform or modify a behaviour and
few barriers to understanding and performing the behaviour. The individual
must have the skills required to undertake the behaviour, a belief that the
behaviour has value and that the change is desirable from an individual and
societal perspective (Elder, Ayala et al. 1999).  Thus, there must be an
element of readiness in considering the use of SM for particular chronic
disorders.
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Stages of Readiness for Self-Management
Some people respond better than others to SM. There are those who will
undertake behavioural changes inherent to SM, and those who will not.  It
has been suggested that for SM to be effective, those who attend programs
must be at a stage where they are receptive to the concepts of SM.
Von Korff (1997) and Keefe, et al (2000) describe 5 different stages of
readiness.
• Pre-contemplation: In this stage, people are often unaware that they
have a problem and are unlikely to modify their behaviour.
• Contemplation: In this stage, people are aware of their problem and
are contemplating taking action to improve their condition however,
they are not yet committed to take action.
• Preparation: This is a decision making stage. People are ready to take
action in the immediate future.
• Action: Efforts are made to make change. These people may already
have made changes to their behaviour.
• Maintenance: Changes have been made and these people are
working to maintain and stabilise their behaviour changes (Von Korff
1997; Keefe, Lefebvre et al. 2000).
The ability to identify people at these stages would be useful for improving
cost effectiveness by modifying existing SM programs to cater for peoples’
needs during these stages. To recruit people at the Preparation, Action and
Maintenance stages and to include strategies to identify those people who
are at a stage where they would most benefit from SM may be a more
effective use of resources. Additionally, these stages may also be a useful
predictor of early drop out and responder success (Keefe, Lefebvre et al.
2000).
Bandura (2005) has a slightly different perspective on stages of readiness.
He describes three stages. The first stage includes people who are highly
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motivated. They have high levels of SE and also have positive expectations
for behaviour change.  Bandura (2005) suggests that these people will
succeed in accomplishing their goals with only minimal guidance (Bandura
2005).
People in Bandura’s (2005) second stage have far more self-doubts. They
will make half hearted attempts at behavioural change, are quick to give up,
and are unsure about the benefits of the activities they are attempting. They
need more guidance and support in order to succeed.  Individuals in the third
stage have little chance of success if left on their own. Far more guidance
and encouragement are required, as they believe that their health is beyond
their control, and that attempts at SM and behaviour change are futile. They
will need constant guidance and encouragement.  However, they may
succeed if small goals are achieved – leading to improved feelings of SE
(Bandura 2005).
Recently, SM has become more comprehensive, and information as well as
both practical and psychological issues have been added to the content of
SM programs (Newman, Mulligan et al. 2001). The concept of SE, based on
Albert Bandura’s social cognitive theory (Bandura 2003), is central to many
SM programs.
Social Cognitive Theory
Bandura’s theory, formulated in 1986, differed from the current theorists’
views of the day in that it suggested that internal influences, or the
individual’s perception of their own ability, was the most important
determinant of success, whereas other theories placed the emphasis on
external or environmental forces. (Pajares 2002; Stone 2003). Bandura is
one of the chief proponents of SE. He believes that it is the prime motivator
underlying successful SM because people need to believe that the actions
they undertake will produce the desired outcomes - otherwise there is little
incentive to act or persevere (Bandura 2005).
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The components of arthritis SM programs, that is, goal setting, problem
solving, pain management techniques, and modelling, are thought to result in
improved SE (Newman, Steed et al. 2004). This is significant because not
only does SE predict health outcomes, it also allows people to manage their
condition without altering the disease itself.  It achieves this by allowing the
person to have a heightened sense of confidence and a feeling of greater
control (Bandura 2005).
Education alone is not enough to result in behavioural changes (Newman,
Mulligan et al. 2001) and SE beliefs are themselves critical factors in how
well knowledge and skill are acquired initially (Pajares 2002). While SE is a
powerful determinant of success, people still require skills and knowledge to
achieve their goals, that is the information needs to be considered important
and valuable before it is acted upon (Gist and Mitchell 1992).
Confident people expect that they will have positive outcomes. SE will
influence the choices that people make and also how much effort they put
into an activity (Bandura 2004). The higher their sense of SE, the longer they
will persevere when faced with obstacles and the more resilient they will be
when faced with adversity. Quick and easy success will not promote
resilience. Those who overcome obstacles through perseverance will
become stronger and will be more likely to stick to activities and rebound
after setbacks. Problem solving is thought to help provide people with the
skills necessary to overcome setbacks without giving up (Bandura 2001).
SE will affect cognition and emotional reactions. Those with high levels of SE
will face a problem as a challenge to be mastered rather than viewing it as an
insurmountable hurdle. With success, will come enhanced levels of SE
(Pajares 2002). Having internal or self-motivation is likely to result in greater
success in achieving desired outcomes than being externally motivated (told
to do something by another). It also results in more motivation to initiate
relevant activities (Tillema, Cervone et al. 2001; Williams, McGregor et al.
2004). Self-initiation of behaviours likely to improve health outcomes results
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in a greater feeling of control, enhanced SE and better long-term adherence
to changes in health behaviour (Williams, McGregor et al. 2004).
SE is identified as one of the factors that predict improved physical function
over time especially in combination with weight loss, exercise and pain
control.  It is suggested that these factors need to be address when treating
OA (Sharma, Cahue et al. 2003).
A key element of Bandura’s social cognitive theory is that individuals have
self-beliefs that allow them to exercise control over their thoughts and actions
(Bandura 2001). It is these self-beliefs that are the essence of SE. Bandura’s
theory states that certain cognitive capabilities are influential in the process
of determining control.
Pajares (2002) in an overview of social cognitive theory describes self-beliefs
in the following terms:  the capacity to symbolise, forethought, vicarious
learning and self-regulation (Pajares 2002).  Symbolising allows the
extraction of meaning from cognitive things. It allows the storage of
information that will help in decision making later on, and it allows learning
from the modelled behaviour of others. Forethought allows for planning a
course of action, anticipation, and solving problems. Forethought permits the
anticipation of consequences without actually engaging in the behaviour.
Vicarious learning (related to Bandura’s (1998) vicarious learning and to
modelling) is so effective because through vicarious learning, information can
be gained that will be useful for future action. Experience is acquired without
actually undergoing the behaviour and learning can occur without making
mistakes. If the modelled behaviour is valued, it will be adopted and repeated
in the future.  Self-regulatory mechanisms include self-evaluation of
behaviour and actions that allow modification or changing the course of
action. It also includes self-reflection which allows people to make sense of
their experiences and to alter behaviour and thinking as necessary (Pajares
2002).
These processes are involved with cognition, motivation, affect and selection.
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SE beliefs determine how people think, motivate themselves, feel and
behave (Bandura 1994). Many people have the knowledge, education and
motivation to undertake SM, but do not succeed in performing the necessary
behavioural changes in their daily life due to a lack of SE (Schreurs, Colland
et al. 2003).
Pajares (2002) in his overview of social cognitive theory also describes the
formation of SE beliefs from four primary sources that include: mastery
experience, vicarious experience, social persuasion and mood. Pajares
(2002) suggests further that mastery experience is the assessment of action
taken based on previous performance.  These results assist in the
development of beliefs about capabilities relating to the outcome of the
performance. Bandura (1998) states that the most effective way of
strengthening the sense of SE is through mastery experiences (Bandura
1998). Usually a good outcome will result in higher SE and a poor outcome
will result in lower SE (Pajares 2002). In other words, SE will improve as
success is achieved in tasks that have been attempted.
Vicarious experience also promotes robust SE. Observing similar people
succeed raises the onlooker’s perception of their own abilities (Bandura
1998). The onlooker however, needs to perceive that the person modelling
the behaviour has similar attributes to themselves, and that the activity will
benefit them. Modelling sends messages through which people can learn
skills and behaviour (Bandura 1999) and in SM programs, leaders are able to
model behaviour themselves in the anticipation that participants will
undertake these behaviours.
SE beliefs are developed as a result of social persuasion. Social persuasion
is also used in SM, and persuaders (group facilitators) play an important role
in the development of individuals’ self-beliefs (Pajares 2002). Group
influences can enhance participant’s beliefs in themselves, which will enable
participants to boost their efforts and be more likely to succeed in activities
(Bandura 1998).
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Mood also influences SE (Pajares 2002). Depression leads to poor
performance, whereas a positive mood enhances the feeling of SE (Bandura
1998). Similarly, affect will also influence success and may play a role in
setting SE perceptions and the standards of tasks attempted. Depression
may lead to setting higher standards that slightly exceed the scope of SE
expectations that ultimately become self-defeating (Bandura 1999). Even
with familiar tasks, people who are depressed may set higher standards for
performance than normal, which may inevitably lead to failure to complete
the task (Tillema, Cervone et al. 2001).
With a poor sense of SE, new activities will promote a heightened sense of
anxiety, which may result in dwelling on inadequacies, and perceived
environmental dangers (Pajares 2002). Thus worry about possible threats is
likely to have an adverse effect on functioning (Bandura 1994). With a
stronger sense of SE, bold and threatening activities are more likely to be
viewed as a challenge rather than a threat. This sense of efficacy will also
determine what goals are undertaken and the extent of motivation to achieve
them (Bandura 2001).
Because pain is often a significant feature of OA, pain management
becomes an essential element of SM programs.  The next section will
consider this element.
Although SE is accepted as an important component of many SM programs,
including arthritis there are critics of its assumed importance. Taylor and Bury
(2007) suggest that there is no clear evidence to indicate that SE is
responsible for changes in health status, and that the role SE plays may be
overstated (Taylor and Bury 2007). These same authors question whether
SE is an independent variable relating to SM capability, and also question
whether SE is a cause or a result of coping well with a chronic illness. Both
Taylor and Bury  (2007) and Newbould, et al (2006) cite Lorig’s 1999 chronic
diseases SM trial that studied 952 people over 6 months (Lorig, Sobel et al.
1999).   Both papers point out that although there were improvements in SE,
there was not a corresponding improvement in “physiological well-being”
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(Newbould, Taylor et al. 2006; Taylor and Bury 2007). Rogers et al (2008) in
their review of The United Kingdom’s Expert Patients Programme (EPP) that
uses Lorig’s Chronic Disease SM Program nationwide, also questions the
role of SE as an outcome rather than a process and the importance of it in
relation to SM (Rogers, Kennedy et al. 2008). Indeed, Williams (2010)
suggests that despite the commonly perceived notion that SE is responsible
for changes in expected outcomes, the reverse may in fact true, that is, the
expected outcomes that a person perceives will influence their degree of SE
(Williams 2010).
Cognitive Behavioural Therapy
Sleep disturbances, depression, fear and decreased cognitive responses
such as poor memory and concentration often present in people with chronic
pain. For this reason, CBT fits into the SM model. CBT can be described as
being based on the principle that thought processes influence feelings and
behaviors. Identifying negative thought processes and learning to replace
them with positive ideology and strategies is central to CBT (Backman 2006).
Strategies to enhance SE, manage stress and negative emotions, develop
knowledge, skills, and problem solving are taught using goal setting,
education, relaxation, and cognitive techniques such as self-talk, distraction,
visualisation and coping techniques (Backman 2006).
Being able to identify differences in an individual’s pain perception and
subsequent reactions to pain is important in the effective delivery of
treatment (Eccleston 2001). People with chronic pain tend to become
excessively attentive to the prospect of pain and the spinal cord becomes
sensitised causing increased excitability and larger receptive fields (Kosek
and Ordeberg 2000). This continual attention to pain has the potential to
result in increased levels of disability and distress. It also translates to a fear
of performing certain activities, because of the expectation of pain and
ultimately results in a chronic decrease in activity associated with an increase
in disability (Eccleston 2001). Encouraging a gradual increase in activity in
combination with CBT promotes an improved sense of control and SE,
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reduced pain, and improved mood (Turner-Stokes, Erkella-Yuksel et al.
2003). Goal setting, a common component of SM, will often include a gradual
increase in activity in tandem with CBT techniques.
The treatment of chronic pain with CBT is complex, lengthy, and variable, but
never the less, an effective therapy (Morley, Eccleston et al. 1999). Self-
management and CBT can be effective treatments in reducing pain, disability
and distress, however, these therapies are associated with a significant drop
out rate with certain individuals (Kerns and Rosenberg 1999). It is suggested
that people with chronic pain go through different stages of receptiveness,
and that this will identify those people more likely to respond to SM and CBT.
Those who are not at a receptive stage will be less likely to participate or
respond to the therapy and are more likely to drop out.
Elements of SM programs
SM programs are generally based on a number of principles.  These include
the fact that they are best conducted in groups, with emphasis placed on
goal setting, self regulation and problem solving.
Group Effect on Self-efficacy
Bandura (1994) suggested that the strength of groups can be a unifying
factor so that improvements can be made on a united front.  The collective
beliefs of group efficacy will influence what the group chooses to do, how
much effort the group puts into achieving a goal, their endurance when
collective group efforts fail to produce quick results, and their likelihood of
success (Bandura 1994).
This is an important concept in the context of SM, which in terms of arthritis
is usually in a group format. Not only does SE affect an individual’s success,
it also has a powerful impact on group dynamics and the influence the group
has on each individual within that group (Bandura 2001). Group dynamics
are such that they will effect an individual’s performance and the group’s
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enthusiasm will encourage people to achieve more than they may have on
an individual basis (Choi, Price et al. 2003).
Goal Setting
Goal setting is designed to enable completion of small tasks or behaviour
changes. As goals are achieved there is a heightened sense of wellbeing
and improved SE. The combination of goal setting and group persuasion is
likely to have a positive effect on SE provided the goals are achievable. The
content of SM programs can be designed to promote situations where
success is likely, thus enhancing feelings of triumph and consequently SE
(Bandura 1994). Goal setting is an important factor in SM as it encourages
health related behaviour as part of the process, with the associated
achievement of goals enhancing SE.
Self-Regulation
Self-regulation is a concept that is also integral to SM. It underlies the
efficacy of SM. Since SM is aimed at making people their own health
managers, self-regulation plays an important role because at some point
people have to incorporate health information and disease management into
their own personal goals (Karoly 1993). Self-regulation is very much involved
with the process of striving for and achieving goals (Maes and Karoly 2005).
It is at this point that behavioural changes take place.
SM requires the exercise of motivational and self-regulatory skills which
includes self-monitoring of health-related behaviour and feelings of well
being, developing goals and the strategies to achieve them, and the
resolution to maintain the achievement of these goals long term (Bandura
2005). Maes and Karoly (2005) describe goal setting as setting the stage for
self-directed change and implementation strategies that convert goals into
productive actions, with maintenance strategies that help to sustain achieved
behavioural changes (Maes and Karoly 2005). Teaching self-regulated
motivation and activities through goal setting encourages attempts for higher
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achievements (Bandura 1999).  Goal setting motivates progression in the
right direction, rather than staying in the comfort zone.
Self-observation is an important part of self-regulation. It serves to provide
information necessary for setting goals and it allows evaluation of progress
towards that goal (Bandura 1991). To achieve behavioural change it is
essential to reflect and observe behaviour and assess the progress attained
towards the selected goal. A comparison is then made, usually with the
achievements of others or to the group. Past attainments will have some
influence on SE, but usually in terms of the goal being to improve on the past
achievement (Bandura 1998). The achievement will need to involve some
effort, otherwise it will be undervalued and little effort will be expended. This
self-regulation has the effect of providing incentive for behaviour and setting
the standard for the goal. It helps to motivate people to continue to set more
challenging goals.
Problem Solving
Lorig (2003) in her overview of SM education describes chronic illness as
being problem orientated. This being the case, problem solving is an
important component of SM programs (Lorig and Holman 2003). Problem
solving involves identifying problems, making decisions, taking appropriate
actions, and altering these actions as circumstances change. It is seen as an
essential part of the SM process that actively involves both education and
treatment (Toobert and Glasgow 1991). Successful problem solving skills
build the resilience necessary to overcome obstacles and thus enhances SE.
Summary
The prevalence of chronic disease is increasing as the population ages. OA
of the knee is a widespread chronic condition and one of the leading causes
of disability (Walker-Bone, Javaid et al. 2000).
OA affects 1.62 million Australians (Access Economics 2007) and the
prevalence over the age 65 years is 19% in men and 32% in women
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(Australian Institute of Health and Welfare 2005). As there is no cure for OA,
its management is primarily concerned with controlling the pain and
improving function and health-related quality of life.
The burden of chronic disease impacts heavily on health expenditure and the
shift towards patients having responsibility for their own management has
evolved into an increasing acceptance of SM programs. It encourages a
transfer of responsibility from health professionals to the individual (Newman,
Mulligan et al. 2001; Fries, Lorig et al. 2003; Solomon and Lee 2003). Self-
management is considered to be beneficial in the management of chronic
illnesses including OA (Lorig, Sobel et al. 2001; Hootman, Sniezek et al.
2002).
Self-management models vary according to the chronic disease. Some
depend on health professionals for leadership and others utilize lay leaders.
Stanford University’s ASMP (Stanford Patient Education Center ; Lorig,
Mazonson et al. 1993) is considered to be the gold standard for arthritis SM
despite the limited nature of the supporting evidence (Warsi, LaValley et al.
2003; Chodosh, Morton et al. 2005). Lay leaders who are considered to be
experts, as many of them have chronic conditions themselves, deliver ASMP
programs.  Such programs are necessarily based on generic content thus
are not disease specific.  In addition, participants in any given group are
likely to have different arthritic conditions.
Recommendations for future SM have included the use of health
professionals (Taylor and Bury 2007; Rogers, Kennedy et al. 2008)  and the
inclusion of disease specific education to be incorporated into SM constructs
(Hill, Mangovski-Alzamora et al. 2009).
This thesis will introduce a new SM program that is disease specific and
utilizes the knowledge and skills of health professionals for program delivery.
This SM program is designed for people with OA of the knee and is known as
the OAK Program. Chapter 3 contains the publications associated with the
examination of the value of the OAK Program.
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CHAPTER 3
Publications
The four papers that describe the studies that form the basis of this thesis
are presented in this chapter.  Two of these papers have been published and
the other two have been submitted for publication.  Papers 1 and 3 described
the protocol of the two studies and Papers 2 and 4 present the results.
Study 1 (Papers 1 and 2) examined the OAK Program versus a no treatment
control group.  Study 2 (Papers 3 and 4) tested the OAK Program against an
established SM program, the ASMP.
The two studies were carefully designed so that
1. The groups being compared were homogeneous.  That is all
participants had a diagnosis of OA of the knee.  This is an important
point as in previous published studies of SM programs for arthritis,
little attention has been paid to the diagnosis of arthritis among
participants.
2. Participants were randomized to groups.
3. Assessors were blind to group allocation and used the same
standardized assessment tools.
4. Follow-up was for an extended period of time.  For Study 1, the follow-
up was for six months and for Study 2, the follow-up was for 12
months.  The extended follow-up period has not previously been
described in the literature.
5. In both Study 1 and 2, the OAK Program was delivered by health
professionals.  In Study 2, in keeping with the protocol of the ASMP,
the program was led by lay leaders.  This provided the opportunity to
compare the effect of leaders with different attributes.
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Because of the requirements of publication, the introductions and
background sections of the papers tend to contain some repetition of
information.  The results and discussion sections of Papers 2 and 4 clearly
report the outcomes of the studies.
The contribution of co-authors is clearly stated at the end of each paper.
Copyright permission is not required as the two published papers are in an
“Open Acess” journal, BMC Musculoskeletal Disorders Journal – that is they
are freely available for download by the public. Copyright information can be
found at: http://www.biomedcentral.com/info/about/license
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ABSTRACT
Introduction. To determine whether a disease specific SM program for people
with OA of the knee (the OAK program), implemented by health
professionals, would achieve and maintain clinically meaningful
improvements in health related outcomes compared with a control group.
Methods. Medical practitioners referred 146 participants with OA knee.
Volunteers with coexistent inflammatory joint disease or serious co-
morbidities were excluded.
Interventions: Randomisation was to either control or OAK groups. The OAK
group completed a 6-week SM program. The control group had a 6-month
waiting period before receiving the OAK program.
Measurements: Assessments occurred at baseline, 8-weeks and 6-months.
Primary outcomes: WOMAC, SF-36, VAS pain, timed up and go (TUG).
Secondary outcomes: knee range of motion, quadriceps and hamstring
strength- isometric contraction.
Response to treatment (responders) and minimal clinically important
improvements (MCII) were determined.
Results. In the OAK group, VAS pain improved during the 8-week clinic
phase, mean (SE) 5.21 (0.30) to 3.65 (0.29) p=<0.001. Responses to
treatment were demonstrated in WOMAC pain, physical function and total
dimensions. In the SF-36, Physical Function, Role Physical, Body Pain,
Vitality and Social Functioning domains improved in the OAK group
compared with the control group. The proportion of MCII was greater among
the OAK than the control group for all outcomes. Hamstring strength
significantly improved in both legs compared with the control group. TUG
test, range of motion extension and left knee flexion improved when
compared with the control group, although these improvements had little
clinical relevance.
Conclusions: Participants in the OAK program recorded significant
improvements in pain, quality of life and function at 8-weeks and 6-months
compared with a control group.
Trial registration ACTR: 12607000080426
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Introduction
Osteoarthritis (OA) is the most common form of arthritis and the third leading
cause of life years lost to disability (March and Bagga 2004; Access
Economics 2007; Kadam and Croft 2007). It affects 10% of the population
and is more common in women than men.  By age 65 years 50% of the
population will have OA (March and Bagga 2004) and as the population
ages, the prevalence of OA is expected to rise. The knee is a commonly
affected joint with a prevalence of 30% in people aged 65 years or older.
Self-management (SM) is considered to be an effective strategy in the
treatment of chronic illnesses, including OA (Chodosh, Morton et al. 2005).
Numerous SM programs have been developed for different illnesses such as
diabetes, hypertension, asthma, and arthritis. Various models, both disease
specific and generic have been employed including individual, group-based,
postal and internet programs (Warsi, Wang et al. 2004). Most arthritis SM
programs use lay leaders delivering a scripted program.  Face-to-face
interaction with health professionals is an important component of some
programs, especially where medication compliance is considered relevant.
A number of studies have examined the effectiveness of SM for people with
arthritis. One systematic review of SM interventions for various chronic
diseases found a trend towards a small benefit from arthritis programs, the
majority being the Stanford University’s “Arthritis SM Program” (Stanford
Patient Education Center) (ASMP) or derivatives of the ASMP, but the results
were not significant and a suggestion of publication bias was noted (Warsi,
Wang et al. 2004). A comparison of lay leaders versus health professional
leaders has also been published (7), however the study required all leaders,
both lay and health professionals to deliver the same scripted program,
limiting the capacity for the knowledge and skills of the health professionals
to be optimally utilised (Cohen, van Houten Sauter et al. 1986). Given the
design of the study, it was not surprising that no differences were
demonstrated. Despite the popularity of lay led SM programs for arthritis and
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taking into account possible cost advantages, Taylor and Bury (2007)
suggest that such programs have little or no advantage in terms of improved
SE or on the management of chronic illness (Taylor and Bury 2007).
Although lay leaders have the potential to be role models (as they often have
musculoskeletal conditions themselves), health professionals with their
knowledge and skills can also have a powerful influence as models.
Modelling has the potential to transmit knowledge and skills to which people
may aspire particularly if the information is perceived to be important and
relevant, resulting in behaviour change that is more likely to be maintained
long term (Bandura 1994). This platform for behaviour change is constrained
because of the limited knowledge of lay leaders.
SE is an integral component of SM, and resilience goes hand in hand with
SE. Resilient people tend to have well developed SE and when confronted
with an obstacle will see it as a hurdle to overcome rather than an
insurmountable problem. Furthermore, they are more likely to persist for
longer when repeated problems are encountered (Bandura 1998). Those
who attempt and succeed will benefit in terms of improved SE.
Factors influencing SE such as problem solving, pain management, exercise,
modelling, social persuasion, weekly goal setting, and cognitive therapy are
interconnected. Pain management is important because often people are
hesitant to undertake new activities for fear of pain, regardless of whether
pain has previously been experienced with that particular activity. Many
people with OA rely on medication for pain relief but are reluctant to take
medication because of possible side effects. Such people prefer to be aware
of the pharmacologic and treatment options available and then decide on a
course of management. However, if knowledge about the available options is
lacking the treatment choices are more limited and, importantly, this may
have an impact on adherence to treatment (Mitchell and Hurley 2008).
The lack of demonstrated benefits related to SM in arthritis suggests an area
that requires alternative models of SM to be proposed.  This paper reports on
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the evaluation of an SM program for people with OA of the knee (the OAK
program) designed to be delivered by health professionals.
OAK Program
The OAK program differs from other arthritis SM programs in a number of
aspects. It is a disease specific OA SM education program designed for
delivery by health professionals. Its theoretical framework uses Social
Cognitive Theory (Bandura 2001) to enhance participant’s SE and promote
long-term changes in behaviour. Results from an uncontrolled quality
assurance study of the OAK program were positive in terms of improvement
in pain, quality of life, and physical function (Coleman, Briffa et al. 2008a). It
was designed specifically for people with OA of the knee and for
implementation in a community based setting - thus removing the burden of
health care from tertiary institutions. The education component of this
program is detailed, so delivery by health professionals is more appropriate
than delivery by lay leaders. Principles and theories of SM are used to
promote behavioural change in a multifactorial format. In particular, exercise
and disease coping strategies are promoted within a SM construct as a
means to improve quality of life, general health and to reduce pain.
Health professionals delivering the program are required to have the
necessary knowledge and skills to present information about OA of the knee
and respond accurately to complex questions. The fidelity of the OAK
program is maintained by the use of a facilitators’ manual with modules for
program delivery each week designed specifically to maintain consistency
and accuracy of the information delivered.
The OAK program is conducted in a group setting with six weekly sessions of
2.5 hours each. Attendance is voluntary, however participants are
encouraged to attend all sessions. The program is designed so that
participants will progress over time by incorporating and consolidating
information learned from week to week. In addition to the weekly sessions,
participants are given printed information relevant to the course component
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discussed each week. To facilitate optimum group dynamics, the target
group size is 12 participants.
The program takes an holistic approach including multiple aspects of care:
• OA – explanation and implications;
• SM skills (goal setting, problem solving, modelling, positive thinking,
improving SE);
• medication (type, interactions, current trends);
• correct use of analgesia (use of, therapeutic dosing, types of
analgesia, side effects);
• pain management strategies (cognitive and pharmacological);
• fitness and exercise (strength, flexibility, aerobic and balance);
• joint protection;
• nutrition and weight control;
• falls prevention - balance/proprioception, environmental risks,
polypharmacy, and
• coping with negative emotions.   Watch caps and punctuation in such
a list.
People with OA may initially resist physical activity due to discomfort, fear of
pain, or previous advice to avoid exercise (Hootman 2003; Bennell and
Hinman 2005). Many believe that exercise will result in bone and cartilage
loss and are therefore resistant to exercise in general (Bennell and Hinman
2005), yet avoidance of activity is known to contribute to disability long term
(Steultjens, Dekker et al. 2002). The OAK program includes general
information about benefits of exercise and specific advice on joint protection
during exercise for those with OA of the knee. The program aims to
maximize the benefits of physical activity and promote long-term adherence
to an exercise regimen by using structured exercise participation that is
linked to weekly “SMART” goals (Siegert, McPherson et al. 2004) (Specific,
Measurable, Attainable, Realistic, Time bound). The program offers the
added reassurance that health professionals are on hand to give advice, and
the group dynamics offers incentive for participants to comply and maintain
the exercise regimen. Participants’ success with meeting goals each week
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increases SE (Roos 2002), which is the strongest and most consistent
predictor of physical activity behaviour and its maintenance long term (Eyler
2003). Although exercise features strongly in the OAK program, it is not an
exercise school. Exercise is only one component and it is up to each
individual to decide how much emphasis they will give to exercise from week
to week during the program.
Cognitive symptom management strategies are encouraged to help eliminate
“negative” symptoms associated with OA.  Such negativity not only affects
individual symptom control, but also contributes to and exacerbates the
symptoms of OA (Kidd, Langford et al. 2007). Guided imagery, relaxation
techniques, positive self-talk, and problem solving are taught to participants.
These enable them to understand how such influences contribute to their
symptoms and provide the necessary skills to prevent them becoming an
overwhelming negative influence. Health professionals also use their
knowledge to assist participants with problem solving to overcome hurdles
and promote resilience (Bandura 2001).
Objective of the Study
To determine whether a disease specific SM program for people with OA of
the knee (the OAK program), implemented by health professionals, would
achieve and maintain clinically meaningful improvements in health related
outcomes compared with a control group.
This study was approved by the Human Research Ethics Committee at
Curtin University of Technology (HR141). Data access and storage was in
keeping with National Health and Medical Research Council guidelines
(Australian Government 2009). License agreements were obtained for the
SF-36 and WOMAC questionnaires.
The study design adhered to CONSORT guidelines and intention to treat
principles. This trial was registered with the Australia and New Zealand
Clinical Trials Registry, no: 12607000080426. The protocol has previously
been described in greater detail (Coleman, Briffa et al. 2008b). Amendments
to the trial protocol included analysis to determine participant’s response to
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treatment (responders). This was necessary to meet the requirements
suggested in the OMERACT-OARSI guidelines (Pham, van der Heijde et al.
2004). In addition, the proportion of people attaining minimal clinically
important improvements (MCII) was determined.
Methods
Study Design
A two group randomised (ratio 1:1), controlled repeated measures study, was
used to examine between group differences in change over time.
Convenience sampling was employed. The research sample was selected
from those who were referred to the program. Suitable candidates were
invited to enrol in the OAK program. Those who agreed to participate and
provided written informed consent were randomised either to an OAK group
(immediate start) or a control group (delayed start). For ethical reasons those
participants randomised to the control group were offered the OAK program
at the conclusion of the six-month study. Independent of the study, all
participants were allowed to continue with standard medical management for
knee OA. Figure 1 shows the design of the study and the time points at
which the outcome measures were recorded.
Participants
One hundred and forty-six participants (37 male and 109 female) with
established OA knee, of mean (SD) age 65 (8) years, were enrolled into the
study. Inclusion and exclusion criteria are listed in Table 1.  All participants
who were recruited from the Perth metropolitan area and immediate
surrounds, provided written informed consent prior to enrolment.
Socio-economic status was estimated according to residential postcodes
using a method developed by the Australian Bureau of Statistics – “The
Index of Relative Socio-Economic Disadvantage” (Australian Bureau of
Statistics 2001). The index provides a weighted value with a low index value
representing disadvantage and a high index value representing advantage
(Table 2).
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During the recruitment phase the OAK program was actively promoted to
general practitioners, rheumatologists and health professionals through
professional societies and to the general public through advertising and
media coverage. Invitations were also extended to those people with OA of
the knee who made general inquiries to Arthritis Western Australia. The OAK
program was conducted at Arthritis Western Australia, a community setting
that is close to public transport and has available infrastructure to run the
program and co-ordinate the study. This project was funded with in-kind
support from Arthritis Western Australia. The research undertaken was
independent from the funding body.
Randomisation and Blinding
Participants were allocated to study groups using simple randomisation
performed in batches of approximately 24 depending on recruitment success.
Once a group of 24 volunteers had been recruited, they were randomised to
OAK or control groups. Twenty-four pre-made cards (12 intervention and 12
control) in sealed opaque envelopes were placed in a box. An envelope was
drawn from the box by an independent person to determine group allocation.
Blinding of participants was not possible due to the nature of the intervention;
however, the physiotherapists performing the assessments did not
participate in the facilitation of the OAK program so were blind to group
allocation.  To maintain blinding they were asked not to discuss group
allocation with the participants during assessments.
Outcome Measures:
The outcome measures included both primary and secondary measures.
Primary measures.
• Health status; measured using the self-administered WOMAC OA
index for OA of the knee (WOMAC LK3.0) (Bellamy 2002; Bellamy
2005).
• Quality of life; measured using the Short Form 36v1 (SF-36)
questionnaire (Kantz, Harris et al. 1992; Ware, Kosinski et al. 2002).
• VAS pain (Melzack and Katz 1994; Creamer, Lethbridge-Cejku et al.
1999) was assessed at weekly intervals in the OAK group during the
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delivery of the OA knee program from baseline to the 8-week
assessment. The control group completed VAS pain scores at
baseline and at week 8. (See Figure 1: Study Design Flow Chart).
• Functional mobility was assessed using a modified “Timed Up and
Go” test (TUG) (Podsiadlo and Richardson 1991; Vellas, Wayne et al.
1997; Huxham, Goldie et al. 2001). For this study the addition of
ascending and descending a 15cm step was added to the outward
walk. Two measurements were performed and the average of these
measurements was used for analysis.
Secondary measures.
• Range of motion of the knee joints; measured using a long-armed
goniometer (Gogia, Braatz et al. 1987; Watkins 1991).
• Isometric strength of the hamstrings and quadriceps muscles;
measured at 90 degrees of knee flexion using a Mecmesin Force
Gauge Dynamometer (Bohannon 1986). Each knee was measured 3
times. The first (practice) measurement was excluded. The 2
subsequent measures were averaged for analysis.
Statistical Power Calculation
An a priori power calculation based on the quality of life outcome as
measured by the SF-36 (Ware, Kosinski et al. 2002) was undertaken. The
SF-36 was chosen as it is the least sensitive and requires greater sample
size to detect changes in treatment differences with respect to pain and
physical functioning in people with OA (Davies, Watson et al. 1999). Sample
size was calculated according to guidelines in the SF-36 Users Manual, to
determine differences in changes over time between the intervention and
control groups using a repeated measures design allowing an inter temporal
correlation between scores of 0.60 (Ware, Kosinski et al. 2002). Previously,
the OAK program quality assurance study SF-36 data showed an average
difference of 10 points across the 8 domains measured (Coleman, Briffa et
al. 2008a). Assuming this level of improvement was likely to be achieved in
the OAK group and no change in the control group and allowing for a 10%
drop out rate, the number of participants required per group would be 60
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(Ware, Kosinski et al. 2002). In the quality assurance study, the drop out rate
was 5% over 3 years, so allowing 10% was a conservative estimate.
Differences in changes in functional ability measured using the WOMAC,
similar in magnitude to those previously documented (Fransen 2001) would
also be detectable in a sample of this size.
Data Analysis
Data were analysed in a blinded manner using SPSS v17 for Macintosh.
Treatment groups were examined for comparability at baseline. Despite
randomisation, there were between group differences in severity at baseline.
Therefore baseline values (as recorded in Table 2) were used as covariates
in the analyses (Overall and Ashby 1991). This has the effect of the pre-
intervention mean (SE) values being the same at baseline in both groups.
Main comparisons between groups were performed using an intention to
treat analysis. All participants were encouraged to attend follow-up
measurements regardless of the level of attendance. Where data were
missing the previous value was carried forward. To test the effects of
treatment, between group differences in changes over time (baseline, 8-
weeks and 6-months) were examined using repeated measures ANCOVA. A
separate analysis was conducted for each outcome variable.
For secondary analyses, a favourable response to treatment (responder) was
as defined in the OMERACT-OARSI criteria (Pham, van der Heijde et al.
2004). We used scenario D: An improvement of ≥50% and an absolute
change of ≥20 points on a 100 point scale in pain or function, OR an
improvement of at least two of the following: An improvement of ≥20% and
an absolute change of ≥10 in two of pain, function and global health.
However as patient’s global health was not recorded in this study only the
pain and function section of the second alternative were available.
Furthermore, the proportion of participants achieving MCII independently in
health status, quality of life, pain, and the TUG test were computed for each
group at each observation time.
The criteria for minimal clinically important improvements are (Tubach,
Ravaud et al. 2005):
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• Health status using WOMAC physical function (0 to 100)
o absolute change:  –9.1
o percent change:  –26.0
• VAS Pain
o absolute change:  –1.99
o percent change:  –40.8
• Quality of life using SF-36 (pain and physical function domains)
o absolute change:  +5 points
• TUG
o percent change:  -9
The proportion of participants achieving MCII and responder criteria was
computed for each group at each observation time. Chi-square test was used
to examine the effect of the treatment, in terms of the proportion of MCII and
responders. Statistical significance was inferred at a 2-tailed p<0.05. Results
were not adjusted for multiple comparisons as all outcomes of interest were
nominated a priori and such adjustment would likely render all findings of
interest, despite their clinical importance, non-significant (Perneger 1998).
Results
Table 2 shows the number, characteristics and distribution of all subjects.
The male to female ratio was not significantly different between groups (Chi-
Square 2.311(1,146) p=0.182). Sixty-eight participants from each group
completed the program and returned for the follow-up assessments at 6-
months. All participants included in the analyses attended at least 4 of the 6
SM sessions. The mean (median) attendance in the OAK group was 5.77 (6)
sessions. The reasons cited for withdrawal were overseas relocation, work,
family, and time commitments, and not being randomised to the OAK group.
Participants from the highest socio-economic group were over represented
and approximately 90% had co-existing disease (Table 2).
Mean Differences
Primary measures
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WOMAC pain, physical function and total scores improved significantly more
in the OAK group when compared with the control group (Table 3).  The
advantage in between-group difference in change was evident at post-
treatment and 6-months follow-up in the physical function and total scores,
however by 6-months the improvement in pain was comparable between
groups.
There were improvements from baseline to 8-weeks in the SF-36 scales
Physical Function, Role Physical, Body Pain, Vitality and Social Function in
the OAK group compared with the control group. These differences were
maintained at 6-months (Table 3).
In the OAK group, VAS pain decreased 30% during the 8-week intervention
phase [mean (SE) 5.21 (0.30) to 3.65 (0.29) p=<0.001], while the control
group had a 17% increase in pain [5.27 (0.30) to 6.19 (0.32) p=<0.001]
during the same period. The difference in the mean change between groups,
baseline to week eight, was 2.54 cm (95%CI 1.66 to 3.41).
TUG results showed a significant improvement in the OAK group compared
with the control group post- intervention and at 6-months, however the
improvement was small (Table 4) (van Iersel, Munneke et al. 2008). An MCII
for TUG was observed in 3 times as many OAK group participants as control
group participants at 8-weeks (OAK: 46 and control group: 15), however this
ratio was appreciably lower at 6-months (OAK: 38 and control: 26).
Secondary measures
Hamstring strength improved in both right and left legs in the OAK group
compared with the control group. In the right hamstrings there was a 34%
improvement post-intervention and a 29% improvement at 6-months. In the
control group, improvements of 10% post-intervention and 14% at 6-months
were achieved. Similar improvements were observed in the left hamstrings
(Table 4). Despite the significance of these results, they have little clinical
meaning due to the limited magnitude of the improvement. There was no
significant difference between groups in quadriceps strength in either left or
right legs.
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Small increases in range of motion were observed. Extension in both knees,
and flexion in the left knee in the OAK group improved significantly compared
with the control group, however these improvements also were of
questionable clinical significance due to the magnitude of the improvement.
Responders
Following the intervention, the proportion of responders at 8-weeks in the
OAK group was more than 3 times that of the control group (Table 5). At this
post-treatment assessment 26 people from the OAK group and 8 from the
control group were classified as responders according to the pre-specified
criteria for response to treatment (Tubach, Ravaud et al. 2005). There were
more responders in the OAK group than in the control group at 6-months,
however the proportion of responders was lower in both groups and the
difference between groups was not statistically significant.
Minimal Clinically Important Improvements
The OAK group had a greater proportion of MCII’s in all outcome measures
at all time-points when compared with the control group. The differences
were significant for all variables apart from SF-36 pain at 8-weeks and 6-
months and physical function at 6-months (Table 5). The proportion of MCII’s
between the OAK and control groups was greatest immediately post
intervention. In the OAK group approximately 3 times as many participants
were observed to achieve a MCII compared with the control group at 8-
weeks and almost twice the number at 6 months.
Discussion
In this RCT we have demonstrated that participants in a SM program
specifically designed for people with OA of the knee and delivered by health
professionals experienced improvements in a number of health domains that
people with OAK have identified as important problems associated with their
condition (Tallon, Chard et al. 2000).
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SM aims to motivate people to undertake the changes in behaviour
necessary to improve their condition. The priorities of people with OA knee
have been identified as problems with pain and activities of daily living and
their preference is to actively manage their condition (Tallon, Chard et al.
2000; Mitchell and Hurley 2008). The OAK program was designed as a
community based SM education program that aims to improve pain, function
and quality of life and empower people to address these preferences with the
support of health professionals who have expertise in this area. The OAK
program incorporates education with an emphasis on OA related information
and the benefits of exercise within SM constructs to promote improved SE
and changes in behaviour. Utilising the knowledge and skills of health
professionals is a chief component of the OAK program because knowledge
is an important part of SE in that no amount of confidence will produce
success unless the required knowledge and skills are present (Pajares
2002).
The mechanisms involved in successful SM are not well understood. The
highly structured nature of the intervention may be important and other non-
specific mechanisms such as group dynamics may be contributory.
Nevertheless, there appears to be consensus that the efficacy is likely to be
due at least in part to increased adherence to medications (Chodosh, Morton
et al. 2005). It should be noted that in the OAK program, educational material
concerning pharmacological therapy and pain relief are included in the
syllabus.
WOMAC and SF-36 questionnaires are both tools that can demonstrate
improvements in pain and in patients overall health status (Angst,
Aeschlimann et al. 2001), however in people with OA, WOMAC is more
sensitive to change in pain and physical function than SF-36 (Davies,
Watson et al. 1999). Improvements in pain scores demonstrated in the VAS
were reflected in WOMAC and SF-36 in the OAK group when compared to
the control group and they were maintained to 6-months. Similarly, a greater
proportion of responders were demonstrated at both 8-weeks and 6-months
in the OAK group, when compared with the control group.
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Determining the value patients place on improvements in pain can be
difficult. In response to rofecoxib or ibuprofen improvements of 9% to 10% in
WOMAC scores were perceptible to patients with OA knee (Bellamy, Bell et
al. 2005). The OAK group demonstrated improvements in WOMAC pain of
23% pre to post intervention and 13.7% pre intervention to 6-months. By
contrast at the same time-points the control group had improvements in
WOMAC pain of 2.3% and 7%.
One limitation of the study was that it compared a treatment program with a
no-treatment control group.  Therefore the only blinding that could be
maintained was assessor blinding, an important consequence of which is the
risk of reporting, attrition, and other types of bias.  In addition, self-reporting
of pain may be affected by bias, as patients are keen to “do well” and to
please health care providers by reporting an improvement when there may
not have been one. Moreover, the perception of the efficacy of the treatment
by the health care providers may influence how the patients perceive their
pain and result in improved pain rating (Hirsh, Atchison et al. 2005)
suggesting that the bias related with no-treatment control groups is generally
underestimated (Hrobjartsson and Gøtzsche 2004).
As with pain, there were significant improvements in quality of life and
function in the OAK group compared to the control group, with improvements
seen in WOMAC and SF-36 maintained to 6-months. Physical improvements
were also maintained at 6-months when compared with the control group.
Self- reported functional outcome measures tend to be influenced by pain, so
it is important to have functional as well as self-reported outcome measures
as the combination gives a more realistic appraisal of functional ability than
self-reported outcomes alone (Boonstra, De Waal Malefijt et al. 2008).
The control group also demonstrated improvements in many outcomes. It is
difficult to explain these improvements other than in terms of patient health
care provider interactions at assessments. Patients in untreated control
groups may interact with health care providers and Hrobjartsson and
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Gøtzsche (2004) suggest that the possibility of patient-provider interaction
could have clinically useful effects (Hrobjartsson and Gøtzsche 2004). Within
group improvements were evident in WOMAC (stiffness and total scores),
SF-36 (physical function, role physical, general health, vitality and role
emotional), and TUG over time.
The significant improvements seen in hamstring strength, but not quadriceps
strength are difficult to explain. The OAK program is not an exercise school
and although participants are encouraged to exercise, the exercises are
delivered within a SM format that requires individuals to adopt an exercise
regimen that best meets their needs.
These results reflect the improvements seen in a previously reported quality
assurance study testing the OAK program (Coleman, Briffa et al. 2008a). The
use of a more rigorous study design further strengthens the earlier findings.
The combined information should prove useful for planning future models of
SM in arthritis and although the use of health professionals as facilitators will
add to the costs there is only weak evidence to support SM programs that
use lay leaders. Cost analysis was not within the scope of this study. Future
research comparing the OAK program with a lay lead SM program will be a
useful step in determining the most effective model.
The highest socioeconomic group was over represented in this study. It is
possible that the study results may overstate the likely impact on the wider
community, as there is the potential that people with higher education levels
may have better outcomes. Arthritis WA is located in a middle class area,
and previous attempts were made to recruit from lower socio-economic
areas, with limited success. Strategies for outer metropolitan and rural clinics
were discussed and may be pertinent for future studies.   Moreover, self-
initiated enrolment may produce a potential bias as those people who
volunteer may already be predisposed to SM (Newbould, Taylor et al. 2006;
Taylor and Bury 2007).
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Conclusions
In participants with OA of the knee, statistically significant improvements in
pain, quality of life and function were observed in the group randomised to an
OAK intervention program delivered by health professionals, compared to
those randomised to a control group. The number of participants achieving
MCII and responder criteria at 8-weeks and 6-months in the OAK group
compared with the control group adds strength to these findings.
Abbreviations:
OAK: OA of the knee program
MCII: Minimal clinically important improvement
TUG: Timed up and go test
OA: OA
SM: SM
ASMP: Arthritis SM Program
The authors declare that they have no conflicting interests.
Authors’ contributions:
SC collected the data. SC and KB were responsible for data analysis and
writing the manuscript. GC, CI, NC and JM assisted with study design and
provided comments on the drafts and all authors approved the final version
of the manuscript.
Acknowledgements: Special thanks to Hannah Goldstone for assistance with
data entry and Jessica Rose for editorial assistance.
Supported by Arthritis Western Australia
78
1. March L, Bagga H: Epidemiology of OA in Australia. Medical Journal of
Australia 2004, 180:S6-10.
2. Access Economics: Painful Realities: The economic impact of arthritis in
Australia in 2007. Canberra: Arthritis Australia; 2007.
3. Kadam U, Croft P: Clinical comorbidity in OA: Associations with physical
function in older patients in family practice. Journal of Rheumatology
2007, 34(9):1899-1904.
4. Chodosh J, Morton S, Mojica W, Maglione M, Suttorp M, Hilton L, Rhodes
S, Shekelle P: Meta-analysis: chronic disease SM programs for older
adults. Annals of Internal Medicine 2005, 143:427-438.
5. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: SM education
programs in chronic disease. A systematic review and methodological
critique of the literature. Archives of Internal Medicine 2004,
164(15):1641-1649.
6. Arthritis SM (Self-Help) Program
[http://patienteducation.stanford.edu/programs/asmp.html]
7. Cohen J, van Houten Sauter S, DeVellis R: Evaluation of arthritis SM
courses led by lay persons and by health professionals. Arthritis and
Rheumatism 1986, 29:388-393.
8. Taylor D, Bury M: Chronic illness, expert patients and care transition.
Sociology of Health & Illness 2007, 29(1):27-45.
9. Bandura A: Self-efficacy. Volume 4. New York: Academic Press; 1994.
10. Bandura A: Health promotion from the perspective of social cognitive
theory. Psychology and Health 1998, 13(4):623-649.
11. Mitchell H, Hurley M: Management of chronic knee pain: A survey of
patient preferences and treatment received. BMC Musculoskeletal
Disorders 2008, 9(123).
12. Bandura A: Social cognitive theory: An agentic perspective. Annual
Review of Psychology 2001, 52:1-52.
13. Coleman S, Briffa K, Conroy H, Prince R, Carroll G, McQuade J: Short and
medium-term effects of an education SM program for individuals with
OA of the knee, designed and delivered by health professionals: a quality
assurance study. BMC Musculoskeletal Disorders 2008, 9(117).
14. Hootman JM, Macera, C.A., Ham, S.A., Helmick, C.G., Sniezek, J.E.:
Physical activity levels among the general US adult population and in
adults with and without arthritis. Arthritis and Rheumatism 2003,
49(1):129-135.
15. Bennell K, Hinman R: Exercise as a treatment for OA. Current Opinion in
Rheumatology 2005, 17(5):634-640.
16. Steultjens M, Dekker J, Bijlsma J: Avoidance of activity and disability in
patients with OA of the knee. Arthritis & Rheumatism 2002, 46(7):1784-
1788.
17. Siegert R, McPherson K, Taylor W: Toward a cognitive-affective model of
goalsetting in rehabilitation: is self-regulation theory a key step?
Disability and Rehabilitation 2004, 26(20):1175-1183.
18. Roos E: Physical activity can influence the course of early arthritis. Both
strength training and aerobic exercise provide pain relief and functional
improvement. Lakartidningen 2002, 99(45):4484-4489.
79
19. Eyler AA: Correlates of physical activity: Who's active and who's not?
Arthritis and Rheumatism 2003, 49(1):136-140.
20. Kidd B, Langford R, Wodehouse T: Current approaches in the treatment
of arthritic pain. Arthritis Research & Therapy 2007, 9(3):214-221.
21. Nat iona l  Hea l th  and  Medica l  Research  Counc i l
[http://www.nhmrc.gov.au/privacy.htm]
22. Coleman S, Briffa NK, Carroll G, Inderjeeth C, Cook N, McQuade J: Effects
of SM, education and specific exercises, delivered by health
professionals, in patients with OA of the knee. BMC Musculoskeletal
Disorders 2008, 9:133.
23. Pham T, van der Heijde D, Altman R, Anderson J, Bellamy N, Hochberg M,
Simon L, Strand V, Woodworth T, Dougados M: OMERACT-OARSI
Initiative: OA Research Society International set of responder criteria
for OA clinical trials revisited. OA and Cartilage 2004, 12:389-399.
24. Australian Bureau of Statistics: Census of Population and Housing: Socio-
Economic Indexes for Area's (SEIFA). Australian Bureau of Statistics;
2001:1-90.
25. Bellamy N: WOMAC OA index: User guide. Queensland: CONROD, The
University of Queensland; 2002.
26. Bellamy N: The WOMAC knee and hip OA indices: development,
validation, globalization and influence on the development of the
AUSCAN hand OA indices. Clinical and Experimental Rheumatology 2005,
23(Suppl.39):148-153.
27. Ware JE, Jr, Kosinski MA, Gandek B: SF-36 Health Survey Manual &
Interpretation Guide. Lincoln RI: QualityMetric Inc; 2002.
28. Kantz ME, Harris WJ, Levitsky K, Ware JE, Jr, Davies AR: Methods for
assessing condition specific and generic functional status outcomes after
total knee replacement. Medical Care 1992, 30(5):240-252.
29. Creamer P, Lethbridge-Cejku M, Hochberg MC: Determinants of pain
severity in knee OA: effect of demographic and psychosocial variables
using 3 pain measures. Journal of Rheumatology 1999, 26(8):1785-1792.
30. Melzack R, Katz J (Eds.): Pain measurement in persons in pain. London:
Churchill Livingstone; 1994.
31. Podsiadlo D, Richardson S: The timed "Up and Go": a test of basic
functional mobility for frail elderly persons. Journal of American Geriatric
Society 1991, 39(2):142-148.
32. Vellas B, Wayne S, Romero L, Baumgartner R, Rubenstein L, Garry P: One-
legged balance is an important predictor of injurious falls in older
persons. Journal of American Geriatric Society 1997, 45:735-738.
33. Huxham F, Goldie P, Patla A: Theoretical considerations in balance
assessment. Australian Journal of Physiotherapy 2001, 47:89-100.
34. Watkins MA, Riddle, D.L., Lamb, R.L., Personius, W.J.: Reliability of
goniometric measurements and visual estimates of knee range of motion
obtained in a clinical setting. Physical Therapy 1991, 71(2):90-96.
35. Gogia P, Braatz JH, Rose SJ, Norton BJ: Reliability and validity of
goniometric measurements of the knee. Physical Therapy 1987, 67(2):192-
195.
36. Bohannon R: Test-Retest Reliability of Hand-Held Dynamometry During
a Single Session of Strength. Physical Therapy 1986, 66(2):206-209.
80
37. Davies M, Watson DJ, Bellamy N: Comparison of the responsiveness and
relative effect size of the Western Ontario and McMaster Universities
OA Index and the Short-Form Medical Outcomes Study Survey in a
randomized, clinical trial of OA patients. Arthritis Care and Research
1999, 12(3):172-179.
38. Fransen M, Crosbie, J., Edmonds, J.: Physical therapy is effective for
patients with OA of the knee: a randomised controlled clinical trial.
Journal of Rheumatology 2001, 28(1):156-164.
39. Overall J, Ashby B: Baseline corrections in experimental and quasi-
experimental clinical trials. Neuropsychopharmacology 1991, 4(4):273-281.
40. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N,
Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M:
Evaluation of clinically relevant states in patient reported outcomes in
knee and hip OA: the patient acceptable symptom state. Annals of
Rheumatic Disease 2005, 64:43-47.
41. Perneger T: What’s wrong with Bonferroni adjustments. British Medical
Journal 1998, 316:1236.
42. van Iersel M, Munneke M, Esselink R, Benraad C, Olde Rikkert M: Gait
velocity and the Timed-Up-and-Go test were sensitive to changes in
mobility in frail elderly patients. Journal of Clinical Epidemiology 2008,
61(2):186-191.
43. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N,
Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M:
Evaluation of clinically relevant changes in patient-reported outcomes in
knee and hip OA: the minimally clinically important improvement.
Annals of Rheumatic Disease 2005, 64:29-33.
44. Tallon D, Chard J, Dieppe P: Exploring the priorities of Patients with OA
of the Knee. Arthritis Care and Research 2000, 13(5):312-319.
45. Overview of social cognitive theory and self-efficacy
[http://www.emory.edu/EDUCATION/mfp/eff.html]
46. Angst F, Aeschlimann A, Steiner W, Stucki G: Responsiveness of the
WOMAC OA index as compared with the SF-36 in patients with OA of
legs undergoing a comprehensive rehabilitaion intervention. Annals of
Rheumatic Disease 2001, 60(9):834-840.
47. Bellamy N, Bell M, Goldsmith CH, Pericak D, Walker V, Raynauld J-P,
Torrance G, Tugwell P, Polisson R: The effectiveness of hylan G-F 20 in
patients with knee OA: an application of two sets of response criteria
developed by the OARSI and one set developed by OMERACT-OARSI.
OA and Cartilage 2005, 13:104-110.
48. Hirsh A, Atchison J, Berger J, Waxenberg L, Lafayette-Lucey A, Bulcourf B,
Robinson M: Patient Satisfaction With Treatment for Chronic Pain.
Predictors and Relationship to Compliance. Journal of Clinical Pain 2005,
21:302–310.
49. Hrobjartsson A, Gøtzsche P: Is the placebo powerless? Update of a
systematic review with 52 new randomized trials comparing placebo
with no treatment. Journal of Internal Medicine 2004, 256:91-100.
50. Boonstra MC, De Waal Malefijt MC, Verdonschot N: How to quantify knee
function after total knee arthroplasty? The Knee 2008, 15(5):390-395.
51. Newbould J, Taylor D, Bury M: Lay-led SM in chronic illness: a review of
the evidence. Chronic Illness 2006, 2:249-261.
81
Table 1:  Eligibility criteria
Inclusion criteria Exclusion criteria
English speaking Co-existing inflammatory arthritis
Aged 18 years or over Serious co-morbidity
Diagnosis of OA (X-Ray or clinical Dx) Scheduled knee replacement in < 6 months
Referral from GP or Specialist Cannot meet program time-points
Able to meet program requirements
Figure 1: Study Design Flow Chart and evaluation tools used at each
assessment. N=number of participants included in the data analyses. This
includes values from returned posted questionnaires from non-attendees and
last value carried forward for other missing data.
Recruitment
Enrolment &
telephone screening
Randomisation
N=146
OAK group
N=71
Control group
N=75
Pre-intervention Assessment
N=70
Pre-intervention Assessment
N=74
OAK
(6 weeks)
Usual management
(6 months)
Week 8 assessment
N=69
Week 8 assessment
N=70
6 month assessment
N=68
6 month assessment
N=68
Assessments at
each time-point:
WOMAC
SF-36
VAS pain (wk1-8)
Strength:
Hamstring/quads
Knee ROM:
Extension/flexion
Timed up and go
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Table 2: Characteristics of participants enrolled in OAK program
Control OAK
Age mean (SD) 65 (8.7) 65 (7.9)
Gender (M:F) (23:52) (14:57)
Socio-Economic Index by Post Code
(Australian Bureau of Statistics 2001)
Index measured in quintile ranges Number (%)
Top 25% 43 (57) 46 (65)
50-75% 10 (13) 9 (13)
25-50% 6 (8) 8 (11)
10-25% 11 (15) 6 (8)
Bottom 10% 5 (7) 2 (3)
Co-existing disease Number (%)*
Total number 156 156
Cardiovascular 48 (64) 56 (79)
Gastrointestinal 17 (22) 21 (29)
Musculoskeletal (other than OA knee) 32 (43) 12 (17)
Mental Health 6 (8) 7 (10)
Endocrine 18 (24) 13 (18)
Osteoporosis 8 (11) 8 (11)
Other 27 (36) 39 (55)
None 9 people (12%) 6 people (8.5%)
Multiple coexisting diseases 49 people (65%) 43 people (60%)
Mean (SD) incidence per person 2.39 (1.4) 2.43 (1.65)
* Percentage adds to >100 as some participants have more than one coexisting
disease
Unadjusted baseline values Mean (SD) Control and OAK groups
SF-36 Control OAK p value
Physical Function 43.98 (21.2) 50.41 (22.2) .078
Role Physical 28.38 (36.6) 40.00 (39.7) .070
Body Pain 42.00 (19.1) 49.73 (19.0) .016
General Health 64.81 (17.2) 65.05 (18.4) .936
Vitality 52.70 (21.0) 55.86 (16.4) .321
Social Function 69.43 (26.1) 75.54 (22.1) .133
Role Emotional 57.66 (43.1) 66.19 (42.6) .235
Mental Health 74.92 (15.1) 75.94 (14.8) .683
WOMAC Pain 8.00 (3.6) 6.53 (3.7) .020
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Table 3: Results for primary outcomes: WOMAC and SF-36: pre-intervention (baseline), post-intervention (8-weeks) and 6-months.
Repeated measures ANCOVA with baseline value of the dependent variable as the covariate; Data are estimated marginal mean (SE)
with the mean (95% CI) difference of change between the groups at each time-point.
OAK Control
Dif ference in change
between groups
Difference in change
between groups
Variable
#O A K  &
Control
Pre
Intervention 8wks 6mths 8wks 6mths
Pre to 8
wks
95% Confidence
intervals
Pre to 6
mths
95% Confidence
intervals
WOMAC
Pain* 7.1 (0) 5.5 (0.3) 6.1 (0.3) 7.0 (0.3) 6.7 (0.3) -1.46 -2.18 to -0.73 -0.49 -1.26 to 0.28
Stiffness 3.6 (0) 3.1 (0.2) 3.1 (0.2) 3.6 (0.1) 3.4 (0.2) -0.50 -0.91 to -0.08 -0.29 -0.73 to 0.15
Physical Function* 24.1 (0) 19.1 (0.7) 19.9 (1) 24.4 (0.7) 23.4 (0.9) -5.55 -7.38 to -3.31 -4.35 -6.20 to -0.91
Total* 34.9 (0) 27.7 (1.0) 29.2 (1.2) 34.9 (1) 33.3 (1.2) -7.23 -9.98 to -4.49 -4.08 -7.47 to -0.68
SF-36 (0 to 100)
Physical Function* 48.0 (0) 54.1 (1.4) 54.2 (1.9) 48.5 (1.4) 48.5 (1.9) 5.61 1.84 to 9.37 5.67 0.40 to 10.93
Role Physical* 35.7 (0) 47.9 (4.0) 46.0 (4.8) 30.8 (4.0) 38.6 (4.8) 17.06 5.90 to 28.21 7.37 -5.93 to 20.67
Body pain* 46.3 (0) 51.2 (1.9) 50.8 (2.1) 44.0 (1.9) 44.8 (2.2) 7.19 1.93 to 12.44 6.06 0.04 to 12.07
General Health 65.8 (0) 69.2 (1.3) 69.6 (1.7) 67.1 (1.3) 66.0 (1.7) 2.11 -1.45 to 5.67 3.59 -1.19 to 8.37
Vitality* 54.7 (0) 59.0 (1.5) 60.7 (1.7) 53.0 (1.5) 56.0 (1.8) 6.02 1.87 to 10.16 4.72 -0.11 to 9.55
Social Function* 73.8 (0) 83.0 (2.2) 77.8 (2.6) 72.3 (2.1) 72.7 (2.6) 10.72 4.81 to 16.62 4.07 -2.08 to 12.22
Role Emotional 61.7 (0) 73.7 (3.9) 70.8 (4.5) 68.5 (3.9) 69.4 (4.5) 5.18 -5.64 to 16.00 1.35 -11.06 to13.76
Mental Health 75.8 (0) 77.0 (1.3) 78.5 (1.5) 74.9 (1.3) 74.7 (1.5) 2.08 -1.42 to 5.58 3.85 -0.21 to 7.91
*p value <0.05 for baseline to 6months.
#Pre-intervention values are the same in both groups when using the baseline as a covariate
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Table 4: Results for secondary outcomes: quadriceps, hamstring strength, knee joint range of motion and TUG.
Pre-intervention (baseline), post-intervention (8-weeks) and 6-months using repeated measures ANCOVA with baseline value of the dependent variable as the
covariate; Data are estimated marginal mean (SE) with the mean (95% CI) difference of change between the groups at each time-point.
OAK Control
Difference in change
between groups
Difference in change
between groups
Variable
#OAK &
Control
Pre
Intervention 8wks 6mths 8wks 6mths
Pre to
8wks
95% Confidence
intervals
Pre to
6mths
95% Confidence
intervals
Muscle Strength (kg)
L Quadriceps 18.9 (0) 20.3 (0.5) 19.6 (0.7) 18.6 (0.5) 18.1 (0.7) 1.65 0.34 to 2.95 1.58 -0.31 to 3.47
R Quadriceps 18.0 (0) 19.6 (0.5) 18.9 (0.7) 17.8 (0.5) 18.2 (0.7) 1.79 0.33 to 3.24 0.66 -1.37 to 2.69
L Hamstring* 8.0 (0) 10.1 (0.3) 9.5 (0.4) 8.6 (0.3) 8.8 (0.4) 1.47 0.63 to 2.30 0.74 -0.31 to 1.79
R Hamstring* 7.6 (0) 10.2 (0.3) 9.8 (0.4) 8.4 (0.3) 8.7 (0.4) 1.80 0.89 to 2.70 1.18 0.06 to 2.29
Range of Motion (degrees)
L Knee Flexion* 125 (0) 126 (0.8) 126 (0.9) 123 (0.8) 123 (0.9) 2.80 0.58 to 5.02 2.26 -0.32 to 4.86
R Knee Flexion 123 (0) 123 (0.9) 121 (0.9) 121 (0.9) 121 (0.9) 1.56 -0.90 to 4.02 0.02 -2.53 to 2.57
L Knee Extension* -4 (0) -4 (0.3) -4 (0.5) -4 (0.3) -3 (0.5) 0.1 -0.72 to 0.88 -1.39 -2.71 to -0.06
R Knee Extension* -4 (0) -4 (0.3) -5 (0.5) -5 (0.3) -3 (0.5) 0.9 -0.03 to 1.78 -1.18 -2.63 to 0.26
Timed up-and-go* (s) 12 (0) 10 (0.2) 10 (0.2) 11 (0.2) 11 (0.2) -1.3 -1.81 to -0.86 -0.72 -1.35 to -0.08
*p value <0.05 for baseline to 6months
#Pre-intervention values are the same in both groups when using the baseline as a covariate
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Table 5. MCII and participant responders and using OMERACT-OARSI criteria
(Tubach, Ravaud et al. 2005) pre and post intervention and at six-months
Pearson’s Chi-Square Number with MCII
Pre-intervention to 8 weeks OAK Control
WOMAC PF absolute 10.84 (1, 141)    p=0.001 25 9
WOMAC PF percent 19.34 (1, 141)    p=<0.001 29 7
SF-36 Physical Function 8.34 (1, 140)      p=0.006 40 23
SF-36 Pain 1.38 (1, 139)      p=0.265 23 17
VAS pain absolute 15.95 (1, 139)    p=<0.001 27 7
VAS pain percent 17.37 (1, 139)    p=<0.001 25 5
Responders 13.59 (1, 141)    p=<0.001 26 8
Tug 28.87 (1, 139)    p=<0.001 46 15
Pre-intervention to 6 months
WOMAC PF absolute 3.87 (1, 135)      p=0.057 24 14
WOMAC  PF percent 4.37 (1, 135)      p=0.043 27 15
SF-36 Physical Function 2.93 (1, 136)      p=0.122 40 29
SF-36 Pain 0.95 (1, 135)      p=0.384 31 25
Responders 2.58 (1, 135)      p=0.123 22 14
TUG 5.10 (1, 132)      p=0.036 38 26
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Summary of the OAK Program and the ASMP
The following publication paper introduces Study 2 that is a RCT comparing
the OAK program with the Stanford University’s Arthritis Self-Management
Program (ASMP). In order to understand the differences between these two
SM programs, a brief summary of the two programs is provided below.
Similarities between the OAK Program and the ASMP:
Group size
Both SM programs consist of small groups of between twelve and fifteen
people depending on recruitment. Previous non-study ASMP courses and
the OAK quality assurance study conducted at Arthritis WA have shown that
groups of less than eight people do not exhibit the same cohesiveness and
group dynamics. Similarly, larger groups become less intimate and have the
potential to become unmanageable. Quieter participants tend to become
“lost” within larger groups.
Social Cognitive Theory (SCT)
Both SM program use the SCT as their theoretical basis. They both include
the following aspects of SCT:
Goal Setting (weekly)
Problem Solving
Guided Imagery
Cognitive Behavioural Therapy
Small group discussion
Both the OAK Program and the ASMP have segments that utilise small
groups or pairs of participants. The ASMP has more opportunity for this
format than the OAK Program.
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Length of program
Both SM programs are run for 2.5 hours per week over 6 weeks as this
amount of time is needed to consolidate information learned each week and
for behaviour patterns to become established.
Program fidelity
Both the ASMP and the OAK Program have facilitator’s manuals and ASMP
facilitators are expected to closely adhere to the manual. The OAK Program
also has a facilitator’s manual however there is more latitude for health
professionals to respond to questions on an individual basis since they are
required to meet minimum standards of knowledge and expertise for program
delivery.
Trained facilitators
Both the ASMP and the OAK Program require leaders to be trained prior to
facilitating the programs.
Differences between the OAK Program and the ASMP
The OAK Program:
Exercise
The OAK Program has much more detailed information and a greater
emphasis on exercise than the ASMP. It has detailed information on exercise
with instruction and demonstration that leads to group participation in
practising specific exercises. These are usually strengthening, balance or
flexibility exercises that can be practiced in the clinic room. Health
professionals are available for individual instruction on technique and also to
answer questions and for trouble shooting at subsequent sessions, should
problems arise.
The importance of physical activity as well as structured exercise is covered
at every session with specific examples and requirements. However, being a
SM program, the progression of exercises is solely up to the individual. The
health professionals provide information with a selection of exercise choices
accompanied by demonstration and follow-up support. The principles of
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progressing beyond the comfort zone (with relevance to OA) and adding and
consolidating from week to week are discussed and encouraged.
Progression is important and the influence of group dynamics, goal setting
and problem solving to improve self-efficacy plays an important role. Pain
management is an important component of the syllabus because many
people are hesitant to undertake new activities for fear of pain.
The importance of balance and proprioception exercise is particularly
stressed and different exercises are introduced throughout the 6-week
program. Incidental balance exercises are encouraged with the aim of these
becoming “habits”. Portions of the day that are otherwise wasted are
suggested for balance practice; for example alternate standing on one leg
while ironing or washing up (with safety issues being highlighted).
Pain management covers an entire session and includes medication and
cognitive techniques. Analgesia and principles of therapeutic dosing to
ensure adequate pain relief is achieved, with instruction on the differences
between acute pain and chronic pain analgesia dosing regimens are
discussed. The hazards of polypharmacy with relation to interaction between
multiple medications and the increased risk of falls are also discussed.
Strategies for regular review of medications with physicians are included.
Current trends are continually reviewed and updated (for example the current
controversy with NSAIDs). Participants have opportunity to ask questions
relating to medications, surgical procedures and treatment options.
Prescriptive advice is not offered; participants are encouraged to discuss
issues with their medical practitioner, however strategies for communicating
with health professionals are discussed.
Evidence-based information on “alternative treatments” is discussed with
techniques for scrutiny of Internet “information” and suggestions for
discerning credible sites that are reputable.
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Pathophysiology of OA and OA knee are included in the OAK Program
syllabus, with signs, symptoms and disease progression. This information is
constructed in a format along with diagrams that is equivalent for a year 9
student to understand. This session includes time for questions and answers.
The ASMP:
Many of the topics covered in the OAK Program are included in ASMP. The
crucial difference is the length and depth to which they are discussed. This is
appropriate as lay leaders do not have the knowledge and skills of health
professionals.  The premise of the ASMP is that lay leaders are “experts”
since many of them have arthritis themselves and the ASMP is purposely
designed to have a general approach to arthritis.
Exercise is discussed at a cursory level. The difference between aerobic,
strength and flexibility exercises is highlighted and exercise is encouraged
however in general terms with no specific recommendations, instruction or
exercise related problem solving. Goal setting is not exercise orientated,
unlike the OAK Program.
The ASMP generally has heterogenous groups of participants. People with
any musculoskeletal condition may enrol into the program (though this is not
the case in Study 2. All participants in both the ASMP and the OAK Program
were required to have OA of the knee). The OAK Program requires that all
people enrolling into the program must have diagnosed OA of the knee.
The emphasis of the ASMP is more orientated towards a support group
dynamic. Every session includes some form of support, either group or pairs
of individuals discussing problems that might arise relating to arthritis. In the
ASMP, there is more scope for group discussion than in the OAK Program.
Participants have greater opportunity for individual problems to be vocalised;
the ASMP course content allocating time for this during each session.
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The ASMP has much less didactic content than the OAK Program, with more
individual and group discussion. In the OAK Program, didactic teaching was
necessary for pathophysiology, medication and exercise instruction, with time
allocated for questions and group discussion after each topic.
The ASMP encourages partner participation (though partners were not
permitted in Study 2). In future OAK Programs, this will certainly be
encouraged, however at this stage of testing limiting extraneous influences
seemed prudent.
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Inclusion Exclusion
Confirmed OA knee Co-existing inflammatory disease
>18 years of age Unable to meet study time-points
English speaking Scheduled knee replacement < 6months
Agrees to randomisation Serious co-morbidity
Referral from physician
Able to meet program requirements
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ABSTRACT
Objectives
The aim is to compare a disease specific self-management program for
people with osteoarthritis (OA) of the knee (the OAK Program), implemented
by health professionals with the Stanford University’s Arthritis Self-
management Program (ASMP) implemented by lay leaders, to determine
which whether the OAK Program was more effective that ASMP in terms of
function, pain stiffness and quality of life.
Methods
Participants: Medical practitioners referred 180 participants with established
OA knee, mean (SD) age of 66.9 (9) years. Volunteers were excluded for
coexistent inflammatory joint disease or serious co-morbidities.
Interventions: Participants were randomised into either OAK or ASMP
groups. Both groups completed their allocated six-week self-management
program following randomisation. Follow-up assessments were completed at
eight weeks, six and twelve months.
Measurements: All participants were assessed at baseline, eight weeks, six
and twelve months. Primary outcomes measures were WOMAC, SF-36 and
VAS pain. Secondary outcomes were self-efficacy; balance using a step test
and a timed one-legged balance test; a modified timed get up and go test;
global health, and global improvement for achievement in responder and
Minimal Clinically Important Improvement (MCII) criteria.
Results
The proportion of responders was greater in the OAK Program group than
the ASMP group (46% versus 29% at eight weeks), although significance
declined over time.
OAK had significant improvements compared with ASMP in WOMAC Pain,
Physical Function and Total score domains. In both groups, participants’
response to treatment were demonstrated in SF-36, with OAK demonstrating
significant improvements in Physical Function and General Health until
12months. VAS pain improved during the eight week clinic phase in the OAK
group, mean (SE) 5.51 (0.25) to 4.57 (0.25) compared with the ASMP group,
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5.12 (0.24) to 4.71 (0.25) p=0.04. There was no significant difference
between groups in the secondary outcomes.
Conclusions
The OAK Program demonstrated more improvements than the ASMP in
most outcomes over time although not necessarily at the same level since
some became non-significant over time. The improvements in pain and
function have implications for improved mortality and decreased disability for
people with OA of the knee.
This study is registered with the Australian New Zealand Clinical Trials
Registry: 12607000031460
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Background
As the population ages chronic diseases are a major concern in Australia.
Arthritis accounts for greater health expenditure than coronary heart disease,
depression, asthma, stroke and diabetes (Brooks and Hart 2000).
Osteoarthritis (OA) is the most common form of arthritis and occurs in the
knees, neck, lower back, hip and fingers. The most commonly affected joint
is the knee and it has a substantial influence on quality of life and imposes a
heavy economic burden on the community (Access Economics 2007).
SM is increasingly being utilised in the treatment of chronic diseases
because it aims to enable the patient to gain the skills and motivation needed
to manage their chronic illness.  Asthma, hypertension, diabetes, and arthritis
are among those chronic diseases that use SM as a treatment option. There
are many different styles and models vary depending on the illness. Some
use health professionals to lead the groups while others use lay leaders.
Delivery of the program can be face-to-face, in groups, via the Internet, or by
telephone or mail. Systematic reviews have suggested that SM has less
effect on arthritis than other health conditions such as asthma, diabetes and
hypertension because pain and function are more complex components of
SM than medication compliance (Warsi, LaValley et al. 2003; Chodosh,
Morton et al. 2005).
SM differs from most medical interventions in that the core premise is to
improve the patient’s confidence in managing the chronic illness by
strengthening self-efficacy. It is argued that this allows the use of lay leaders
to deliver general information related to the chronic illness, rather than
specific skills or information. Certainly, for arthritis SM, lay leaders are used
more than health professionals, however for other chronic diseases such as
asthma and diabetes that are medication orientated, the facilitators are
usually health professionals.
The industry standard for arthritis SM is the Stanford University Arthritis Self-
Management Program (ASMP). The central tenet of the ASMP is based on
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self-efficacy theory (Lorig and Holman 2003) and it is facilitated by lay
leaders who deliver a scripted, generic program.
Meta-analyses have shown that there is little robust evidence to support the
claims of benefit following use of the ASMP, with little evidence of
improvements if any, seen in pain and function (Warsi, Wang et al. 2004;
Chodosh, Morton et al. 2005). Furthermore, there is some suggestion of
publication bias (Warsi, LaValley et al. 2003; Chodosh, Morton et al. 2005).
As well as limited evidence to support the value of SM in arthritis, recent
recommendations suggest that the skills and expertise of health
professionals should be incorporated in SM programs (Jordan and Osborne
2006; Jordan and Osborne 2007; Taylor and Bury 2007).
A SM education program designed for people with OA of the knee (the OAK
Program) delivered by health professionals, has previously demonstrated
improvements in pain, function and quality of life, in a quality assurance
study and a randomised controlled trial (Coleman, Conroy et al. 2002;
Coleman, Briffa et al. 2008a). The OAK Program is condition specific, with
the content tailored to meet the needs of people with OA of the knee and is
designed to utilise the skills and expertise of health professionals within a SM
format.
To test the OAK Program further, we designed a randomised controlled trial
(RCT) comparing it with the ASMP. The results of this study are described in
this paper.
Hypothesis
A greater proportion of people with OA of the knee completing the OAK
Program will achieve a minimal clinically important difference in pain, function
and quality of life, at eight weeks, six and twelve months compared with
those who complete the ASMP.
Methods
Study Design
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Recruitment
Enrolment &
telephone screening
Randomisation
N=180
OAK group
N=90
ASMP group
N=90
Pre-intervention Assessment
N=87
Pre-intervention Assessment
N=90
OAK
(6 weeks)
ASMP
(6 weeks)
Week 8 assessment
N=85
Week 8 assessment
N=83
6 month assessment
N=79
12 month assessment
N=79
12 month assessment
N=77
6 month assessment
N=79
Assessments at
each time-point:
WOMAC
SF-36
VAS pain
Self Efficacy
Step test
Single leg balance
Global health
Time up and go
A two-group randomised, controlled, repeated measures study design
compared the disease specific OAK Program delivered by health
professionals with the generic ASMP delivered by lay leaders. Throughout
the study all participants in both groups continued to receive standard
medical management as required. This study adhered to intention to treat
principles and complied with CONSORT guidelines. The study design is
summarised in Figure 1 and has been described in greater detail elsewhere
(Coleman, McQuade et al. 2010).
Figure 1: Study Design Flow Chart and evaluation tools used at each assessment.
N=number of participants included in the data analyses. This includes values from returned
posted questionnaires from non-attendees and last value carried forward for other missing
data.
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Group allocation: Participants were randomised in blocks. Pre-prepared
cards indicating group assignment were placed in sealed opaque envelopes
and drawn as a lottery by a third party for allocation to treatment groups (ratio
1:1). Allocation did not take place until a whole block was recruited in order to
ensure optimum group sizes. This method of randomisation had been shown
to be successful in a previous OAK RCT (Coleman, Conroy et al. 2002).
Both programs had four facilitators. Health professionals delivering the OAK
Program had been trained in the delivery of SM programs. The four lay
leaders delivering the ASMP were skilled ASMP facilitators having completed
the “Train the Trainer” course conducted at Arthritis Western Australia, under
licence from Stanford University. Both the OAK Program and ASMP have
manuals for program delivery to ensure that fidelity is maintained.
Facilitators delivering either the OAK program or the ASMP were
unavoidably aware of which program participants attended however
participants were unaware which program they were allocated to, and
assessors and data analysts were blinded to group allocation.
Sample
Convenience sampling was used for recruitment of the study participants.
People who enquired about arthritis SM at Arthritis Western Australia were
invited to enrol in the study as with previous OAK Program studies. It was
also offered to the general public through advertising and media coverage.
Further recruitment strategies included active promotion to general
practitioners, rheumatologists and health professionals through professional
societies.
Interventions –
The OAK Program
The Program involves many aspects of care:
• OA – explanation and implications
• Pain management strategies (cognitive and pharmacological)
• Fitness and exercise (strength, flexibility, aerobic and balance)
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• Joint protection
• Nutrition and weight control
• Medication (type, interactions, current trends)
• Correct use of analgesia (therapeutic dosing, types of analgesia, side
effects)
• Balance/falls prevention, proprioception
• Coping with negative emotions
• Self-management skills (specific, measurable, achievable realistic
time-framed goals; problem solving; modelling; positive thinking;
improving self-efficacy).
ASMP
The ASMP content is general rather than specific as the central tenet is that
improved self-efficacy rather than the acquisition of skills and knowledge
improves health outcomes (Marks and Allegrante 2005; Taylor and Bury
2007) and the use of lay leaders is more effective in this process than health
professionals.
Subjects covered in the ASMP include: (Stanford Patient Education Center)
• Techniques to deal with problems such as pain, fatigue, frustration
and isolation,
• Appropriate exercise for maintaining and improving strength, flexibility,
and endurance,
• Appropriate use of medications,
• Communicating effectively with family, friends, and health
professionals,
• Healthy eating,
• Making informed treatment decisions,
• Disease related problem solving
•  Getting a good night's sleep.
To facilitate optimum group dynamics, the target group size for each group
was set at twelve participants.
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Subjects
Participants: 180 people 59 male and 121 female of mean (SD) age 66.9 (9)
years referred by medical practitioners with previously diagnosed OA of the
knee were enrolled into the study. The operational definition for OA knee was
diagnosis by a medical practitioner, based on clinical examination and/or
medical imaging. Participants were not excluded on the basis of severity of
symptoms. The inclusion criteria for determining suitability have successfully
been employed for a previous Quality Assurance study and a RCT
(Coleman, Briffa et al. 2008a; Coleman, Briffa et al. 2008b).  Inclusion and
exclusion criteria are indicated in Table 1.
Table 1: Eligibility criteria
Ethical Issues
This study was approved by the Human Research Ethics Committee at
Curtin University of Technology (HR12) and registered with the Australian
and New Zealand Clinical Trial Registry, number: 12607000031460.
All participants provided written informed consent prior to randomisation.
Data access and storage was in keeping with National Health and Medical
Research Council guidelines (National Health and Medical Research Council
2007).  License agreements were obtained for the SF-36 and WOMAC
Questionnaires.
Inclusion Exclusion
Confirmed OA knee Co-existing inflammatory disease
>18 years of age Unable to meet study requirements
English speaking Scheduled knee replacement <6months
Agrees to randomisation Serious co-morbidity
Referral from physician
Able to meet program requirements
109
A number of amendments to the trial protocol were implemented between the
initial registration and commencement of the study.  The number of
participants recruited was increased from 146 to 180, as the rate of dropouts
in the RCT underway at the time was greater than anticipated.  Furthermore,
the follow-up component of the study was extended to twelve months as it
was considered that important information on long-term effects would be
obtained by this extension. In addition, self-reported global health and global
improvement measures were added, as this was necessary to meet
OMERACT/OARSI responder criteria.
A modified timed up and go test was also included as there is evidence to
suggest that using a functional measure as well as a self-reported measure
is preferable in order to obtain the most comprehensive assessment of
functional limitations (Maly, Costigan et al. 2006)  as self- reported functional
outcome measures tend to be influenced by pain (Boonstra, De Waal Malefijt
et al. 2008)
Response to Intervention
Participants were assessed using the outcome measures listed in Figure 1 at
each of the time points shown.  In addition, VAS pain was assessed on a
week-to-week basis during the first eight weeks including the six intervention
weeks.
The proportion of participants achieving MCII in health status, quality of life,
pain, global health and TUG were computed for each group at each
observation time. MCII data are not available for all variables as there are not
published values for all variables measured in this study.
MCIIs were defined as: (Bellamy, Bell et al. 2005; Tubach, Ravaud et al.
2005)
Health status using WOMAC Physical Function (0 to 100),
• Absolute change of –9.1
Pain (0 to 100mm VAS)
• absolute change of –19.9
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Quality of life using SF-36
• absolute change of +5 points
Global health
• absolute change of 18.3
Participants were further classified as overall responders or non-responders.
A favourable response to treatment (responder) was defined according to the
guidelines of the Outcome Measures in Rheumatology Clinical Trials and
Osteoarthritis Research Society International (OMERACT-OARSI) (Pham,
van der Heijde et al. 2004). That is, an improvement of ≥50% in pain or
function and an absolute change of ≥20 points on a 100 point scale, OR an
improvement of at least two of the following: An improvement of ≥20% and
an absolute change of ≥10 in two of pain, function and global health.  The
proportion of participants achieving MCII and responder criteria was
computed for each group at each observation time.
Statistical Power
A priori power calculations were based on the achievement of a minimal
clinically important improvement (Tubach, Ravaud et al. 2005). This study
was designed to have a power of 80% to show that the response rate for the
ASMP was at least as high as the response rate for the OAK Program. This
assumes that the response rates for the ASMP and OAK groups are equal
(at 38.0%, the level of response achieved for the WOMAC function scale in
our earlier RCT (Coleman, Conroy et al. 2002)), and that a difference of 20.0
points or less is unimportant, with a sample size of 180 and allowing for 20%
drop out, and an alpha (1 tailed) of 0.05.
Single tail design was chosen since the QA study and the RCT comparing
OAK and a control group both showed that the OAK program resulted in
improvements in pain, function and quality of life; it was expected that the
same results would be apparent in this RCT. Similar claims have been
published on ASMP, and it was likely that both groups would improve with
the primarily objectives looking at the difference in improvements between
groups. We did not expect either group to decline during the RCT and
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therefore chose single tailed study design.
Data Analysis
Data were analysed in a blinded manner using SPSS v17 for Macintosh.
Comparisons between treatment groups were performed using an intention
to treat analysis. All participants were encouraged to attend all follow-up
measurements regardless of the level of attendance at the group sessions.
Where data were missing the previous value was carried forward. The
proportion of participants achieving responder criteria and MCII was
computed for each group at each observation time and Chi-square tests
were used to compare proportions between groups.
Further, between group differences in changes over time (baseline, eight-
weeks, six and twelve months) were examined using repeated measures
ANOVA.
A separate analysis was conducted for each outcome variable. Statistical
significance was inferred at a 1-tailed p<0.05. Results were not adjusted for
multiple comparisons as all outcomes of interest were nominated a priori and
such adjustment would likely render all findings of interest non-significant
despite their clinical importance (Perneger 1998).
Results
Although every effort was made to assess participants in both groups at all
time-points, some participants, especially in the ASMP group refused to
comply even with postal assessments. There was discernible discontent to
requests for follow-up assessment with some participants refusing any
communication with study co-ordinators. Anecdotally, the common thread of
complaint was that the ASMP resembled a “support group” rather than a
specific OA program, and some of those participants that were drop-outs
were dissatisfied enough to refuse to commit to follow-up assessments or to
complete posted questionnaires. Another anecdotal comment from the
ASMP group participants was that they expected exercise instruction and
specific information on OA of the knee and neither was forthcoming. Several
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participants who were employed but had arranged time off from work to
attend the ASMP were disgruntled about their “waste of time” and refused
any further participation.  In some of the ASMP group participants there was
palpable anger associated with this sentiment. One ASMP participant wrote a
formal letter of complaint to Arthritis Western Australia.
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Groups were comparable at baseline (Table 2).
Table 2:
Baseline characteristics of participants enrolled in the OAK Program and the ASMP
Patient Characteristics OAK n=90 ASMP n=90
Male:Female 30:60 29:61
Age (years) Mean (SD) 67.6 (8.23) 66.3 (9.84)
Socio-Economic Index* by Post Code Number (%)
Top 25% 53 (58.8) 56 (66.2)
50-75% 11 (12.2) 13 (14.4)
25-50% 10 (11.1) 9 (10)
10-25% 10 (11.1) 8 (8.9)
Bottom 10% 6 (6.6) 4 (4.4)
*Index measured in quintile ranges
Co-morbidities Number
Total 223 203
Mean (SD) 2.47 (1.9) 2.25 (1.73)
Cardiovascular 73 71
Mental Health 13 15
Gastrointestinal 23 19
Musculoskeletal (other than knee) 59 49
Endocrine 15 13
Osteoporosis 11 12
Other 29 24
None 13 15
Baseline values; mean (SD)
VAS pain  (0 to 10) 5.52 (2.17) 5.12 (1.74)
WOMAC Pain (0 to 10) 3.67 (1.58) 3.65 (2.47)
WOMAC Physical Function (0 to 10) 3.66 (1.83) 3.57 (1.68)
SF-36 PCS (0 to 100) 34.17 (9.05) 35.47 (8.85)
SF-36 MCS (0 to 100) 50.44 (10.78) 50.63 (10.73)
Global Health (0 to 10) 6.40 (2.29) 6.32 (2.34)
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MCIIs
The proportion of participants achieving MCIIs in WOMAC Physical Function
between baseline and post-intervention was greater for the OAK Program
participants than for the ASMP (Table 3). At later follow-ups the proportion of
people maintaining the MCII compared with baseline remained greater in the
OAK Program group but the difference between groups was no longer
significant.
Post-intervention more participants from the OAK Program group achieved
MCIIs than from the ASMP group in all SF-36 domains apart from SF-36
Mental Health (Table 3), albeit with difference not significant for some
variables. The number of participants achieving MCII in SF-36 Physical
Function was substantial in both groups and well maintained throughout
follow-up.  However, the proportion from the OAK Program group was
significantly greater immediately post-intervention and at six months, and
approached significance at 12 months (Table 3).
Similar results were seen in General Health with more people from the OAK
Program group achieving more MCIIs than ASMP at all time points –with
differences approaching significance (p=0.07) immediately post-intervention
and significant at six and twelve months (Table 3).
Responders
The number of the OAK group responders was greater than the ASMP group
responders at all time-points (Table 3), however this difference was only
significant at the post-intervention time-point. Post-intervention almost half
the OAK group were classified as responders compared with less than one
third of the ASMP group.
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Table 3: Minimal Clinically Important Improvements and participant responders
using OMERACT-OARSI criteria (Tubach, Ravaud et al. 2005) pre-intervention
(baseline), post-intervention (week eight), six-months and twelve-months
% (Number with MCII)
Pre-intervention to 8 weeks OAK ASMP P value
WOMAC PF 36% (31) 23% (21) 0.04
SF-36
Physical Function 70% (60) 42% (38) <0.001
SF-36 Role Physical 41% (36) 32% (29) 0.13
SF-36 Pain 48% (42) 44% (40) 0.36
SF-36 General Health 47% (41) 35% (32) 0.07
SF-36 Social Function 42% (37) 40% (36) 0.42
SF-36 Vitality 53% (46) 44% (40) 0.16
SF-36 Role Emotional 32% (28) 26% (24) 0.26
SF-36 Mental Health 29% (25) 39% (35) 0.10
VAS Pain 39% (34) 32% (28) 0.20
Global Health 25% (22) 22% (20) 0.36
Responder 46% (40) 29% (26) 0.01
Pre-intervention to 6 months
WOMAC PF 35% (30) 30% (27) 0.30
SF-36
Physical Function 65% (57) 51% (46) 0.04
SF-36 Role Physical 33% (29) 36% (33) 0.38
SF-36 Pain 45% (39) 50% (45) 0.30
SF-36 General Health 52% (45) 33% (30) 0.01
SF-36 Social Function 42% (37) 36% (33) 0.26
SF-36 Vitality 54% (47) 49% (44) 0.29
SF-36 Role Emotional 23% (20) 33% (30) 0.08
SF-36 Mental Health 30% (26) 29% (26) 0.50
VAS Pain 36% (31) 31% (27) 0.30
Global Health absolute 25% (22) 25% (23) 0.57
Responder 41% (36) 33% (30) 0.17
Pre-intervention to 12 months
WOMAC PF 36% (31) 29% (26) 0.20
SF-36
Physical Function 62% (54) 50% (45) 0.07
SF-36 Role Physical 45% (39) 41% (37) 0.36
SF-36 Pain 54% (47) 55% (50) 0.48
SF-36 General Health 56% (49) 36% (33) 0.007
SF-36 Social Function 35% (31) 37% (34) 0.44
SF-36 Vitality 50% (44) 53% (48) 0.41
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SF-36 Role Emotional 31% (27) 36% (33) 0.26
SF-36 Mental Health 38% (33) 39% (35) 0.50
VAS Pain 42% (37) 37% (33) 0.30
Global Health 30% (24) 20% (18) 0.15
Responder 43% (39) 37% (34) 0.21
Changes over time
Overall, participants had significant improvements (time p<0.02) in all of the
WOMAC domains (Table 4).  The magnitude of improvement was greater in
the OAK Program group in all domains with significant differences in the
Physical Function and Total domains (group x time p = 0.04 and approaching
significance in the Pain domain (group x time p=0.08).
Similarly, there were improvements over both groups in all SF36 domains
except GH (time p≤0.05). The magnitude of improvement in the OAK
Program group was significantly greater than the ASMP group in Physical
Function (group x time p≤0.002) (Table 4). General Health decreased in the
ASMP group but increased in the OAK Program group (-1.5 versus +4.7
respectively; group x time p=0.009)
There were also significant improvements in VAS Pain scores (Figure 2), SE,
TUG, and step tests (time p<0.001) but the magnitude of the change did not
differ significantly between groups in any of the variables (group x time
p≥0.09) (Table 4).
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Figure 2:  VAS pain mean (SE) OAK and ASMP pre-intervention (baseline),
weekly until post-intervention (week eight); group x time differences, p=0.02
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Table 4: Results for WOMAC, SF-36, mTUG, Step Test, Single Leg Balance, Global
Health and Self-Efficacy: pre-intervention (baseline), post-intervention (week eight),
six-months and twelve-months using repeated measures ANOVA; Data are
estimated marginal mean (SE) with the mean (single sided 95% CI) difference of
change between the groups at each time-point. Single sided lower confidence limit
indicating that the 95% CI is greater than the value shown.  All p-values are single
tailed.
WOMAC
OAK
Mean
(SE)
ASMP
Mean
(SE)
Difference
in change
between
group
means
Single
sided 95%
CI of the
mean
difference
p-value
for
difference
in change
between
groups
p-value
for
ANOVA
Group x
time
interaction
Pain (0 to 20)
Pre intervention
7.34
(0.36)
7.31
(0.35)
Post intervention
6.16
(0.35)
6.76
(0.34) 0.64 0.00 0.05
6 Months
5.84
(0.39)
6.26
(0.38) 0.45 -0.35 0.17
12 Months
5.26
(0.37)
6.17
(0.36) 0.94 0.13 0.02 0.08
Stiffness (0 to 8)
Pre intervention
3.57
(0.21)
3.54
(0.22)
Post intervention
3.20
(0.19)
3.21
(0.20) -0.02 -0.42 0.45
6 Months
3.25
(0.18)
3.06
(0.19) 0.16 -0.26 0.21
12 Months
2.88
(0.18)
3.12
(0.19) -0.26 -0.72 0.17 0.17
Physical Function (0 to 68)
Pre intervention
24.94
(1.29)
24.31
(1.26)
Post intervention
20.37
(1.28)
21.55
(1.25) 0.26 -0.52 0.05
6 Months
21.15
(1.43)
20.86
(1.40) 0.50 -0.22 0.40
12 Months
18.73
(1.39)
21.05
(1.36) 0.43  0.06 0.02 0.04
Total (0 to 96)
Pre intervention
35.86
(1.71)
35.05
(1.68)
Post intervention
29.75
(1.69)
31.53
(1.65) 2.58 0.04 0.04
6 Months
30.27
(1.88)
30.20
(1.84) 0.73 -2.51 0.35
12 Months
27.16
(1.85)
30.35
(1.81) 4.00 0.55 0.02 0.05
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SF-36 (0 to 100)
Physical Function
Pre- intervention
46.43
(2.41)
50.77
(2.37)
Post-intervention
56.89
(2.30)
54.44
(2.26) 7.79 3.77 0.001
6 Months
58.50
(2.37)
55.77
(2.33) 7.07 2.80 0.003
12 Months
57.98
(2.57)
55.61
(2.53) 6.71 1.74 0.01 0.002
Role Physical
Pre- intervention
30.74
(4.17)
32.22
(4.10)
Post-
intervention
49.13
(4.38)
41.94
(4.31) 8.66 -1.07 0.07
6 Months
43.10
(4.53)
43.88
(4.45) 0.69 -9.51 0.45
12 Months
47.59
(4.52)
48.61
(4.52) 0.46 -10.74 0.47 0.23
Body Pain
Pre- intervention
44.13
(2.11)
43.98
(2.08)
Post-
intervention
49.80
(2.01)
49.22
(1.98) 0.43 -4.35 0.48
6 Months
50.43
(2.17)
49.63
(2.31) 0.65 -4.43 0.41
12 Months
52.37
(2.27)
51.64
(2.24) 0.58 -4.54 0.42 0.49
General Health
Pre- intervention
63.16
(1.90)
66.77
(1.86)
Post-
intervention
66.93
(1.98)
66.14
(1.95) 4.40 1.21 0.02
6 Months
67.56
(1.90)
65.94
(1.87) 5.23 1.69 0.007
12 Months
67.90
(1.92)
65.26
(1.89) 6.25 2.43 0.003 0.009
Vitality
Pre- intervention
51.95
(2.17)
51.77
(2.13)
Post-
intervention
57.29
(1.92)
55.44
(1.89) 1.67 -2.41 0.24
6 Months
56.55
(2.02)
55.50
(1.99) 0.87 -3.85 0.37
12 Months
57.06
(1.99)
56.77
(1.96) 0.11 -4.79 0.48 0.45
Social Function
Pre- intervention
67.38
(2.64)
71.94
(2.59)
Post-
intervention
75.14
(2.43)
75.27
(2.39) 4.43 -1.76 0.16
6 Months
74.28
(2.54)
74.72
(2.49) 4.12 -1.86 0.12
12 Months 71.21
(2.75)
76.11
(2.70)
-0.34 -6.81 0.46 0.45
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(2.75) (2.70)
Role Emotional
Pre- intervention
60.15
(4.44)
62.22
(4.36)
Post-
intervention
68.58
(4.28)
71.11
(4.20) -0.46 -10.10 0.46
6 Months
60.15
(4.46)
71.85
(4.39) -9.63 -20.79 0.07
12 Months
64.67
(4.20)
75.55
(4.13) -8.81 -20.48 0.10 0.12
Mental Health
Pre- intervention
72.13
(1.63)
71.77
(1.61)
Post-
intervention
73.37
(1.69)
73.46
(1.67) -0.45 -3.88 0.41
6 Months
73.47
(1.73)
74.22
(1.70) -1.11 -4.51 0.29
12 Months
74.48
(1.60)
75.46
(1.57) -1.34 -4.89 0.26 0.45
mTUG (seconds)
Pre intervention
12.32
(0.45)
13.47
(0.44)
Post-intervention
11.52
(0.44)
12.63
(0.44) -0.03 0.68 0.46
6 Months
11.71
(0.52)
12.35
(0.52) 0.50 1.35 0.16
12 Months
11.12
(0.48)
12.23
(0.47) -0.04 0.76 0.46 0.30
Step test R (steps /30 seconds)
Pre intervention
24.00
(0.76)
23.23
(0.75)
Post-intervention
27.72
(0.76)
26.97
(0.75) -0.02 -1.31 0.46
6 Months
29.47
(0.81)
27.51
(0.81) 1.19 -0.32 0.08
12 Months
30.02
(0.84)
28.40
(0.83) 0.85 -0.64 0.17 0.15
Step test L (steps /30 seconds)
Pre intervention
23.93
(0.73)
23.06
(0.72)
Post-intervention
28.11
(0.80)
26.80
(0.79) 0.44 -0.88 0.26
6 Months
29.82
(0.80)
27.54
(0.80) 1.41 -0.02 0.05
12 Months
30.49
(0.85)
28.11
(0.85) 1.51 -0.01 0.05 0.06
Balance Right (seconds)
Pre-intervention
16.85
(1.20)
16.36
(1.17)
Post-intervention
19.12
(1.22)
18.73
(1.19) -0.09 -2.28 0.47
6 Months
16.98
(1.20)
17.28
(1.17) -0.78 -2.88 0.27
12 Months
16.69
(1.22)
16.92
(1.19) -0.72 -2.97 0.29 0.48
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Balance Left (seconds)
Pre-intervention
16.97
(1.22)
17.03
(1.20)
Post-intervention
17.94
(1.20)
17.80
(1.18) 0.38 -1.95 0.36
6 Months
16.09
(1.22)
16.99
(1.19) -0.65 -2.97 0.31
12 Months
16.15
(1.22)
15.90
(1.19) 0.48 -1.90 0.36 0.41
Global Health (0 to 10cm)
Pre-intervention
6.40
(0.25)
6.32
(0.24)
Post-intervention
6.61
(0.18)
6.18
(0.18) 0.34 0.21 0.18
6 Months
6.58
(0.20)
6.56
(0.20) -0.07 -0.72 0.43
12 Months
6.42
(0.19)
6.32
(0.18) 0.01 -0.62 0.48 0.31
Self- Efficacy (0 to 80)
Pre-intervention
48.41
(1.66)
47.60
(1.62)
Post-intervention
55.75
(1.55)
51.92
(1.51) 3.01 -1.13 0.49
6 Months
54.91
(1.54)
52.50
(1.50) 1.60 -2.64 0.26
12 Months
54.93
(1.57)
53.13
(1.53) 1.00 -3.27 0.45 0.30
Discussion
In our comparison between two SM programs we found that the number of
responders immediately following the intervention was substantially greater
in the OAK Program group than the ASMP group, providing solid support for
the value of the disease specific OAK Program led by health professions for
people with OA of the knee.
Classification as a responder reflects a reduction in pain and an improvement
in physical function. Pain relief or improved function is not a common finding
in SM programs for people with OA of the knee, therefore this study adds a
new dimension to the discussion of SM programs. Furthermore, it is
supported by the evidence that the combination of improvements in physical
function and pain variables are associated with improved function in people
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with OA knee (Fransen and McConnell 2008) and that can be directly related
to reduction in disability and mortality (Nuesch, Dieppe et al. 2011).
Pain was assessed using several measures.  While WOMAC Pain is disease
specific, SF-36 Body Pain is known to reflect pain from other causes, notably
co-morbidities and it may be that this measure captured non OA knee pain
(Bombardier, Melfi et al. 1995). VAS pain decreased significantly in the OAK
group at four weeks and continued to decrease until eight weeks, whereas
there was no consistent pattern of improvement in the ASMP group. This
same pattern of improvement in the OAK Program participants has been
identified in previous studies (Coleman, Briffa et al. 2008a; Coleman, Briffa et
al. 2008b).
An important finding of the study is the number of participants from both
groups that responded favourably to the self-management intervention with
improvements demonstrated in the majority of variables measured.  As all
participants participated in a group SM intervention the results of this study
provides no comparison with a no intervention control. In our earlier study
comparing the OAK Program with a usual care control group (Coleman,
Conroy et al. 2002) we found the OAK program to result in significantly
greater improvement in WOMAC pain, physical function and total scores.
The advantage in between-group difference in change was evident at post-
treatment and 6-months follow-up in the physical function and total scores,
however by 6-months the improvement in pain was comparable between
groups.  In addition, there were improvements from baseline to 8-weeks in
the SF-36 scales Physical Function, Role Physical, Body Pain, Vitality and
Social Function in the OAK group compared with the control group. These
differences were maintained at 6-months. Although direct comparison with
the findings of this study need to be interpreted with caution, the magnitude
of the difference of changes and proportion of participants responding to the
OAK Program were very similar between the two studies, suggesting that
both of the SM interventions implemented in this study would be more
effective than usual care.
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There is no clear evidence that identifies the mechanisms involved with
successful SM and it may be that it is due to the structured nature of the
intervention or other non-specific mechanisms such as group dynamics.
Nevertheless, in SM programs that are medication-orientated there appears
to be consensus that they increase adherence to medications (Chodosh,
Morton et al. 2005). Certainly in the OAK Program, pharmacological therapy
and pain relief are included in the syllabus. Although pain and medications
are included in the syllabus of the ASMP, these areas are covered at a very
superficial level in keeping with the knowledge of lay leaders.
The components of the OAK Program that may have contributed to the
marked decrease in pain at week four included the emphasis placed on the
benefits of exercise and the encouragement provided to progressively
increase exercise. The health professional leaders also provided exercise
modelling and advice when participants encountered difficulties. In addition,
instruction in pharmacological and cognitive pain management and
information on therapeutic drug dosing to promote effective pain relief was
emphasised. This emphasis appears to be important since it is suggested
that a person in chronic pain could be fearful of an activity they expect to
aggravate pain and avoidance behaviour due to fear of pain is known to
result in decreased daily activity that eventually leads to disability (Vlaeyen
and Linton 1999). Whether or not an activity is performed might be influenced
by confidence in being able to achieve it despite the pain or how well the
individual is able to manage the pain.
Self efficacy is considered the central component of successful SM but there
is no evidence that indicates the extent to which SE is an independent
variable relating to SM. Nonetheless, most SM trials include SE measures
among their primary outcomes. Both the OAK Program group and the ASMP
group demonstrated significant within group improvements in SE that was
maintained until the 12-month follow-up, however the magnitude was small.
Improved SE is consistent with the tenet that SM is based on SE theory
(Lorig and Holman 2003) and with the findings of other studies of SM using
ASMP that have routinely report improvements in SE (Lorig, Mazonson et al.
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1993; Barlow, Turner et al. 1998; Lorig, Gonzalez et al. 1999; Barlow, Turner
et al. 2000). Our study demonstrates that improvements in SE in response to
the OAK Program are of similar magnitude to those in response to ASMP.
However there is no published benchmark upon which to compare the size of
improvement in SE.  Moreover, it is unclear whether high levels of SE are a
consequence rather than a cause of SM (Taylor and Bury 2007).
Enrolment in our study was self-initiated by many of our participants, who
then approached their general practitioners for referral. Self-initiated
enrollment may produce a potential bias as those people who volunteer may
already be predisposed to benefit from SM (Newbould, Taylor et al. 2006;
Taylor and Bury 2007) and may not be a true reflection of health patterns in
the community. The highest socioeconomic group was over represented in
this study with the possibility that our study results may overstate the likely
impact on the wider community since there is the potential that people with
higher education levels will have better improvements.
Because of the nature of the study design, program facilitators could not be
blind. This and the perception of the efficacy of the treatments by the health
care providers may have influenced how the patients perceived their pain
and resulted in improved pain ratings (Hirsh, Atchison et al. 2005). In
addition, self-reporting of pain may be effected by bias, as patients are keen
to “do well” and to please health care providers by reporting an improvement
when there may not have been one.
Global health did not change at any time-point in either group. This may be
partially explained because patients asked to score their health up to twelve
months ago, rely on speculation that is influenced by their current state of
health. Thus the evaluation of difference between current health status and
pre-existing health status is retrospective and may be inaccurate, correlating
highly with their present state (Norman, Stratford et al. 1997).
The attrition rate was not foreseen at the beginning of the study and although
both groups had non-attendees at follow-up assessments it was especially
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problematic in the ASMP group. Every attempt was made to retain the study
population. However, attendance dropped off considerably at six months
(OAK=15% and ASMP=28%) and dramatically at twelve months (OAK=26%
and ASMP=44%). All non-attending participants received posted self-
reported questionnaires with postage paid self-addressed envelopes
enclosed. Not all participants returned the questionnaires.
Conclusion
This report describes the outcome of the first RCT to compare two different
SM programs, one disease specific (the OAK Program and one generic, the
ASMP).
Both program groups demonstrated improvements in most outcomes over
time, however the OAK group consistently demonstrated more significant
improvements when compared with ASMP group in the domains reflecting
physical function.   Importantly, the OAK Program was not inferior in outcome
in any of the important domains. The implications of these findings are of
major importance because improvements in pain and function have been
linked to reductions in disability and mortality (McCarthy, Mills et al. 2004;
Nuesch, Dieppe et al. 2011). Further research is needed to reinforce these
findings and investigate other important issues such as cost-effectiveness of
the interventions.
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CHAPTER 4
Discussion
Findings from the studies constituting this thesis were positive and provide
valuable support for the premise that SM programs are of great benefit in the
management of OA.  The results also suggest that the incorporation of health
professionals as leaders of such programs produces greater benefits than
when the programs are led by lay leaders.
The comparison of the OAK Program with a control group (Study 1),
demonstrated significant improvements in mean difference of change
between the groups in pain, quality of life and function at eight weeks with
the improvements maintained at six months follow-up. There were also more
responders and participants achieving MCII in the OAK group compared with
the control group at both eight weeks and six months.   The comparison
between the OAK Program and the ASMP (Study 2) identified the fact that
while both groups showed improvement, the participants in the OAK Program
recorded more significant improvements when compared with those in the
ASMP.  Measures such as the VAS pain and the WOMAC indicated that the
OAK Program achieved significant improvements when compared with the
ASMP to final follow-up at twelve months. Of particular interest was the
apparent level of dissatisfaction reported anecdotally by those allocated to
the ASMP group.
The following discussion will present the findings of each of the studies in
turn, examining the variables of interest in detail and comparing findings with
other published literature. Consideration of common components of the two
studies will follow, indicating how the sequence of the studies adds to the
understanding of the value of SM in the long term treatment of OA of the
knee.  Subsequently, limitations of the studies will be considered to examine
issues that may need to be considered when attempting to generalize the
study findings.  In the light of the limitations identified, suggestions for further
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research that could add to the development of knowledge in this area will be
identified.
Study 1
Random assignment to the OAK Program or a Control Group
A randomised controlled study compared the OAK SM Program with a
control group that did not participate in the program but continued with their
routine care.  The participants in both groups were followed to 6 months post
intervention.  At the end of the follow-up period, those in the control group
were offered the opportunity to participate in an OAK Program.
Hypothesis
To determine whether a disease specific SM program for people with
osteoarthritis of the knee (the OAK Program), implemented by health
professionals, would achieve and maintain clinically meaningful
improvements in health related outcomes compared with a control group.
Primary outcome measures included WOMAC, SF-36 questionnaire, VAS
pain and TUG. Secondary outcomes included active ROM of the knee joint
using a long-armed goniometer, and quadriceps and hamstring strength
measured using a fixed Mecmesin dynamometer.
To test the effects of treatment, between group differences in changes over
time (baseline, 8-weeks and 6-months) were examined using repeated
measures ANCOVA. In addition, response to treatment was determined
using responder criteria as defined by OMERACT-OARSI, scenario D
(Pham, van der Heijde et al. 2004). Furthermore, the proportion of
participants achieving minimal clinically important improvements (MCII)
independently in health status, quality of life, pain, and the TUG test were
computed for each group at each observation time and Chi-square tests
were used to examine proportions between groups.
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MCII is becoming more prevalent as an additional means of expressing
improvement that is a result of treatment. It focuses on the patient’s
perspective of the minimal change needed for improvement. Kvien, Heiberg
et al (2007) describe MCII as the smallest change in measurement to detect
an improvement (Kvien, Heiberg et al. 2007). Tubach, Ravaud et al (2005)
suggest that using MCII provides readers with clinically meaningful
information on the effect size by expressing the results (usually) as a
percentage of improved patients which is more easily understood than
conventional p values (Tubach, Ravaud et al. 2005). However, the concept
aims at complementing traditional effect size reporting, not to replace it.
Mean differences
Pain was measured using three variables: WOMAC, SF-36, and VAS. Each
of these outcome measures independently demonstrated a significant
improvement in pain from baseline to 6-months in the OAK group compared
with the control group.
WOMAC Pain, Physical Function and Total scores improved significantly
more in the OAK group when compared with the control group. The
advantage in between-group difference in change was evident at post-
treatment and 6-months follow-up in the Physical Function and Total scores,
however the magnitude of improvement in pain though significant was
slightly less between groups by 6-months. In the OAK group WOMAC Pain
was significantly decreased post intervention with a plateau effect at 6-
months. The control group had almost no change in WOMAC Pain at 8-
weeks with only a very slight improvement at 6-months. The decrease in pain
noted in the OAK group appears to be unique among previously reported
arthritis SM programs (Warsi, Wang et al. 2004; Bury, Newbould et al. 2005;
Chodosh, Morton et al. 2005).
Similar improvements were significant in SF-36 Body Pain from baseline to
8-weeks in the OAK group compared with the control group and these
differences were maintained at 6-months. In the OAK group, VAS pain
decreased 30% during the 8-week intervention, while the control group had
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an 18% increase in pain during the same period. These findings are of
particular interest in light of Bombardier et al (1995) comparisons of two of
these measures.
Bombardier, Melfi et al (1995) compared the disease specific WOMAC Pain
and Physical Function domains with the generic SF-36 Body Pain and
Physical Function dimensions to examine the characteristics of disease
specific and generic instruments (Bombardier, Melfi et al. 1995). The authors
noted that people who were free from pain in WOMAC Pain scores continued
to experience pain and physical disabilities due to co-morbidity, when
measured on the SF-36 instrument. This was expressed by lower SF-36
scores (Bombardier, Melfi et al. 1995). The suggestion made is that WOMAC
is more sensitive to disease specific pain than SF-36, and the SF-36
discriminates better between general health status and co-morbidity due to
other conditions. Bombardier, Melfi et al (1995) concluded that disease
specific instruments are essential in determining improvement due to specific
interventions whereas generic instruments are important in determining
general health and function (Bombardier, Melfi et al. 1995).
VAS pain showed a marked improvement at week three of the intervention in
the OAK group and this coincides with an increase in exercise expectation in
the OAK Program. At the beginning of the Program, participants were
encouraged to incorporate “incidental” exercise into their daily routines. This
incidental exercise included behaviours such as using stairs instead of
elevators, walking to the shopping centre, parking further away from the
entrance of the shopping centre, walking as an alternative to driving short
distances and other short exercises designed to become “habits” of physical
activity. In addition, by week three in the OAK Program participants were
expected to have an established formal exercise regimen that could be
added to and consolidated for the remainder of the Program. By the
completion of the Program, ideally participants would have a structured
exercise regimen as well as incorporating exercise habits into their daily
routines. The increase in physical activity along with the positive results
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noted above are likely to support the assumption that physical function
improved as a result of the OAK Program.
The current findings of significant and maintained decrease in pain are of
particular relevance, since pain has been identified as a major contributing
factor to the loss of function and increase in dependence among people with
OA (McCarthy, Mills et al. 2004).  According to Nuesch, Dieppe et al (2011)
pain and loss of function together are associated with increased mortality
above and beyond that of people with OA knee who themselves have a
greater risk of mortality than the general population.
In contrast to the present findings, Warsi, LaValley et al (2003), in a meta-
analysis of the effect on pain and disability of arthritis SM programs, describe
the reductions in pain as being small (Warsi, LaValley et al. 2003). Warsi’s
study did not account for the heterogeneity between the studies in their meta-
analysis, and a subsequent systematic review by Warsi, Wang et al (2004)
found that arthritis SM programs were not associated with statistically
significant effects (Warsi, Wang et al. 2004). Chodosh, Morton et al (2005) in
their meta-analysis of SM programs also found that OA SM programs do not
appear to have a clinical effect on pain or function (Chodosh, Morton et al.
2005). Considering that the participants in Study 1 were homogeneous, that
is they all had OA of the knee, the improvements in pain demonstrated are
quite unique in SM for OA.
Newman and Mulligan (2004) did note one exception to this general finding
in one study that translated the ASMP into Spanish. However it was not a
direct translation of the ASMP and also included other aspects as well as a
formal exercise component (Lorig, Gonzalez et al. 1999). Commenting on
this study in their meta analysis of SM, Newman and Mulligan (2004) suggest
that the exercise component might be a crucial aspect in OA SM (Newman,
Steed et al. 2004), providing support for the present study, since the OAK
Program encouraged the participants to find and persist with an exercise
program that suited their needs.
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A number of aspects of the OAK Program may have contributed to the
reduced pain levels reported by participants.  Both aerobic and resistance
exercise in a home-based exercise program have been shown to significantly
reduce knee pain in patients with OA (Thomas, Muir et al. 2002). An
important component of the OAK intervention is to encourage the formulation
of a comprehensive exercise program that incorporates strengthening,
endurance and flexibility components.  In accordance with SM principles,
participants are motivated to use this information when planning their weekly
goals.  The use of goal setting is designed to promote long-term adherence
to the exercise regimen.
It is also likely that the OAK intervention facilitated better pain-coping skills
that are important predictors of disability associated with OA (Steultjens
2000; Huang, Yang et al. 2005).  Previous studies have reported that
catastrophising and negative self-statements are associated with increased
knee pain (Keefe, Lumley et al. 2001). In the OAK intervention, participants
are taught strategies for cognitive symptom management such as distraction,
guided imagery, relaxation techniques and negative self-talk that are thought
to be important additional strategies for pain management in people with OA
(Messier, Loeser et al. 2004; Kidd, Langford et al. 2007).
Pain management is an important concept because many people with OA
are hesitant to undertake new activities for fear of pain. As well as exercise
instruction and cognitive therapies, within the OAK Program medication
usage and therapeutic dosing principles with particular emphasis on
analgesia were taught to encourage medication compliance and effective
pain management. The average age of participants was 65-years and most
had several co-morbidities requiring medication. Many participants had an
aversion to medications and would delay taking analgesia until their pain
became acute and therefore more difficult to control. Pain management
principles were discussed to educate participants about their pattern of pain
and the appropriate treatment response eg: “around the clock” analgesia
dosing for acute pain, or “as needed” analgesia for intermittent pain.
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The combination of health professionals modelling exercises and goal setting
together with the knowledge and reassurance of attaining adequate pain
relief specific to the OAK Program, was designed to encourage participants
to participate in appropriate physical activity and exercise that previously may
have been considered by participants to be beyond the scope of someone
with OA of the knee. Additionally, health professionals were available for
reassurance, counselling and trouble shooting should participants experience
problems with exercise or pain control during the Program.
Similar improvements were evident for Stiffness, which is the least sensitive
of the WOMAC domains. As with Stiffness, Physical Function improved
significantly in the OAK group at 8-weeks and this improvement was
maintained until 6-months. The control group showed no improvement at any
time-point. This same pattern was evident in WOMAC Total scores.
The WOMAC was developed using specific questions regarding sources of
discomfort and disability in OA of the knee and/or hip. It was designed to
assess symptoms that occur commonly, are thought of as being important,
and are experienced on a daily or weekly basis.  Thus it aims to monitor and
detect change in clinically important events that recur frequently and are
regarded as important to symptomatic people with OA of the knee/hip
(Bellamy 2002). Of the five “pain” questions, three refer to pain with physical
activities such as walking on a flat surface, going up and down stairs, and
standing upright. The two stiffness questions relate to the severity of stiffness
on wakening, and the severity of stiffness during periods of inactivity. The
seventeen physical function questions relate to functional aspects of daily
living such as climbing up and down stairs, walking, getting in and out of a
car, shopping; dressing, getting in and out of bed, bathing, toileting, and
difficulty performing domestic duties (Bellamy 2002). Therefore an
improvement in WOMAC scores over time would suggest that every day
functional activities are more manageable as a result of the intervention
being tested.
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Few arthritis SM programs are disease specific thus WOMAC is not a
standard measure utilized in many SM studies since it is specifically
designed for OA knee and or hip. Therefore it is difficult to compare our
WOMAC improvements with other SM RCTs. As stated earlier, WOMAC is
more sensitive than SF-36 for OA and is considered to be the best
determinant for physical impairment (Pollard, Johnston et al. 2006). This
suggests that evidence of improvement in the OAK group in all WOMAC
domains in addition to improvements in SF-36 Physical Function and Body
Pain, VAS pain, ROM, quadriceps and hamstring strength and TUG is likely
to equate to a functional improvement. Again, considering the findings of
Nuesch, Dieppe et al (2011), that improving physical function is likely to
reduce mortality in people with OA of the knee (Nuesch, Dieppe et al. 2011),
this is an important outcome.
The SF-36 questionnaire has eight dimensions that are designed to capture
the following health concepts: behavioural functioning, perceived well-being,
social and role disability and personal evaluations of health in general (Ware,
Kosinski et al. 2002). Four of the dimensions relate closely to physical health
with the remaining four relating to mental health status. It is accepted that the
physical health dimensions are more relevant to people with OA (Ware,
Kosinski et al. 2002). These four dimensions include: Physical Function, Role
Physical, Body Pain and General Health. Physical Function assesses
limitations in performing all physical activities including bathing or dressing
thus it measures limitations in behavioural performance in everyday
activities. Role Physical determines difficulties with work or other daily
activities as a result of physical health. It measures the extent of disability in
everyday activities due to physical problems. Body Pain assesses pain or
limitations in activities due to pain. General Health evaluates personal health
status and the prospect of it becoming worse and has been linked to several
indicators of health expenditure, namely hospitalisation, visits to medical
practitioners, and prescriptions per visit. Those with poorer General Health
scores tend to have greater utilization than those with higher scores. Vitality
assesses tiredness and energy all of the time. Social Functioning determines
the level of interference due to physical or emotional problems with normal
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social activities. Role Emotional evaluates interference by emotional
problems with work or daily activities. Mental Health determines the extent of
nervousness and depression, or peacefulness, calmness and happiness all
of the time (Ware, Kosinski et al. 2002).  Although these dimensions are not
disease specific to OA knee they are important predictors of general health
response to treatment especially if they are concordant with the results from
disease specific measures.
There were significant improvements from baseline to 8-weeks in five of the
eight dimensions in the SF-36 scales: Physical Function, Role Physical, Body
Pain, Vitality and Social Function, in the OAK group compared with the
control group. These differences were maintained at 6-months. A difference
of 5 points is considered to be clinically relevant in arthritis populations
(Ware, Kosinski et al. 2002) and this was demonstrated in Physical Function
at both 8-weeks and 6-months; Role Physical at 8-weeks and 6-months;
Body Pain at both time-points; Vitality at 8-weeks; and Social Function at 8-
weeks. General Health improved in the OAK group compared with the control
group at all time-points although it did not reach significance. Scales that
load highest on the physical component such as Physical Function, Role
Physical, and Body Pain are the most sensitive to physical response to
treatment which has implications for reducing mortality in people with OA
knee (Nuesch, Dieppe et al. 2011) and are also the most responsive to knee
replacement (Ware 2004). Although this study is not concerned with knee
replacement, many of the symptoms would be common to people with OA of
the knee.
The SF-36 is a generic instrument that also captures health status symptoms
of co-morbidities (Bombardier, Melfi et al. 1995). Considering that people
over the age of 60 are likely to have more than one co-morbidity (Kadam and
Croft 2007) it is probable that this instrument also captured adverse health
symptoms other than OA of the knee. The interaction of co-morbidities and
OA was discussed in the literature review that highlighted the compound
effect of OA plus another co-morbidity (Kadam and Croft 2007). Considering
the significant improvements in five of the eight SF-36 dimensions (three of
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the physical health dimensions) it is reasonable to suggest that the OAK
program has had a beneficial effect not only on OA knee but also on general
health and health issues relating to co-morbidities.
TUG results showed a significant improvement in the OAK group compared
with the control group post-intervention and at 6-months. An MCII for TUG
was observed in three times as many OAK group participants as control
group participants at 8-weeks (OAK: 46 and control group: 15) This finding
remained statistically significant at 6-months, but it had shown some decline
relative to the value recorded for the control group (OAK: 38 and control: 26).
The TUG normal value for people 60-69 years of age to walk three meters
outbound and three meters return is nine seconds and it is suggested that
slower times may warrant physical interventions (Bohannon 2006). However
in this study an extra 15cm step in the outbound walk was added that would
potentially add time to the exercise. Thus, neither group were expected to
approach the normal value at baseline. Post intervention the OAK group
mean (SD) was 9.8 (0.17) seconds (approaching the norm) and by 6-months
it was 10.1 (0.23) seconds. By contrast, the control group post intervention
was 11.2 (0.17) seconds and 10.8 (0.23) at 6-months.  Thus, even with the
added step task, the intervention group showed improvement at the first time
point and very little decline at the 6-month time point, when compared with
the control group.
Small increases in ROM were observed. Extension in both knees, and flexion
in the left knee in the OAK group improved significantly compared with the
control group. It is difficult to determine what constitutes a clinical
improvement in ROM as it is not defined in the literature, and rather than a
finite quantity, recommendations for improving ROM in patients with OA knee
are based on expert opinion (Richmond, Hunter et al. 2009). However, it is
known that ROM is affected by OA of the knee and that improvement in ROM
in combination with increased lower limb muscle strength equates to
improved functional mobility and activities of daily living such as walking,
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getting in and out of a bath, rising from a chair, gait speed and falls efficacy
(Beissner, Collins et al. 2000; Steultjens 2000).
Hamstring strength improved significantly in both right and left legs in the
OAK group compared with the control group. The significant improvement
demonstrated in the OAK group post intervention in the right hamstrings was
34% and was maintained at 6-months with a 29% improvement. In the
control group, similar improvements of 10% post intervention and 14% at six-
months were achieved. Similar improvements were observed with the left
hamstrings. There were also improvements in both left and right quadriceps
strength in the OAK group, although these improvements were not significant
between groups. In contrast the control group left quadriceps strength
diminished in both legs post intervention and at 6-months with the exception
of the right leg that had a very small non-significant improvement.
There is a reliable association between WOMAC and physical function tests
such as ROM, muscle strength and TUG (Lin, Davey et al. 2001) making the
combination of WOMAC and physical measures useful for the evaluation of
therapeutic interventions that may have an affect on activities of daily living
that influence disability (Beissner, Collins et al. 2000). As previously noted on
page 27 by Liu and Latham (2009), improved muscle strength has a positive
effect on pain and function. Furthermore, as highlighted in the literature
review on page 19, decline in lower limb muscle strength and ROM are
predictors of decrease in functional ability (Beissner, Collins et al. 2000;
Steultjens 2000). Therefore these results support the suggestion that
physical functioning is likely to have improved as determined by
improvements in WOMAC, SF-36, VAS and physical outcome measures
particularly ROM and muscle strength and importantly, these improvements
were maintained over time.
This is particularly relevant in light of evidence of increased mortality in
people with OA of the knee as suggested by Nuesch, Dieppe et al (2011). As
presented in the literature review on page 25, the most striking finding of that
study was that those people with OA of the knee and a walking disability are
140
at an even greater risk of early death than their more active counterparts
leading the authors to suggest than an aggressive approach to encouraging
physical activity even with painful OA seems justified (Nuesch, Dieppe et al.
2011). These suggestions are in concert with the constructs of the OAK
Program.
A favourable response to treatment (responder) was as defined in the
OMERACT-OARSI criteria scenario D (Pham, van der Heijde et al. 2004).
However, since global health was not collected in Study 1 it could not be
included. Therefore only improvements in pain, and WOMAC Physical
Function were used for classification of a responder. Following the
intervention, the significant proportion of responders at eight weeks in the
OAK group was more than three times that of the control group. At this post-
treatment assessment 26 (39%) people from the OAK group and eight (12%)
from the control group were classified as responders. Again there were more
responders in the OAK group 22 (33%) than in the control group 14 (20%) at
six months, however the difference between groups was not statistically
significant at this time-point.
There is some conjecture about the most appropriate point score that
constitutes an MCII for the SF-36. The developers, Medical Outcomes Trust,
suggest that a five point difference is clinically relevant (Ware, Kosinski et al.
2002) however Angst et al (2001) suggest that a range from 3.3 to 5.3 points
for Physical Function and 7.2 to 7.8 points for Body Pain dimensions are
relevant for OA of the knee or hip (Angst, Aeschlimann et al. 2001). For both
Study 1 and 2, a five-point difference in both SF-36 Pain and Physical
Function domains was chosen to represent MCII.
The OAK group had a greater proportion of MCIIs in all outcome measures at
all time-points when compared with the control group. The differences were
significant for WOMAC Physical Function, SF-36 Physical Function, VAS
pain and TUG at eight weeks. At six months the differences in WOMAC
Physical Function MCII and TUG were significant (VAS pain data were not
collected at six months). The OAK group achieved more MCIIs than the
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control group, but the differences between groups in SF-36 Physical Function
and SF-36 Body Pain were not significant at six months. Significance aside,
60% of the OAK group achieved MCIIs in SF-36 Physical Function at both
eight weeks (significant) and six months (not significant) compared with the
control group that achieved 34% and 22% at the same time-points. This is an
important improvement as it may well equate to a reduction in mortality in the
long term (Nuesch, Dieppe et al. 2011).  The proportion of MCIIs between
the OAK and the control group was greatest immediately post intervention,
OAK: 215 and control: 83. In the OAK group more than 2.5 times as many
participants were observed to achieve a MCII compared with the control
group at eight weeks and more than a third more at six months.
The number of MCIIs the control group achieved increased from post-
intervention to 6-months. It is difficult to explain this improvement other than
an interaction with health care providers having clinically useful effects
(Hrobjartsson and Gøtzsche 2004), and possibly the Hawthorne effect that
describes control groups improving simply because of participation in a trial
(Adair 1984).
There are no published results of arthritis SM that evaluate responder or
MCII criteria as outcome measures so it is difficult to speculate whether the
responder and MCII improvements demonstrated in Study 1 are replicated in
other studies. However, the significant improvements in the OAK group in
WOMAC, SF-36, VAS pain, quadriceps and hamstring strength, ROM and
TUG, in addition to the number of responders and MCIIs in the OAK group
further strengthens the assertion of an improvement in function in the OAK
group.
The control group had improvements in some outcomes that need to be
explained. The most likely explanation is the benefit this cohort of people
derived from the patient health care provider interactions at the various
assessment points.   In addition, this cohort continued with their regular
treatment regimen and could well have shown improvement as a result of
this ongoing care.  Thus patients in the untreated control group were likely to
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have interacted with health care providers and the possibility of patient-
provider interaction could have clinically useful effects (Hrobjartsson and
Gøtzsche 2004). Furthermore, this interaction can influence patients’ beliefs
about their illness or treatment. By providing support, empathy, care and
reassurance, the fear and anxiety that patients feel may be lessened and it
may also improve the way they perceive their illness (Di Blasi, Harkness et
al. 2001). There may have been a Hawthorne effect explaining in part the
improvements seen in the control group (Campbell, Maxey et al. 1995).
Summary of Study 1
In summary, the significant improvements in pain, quality of life and function
among the subjects in the experimental group when compared with the
control group were such that further investigation was warranted. Since
Study 1 employed no treatment control group, it was therefore important to
investigate whether the benefits of the OAK Program would be the same if
the control group were enrolled in an alternative SM program such as the
ASMP.
Both Weingarten, Henning et al (2002) in their meta-analysis of chronic
disease management programs and Newbould, Taylor et al (2006) in their
review of lay led self-management suggest that comparison of different
programs is necessary to determine effective SM programs. In Study 2 we
will make such a comparison.
Study 2
Random assignment to the OAK Program or the ASMP Group
The second study was a RCT that compared the OAK Program with the
ASMP with follow-up to 12-months. The hypothesis stated: A greater
proportion of people with osteoarthritis of the knee that complete the OAK will
achieve a minimal clinically important difference in pain, function and quality
of life, at eight weeks, six and twelve months compared to those who
complete the ASMP.
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Participants and assessors were blind to group allocation. The primary
outcomes for Study 2 as described in the ACTR registration were WOMAC,
SF-36, and VAS pain. The secondary outcomes included the Arthritis Self-
Efficacy scale, step test and single leg timed balance. Amendments to the
study protocol included the addition of TUG, VAS global health and VAS
global improvement. This was necessary to meet OMERACT-OARSI criteria
(Pham, van der Heijde et al. 2004). Between group differences in changes
over time using repeated measures ANOVA were examined, and additionally
the proportion of participants achieving MCII and responder criteria was
computed for each group at each observation time and Chi-square tests
were used to examine proportions between groups.
Primary Outcomes
WOMAC ANOVA
Participants in the OAK Program had significantly greater improvements
compared with those in the ASMP from pre-intervention to twelve months in
WOMAC Pain, Physical Function and Total scores. While there was
improvement recorded in stiffness among those in the OAK group compared
with the ASMP group, this difference was not significant.
As considered in Study 1 on page 127, these results are important in relation
to function and disability since pain is a major contributing factor to the loss
of function and increase in disability in people with OA of the knee
(McCarthy, Mills et al. 2004). The WOMAC measure is particularly relevant to
our OA of the knee population as it measures pain related to physical
activities. Thus the combination of an improvement in WOMAC Pain,
Physical Function as well as the Total score domains is highly suggestive of
an improvement in functional abilities in the OAK group compared with the
ASMP group. Moreover, these significant improvements were maintained to
12-months. In light of the findings by Nuesch, Dieppe et al (2011) with
respect to pain and walking disability and the association with increased
mortality, an improvement in these measures is highly significant. These
authors stress the importance of OA treatment programs that target
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strategies to improve physical activity and thereby reduce the risk associated
with increased mortality (Nuesch, Dieppe et al. 2011).
The improvements in WOMAC Pain, Physical Function and Total domains
have not previously been demonstrated in arthritis SM programs and are
therefore unique to the OAK Program. Furthermore, these improvements in
WOMAC outcomes were consistent through out the three studies testing the
OAK Program- the Quality Assurance study, Study 1 and Study 2, and they
were maintained long term.
WOMAC MCII
A greater number of MCIIs in WOMAC pre to post-intervention was recorded
for the OAK Program participants than for the ASMP subjects. Since a MCII
reflects the patient’s perspective of improvement, these results present
another way of observing the same improvement in pain and function seen in
the ANOVA analysis that further strengthens the assertion of a greater
improvement in physical functioning in those people in the OAK group
compared with the ASMP group. These improvements were maintained at all
other time-points although not necessarily at the same level, since some of
them became non-significant.
Responders
The mean change in pain intensity is not always the easiest method of
interpreting treatment results. OMERACT-OARSI developed the responder
criteria to encourage the uniform reporting of results in clinical trials (Pham,
van der Heijde et al. 2004). Responder criteria are based on improvements in
pain, WOMAC Physical Function and Patient Global assessment and aim to
determine an individual’s response to treatment.
The number of the OAK group responders was greater than the ASMP group
responders at all time-points, however this difference was only significant at
the post-intervention time-point. Post-intervention almost half the OAK group
were classified as responders compared to almost one third of the ASMP
group.  This significant result suggests that half the OAK group had a clinical
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response to treatment (the OAK Program). Since responder criteria includes
the assessment of pain and function which has a relationship with disability
and dependence (McCarthy, Mills et al. 2004), this measure is an important
determinant of functional improvement. Importantly, improved function is
associated with reduced mortality risk as described by Nuesch, Dieppe et al
(2011). Thus even when not significant, those in the OAK group were more
likely to be responders than those in the ASMP group with the advantage in
the OAK group maintained albeit to a lesser degree at the later time-points.
SF-36 ANOVA
The significant improvements seen in the OAK group when compared with
those in the ASMP were also demonstrated in the SF-36 ANOVA analysis
pre-intervention to twelve months.  These significant improvements were
demonstrated in the primary outcomes of SF-36 Physical Function and
General Health, both of which are classified as physical dimensions. Physical
Function assesses limitations in performing all physical activities including
bathing or dressing and it measures limitations in behavioural performance in
everyday activities due to health. General Health evaluates personal health
status and the prospect of it becoming worse. As discussed on page 130,
poorer General Health scores are linked to several indicators of health
expenditure, namely hospitalisation, visits to medical practitioners, and
prescriptions per visit and indicate greater utilization than those with higher
scores (Ware, Kosinski et al. 2002).
As noted on page 130, SF-36 physical dimensions are more specific to OA
knee (Ware 2004) therefore an improvement in the SF-36 Physical Function
and General Health dimensions in the OAK group compared with the ASMP
group at all time-points adds strength to other findings that support a
functional improvement. Again, this improvement in function directly relates
to disability, independence and mortality risk (McCarthy, Mills et al. 2004;
Nuesch, Dieppe et al. 2011). The significant improvements demonstrated in
the OAK group compared with the ASMP group were significant post-
intervention and were maintained long-term to 12-months.
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SF-36 MCII
As with Study 1, for this analysis, a five-point difference in both pain and
physical function domains was chosen to represent MCII was chosen.
The OAK group demonstrated significant MCIIs in SF-36 Physical Function
post-intervention. At this time-point 70% of the OAK group achieved MCIIs in
SF-36 Physical Function, and at six and 12-months this percentage was only
slightly decreased. The OAK group demonstrated more MCIIs in SF-36
General Health at all time-points than the ASMP group, with significance at
six and 12-months and approaching significance at post intervention. To
reiterate, improvements in these SF-36 domains reflect functional
improvement in activities of daily living and perceived health status and
reflect improvement (or deterioration) in these domains (Ware, Kosinski et al.
2002).
Again the OAK group compared with the ASMP group demonstrated the
repeating scenario of improvement in pain and functional outcome domains
which may well translate to improved functional ability and less dependence
with an associated reduction in mortality risk (Fransen and McConnell 2008;
Nuesch, Dieppe et al. 2011).
VAS Pain ANOVA
The ANOVA result that compared the VAS Pain mean scores of the two
groups (OAK and ASMP) were of particular interest, since, as for Study 1,
they showed that those in the OAK group recorded significantly less pain
than those in the ASMP group.
VAS pain demonstrated a more dramatic difference in pain scores between
the two groups than other pain variables. The OAK group showed a small
increase in pain until week three followed by a steady reduction in pain for
the duration of the intervention and continued to decrease until six months
when there was a plateau effect. This same pattern of improvement seen in
the OAK group at week four has previously been observed in both the
Quality Assurance study and Study 1 (Coleman, Conroy et al. 2002;
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Coleman, Briffa et al. 2008a). In contrast, among those in the ASMP group
there were fluctuations in pain but no consistent pattern from pre to post-
intervention.
VAS Pain MCII
Additionally, those participating in the OAK Program demonstrated more
MCIIs in VAS pain criteria than ASMP participants at all time-points, although
these were not significant. However, even when not significant, improvement
in MCII VAS pain in the OAK group when compared with the ASMP group
was consistent with improvement in other pain variables and reflects the
same improvements seen in the ANOVA analysis.
Across the three studies in which the OAK Program has been examined
(Coleman, Conroy et al. 2002; Coleman, Briffa et al. 2008 and the present
report) a reduction in pain has been a consistent finding.  This finding
provides solid support for the value of the OAK Program and the use of a
disease specific SM program for people with OA of the knee led by health
professions.  Since no other reports in the literature suggest that pain relief is
a finding in SM programs for people with OA of the knee, this series of
findings add a new dimension to the discussion of SM programs for OA of
the knee. Furthermore, it supports the assertion that the combination of
improvements in physical function and pain variables are associated with
improved function in people with OA of the knee (Fransen and McConnell
2008).
Secondary Outcomes
None of the secondary outcome measures indicated significant differences
between the two groups of participants. Both the OAK and ASMP groups had
small improvements over time in self-efficacy. However as for other
outcomes, between group differences were not significant. The small
magnitude of the improvement is surprising particularly in the ASMP group
as the premise of the ASMP is that SE rather than the acquisition of
knowledge and skills results in improved health outcomes (Marks and
Allegrante 2005; Taylor and Bury 2007) and previous trials of the ASMP
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report improvements in SE (Lorig, Lubeck et al. 1985; Lorig, Feigenbaum et
al. 1986; Lorig, Mazonson et al. 1993).
Summary of Study 2
In summary, in Study 2, while the participants in both the OAK and ASMP
groups demonstrated improvements in most outcomes over time, those in
the OAK group consistently demonstrated more statistically significant
improvements when compared with the ASMP group. The VAS pain and
WOMAC measures clearly demonstrated that participants in the OAK
Program achieved significant improvements when compared with those in
the ASMP to 12 months. Other outcomes were less decisive. For example,
although the OAK group achieved a greater number of responders and MCIIs
than the ASMP group, only a few differences were significant. Those in the
OAK group had greater improvements in almost all the methods used to
measure pain and were statistically significant in the ANOVA VAS analysis
with WOMAC Pain approaching significance at 12 months. The number of
OAK group responders was significantly greater than that for the ASMP post-
intervention, and were maintained over the follow-up period however as time
progressed they became non-significant.
The improvements demonstrated in the OAK group compared with the ASMP
group in pain and physical function measures are important, as these are
predictors of disability and function. The improvements in these measures
suggest a functional improvement and in the context of the findings of
increased mortality associated with a decline in functional ability by Nuesch,
Dieppe et al (2011) this is a very significant association.
Outcomes of Studies 1 and 2
There was a sharp decrease in VAS pain in the OAK group during the third
week of the intervention and this pattern was repeated in both Studies 1 and
2. This coincided with an increase in the exercise component of the OAK
Program that has been described previously in Study 1 discussion on page
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123. Of note, this same pattern of pain decrease was also demonstrated in
the earlier QA study (Coleman, Briffa et al. 2008a).
It has been suggested that there is no clear evidence that demonstrates the
mechanisms involved in successful SM (Newbould, Taylor et al. 2006). It
may be that success is due to the structured nature of the intervention or
perhaps more non-specific mechanisms such as group dynamics are
involved. There is even a suggestion that the improvements demonstrated in
SM interventions are due to the participants involvement rather than the
intervention itself (Taylor and Bury 2007). That there is no clear-cut
relationship between behaviour change and other outcomes has been
demonstrated in studies where behaviour has changed but clinical outcomes
have not (Newman, Steed et al. 2004). Most arthritis SM programs include
heterogeneous cohorts so there are confounding elements that may interfere
with this relationship. However, in both Study 1 and Study 2 all the
participants had OA of the knee and it may be that this created the necessary
environment for change in behaviour to correlate with the change in clinical
outcomes that have been identified. It may be that those heterogeneous
arthritis SM programs in which participants have variety of musculoskeletal
conditions have different requirements and needs that are not being met by a
generic program.
It is often assumed that SE is the central component of successful SM.
However there is no evidence that indicates the extent to which SE is an
independent variable relating to SM. Moreover, it is unclear whether high
levels of SE are a consequence rather than a cause of SM (Taylor and Bury
2007). Yet most SM trials include SE measures among their primary
outcomes. Neither the OAK group nor the ASMP group demonstrated
significant between group changes in SE at any time-point and the small
within group improvements were equivalent in each group. Since the tenet of
ASMP is based on SE theory this is difficult to explain (Lorig and Holman
2003). The result of minimal change in SE in the ASMP group is inconsistent
with other studies of SM using the ASMP as they routinely report
improvements in SE (Lorig, Mazonson et al. 1993; Barlow, Turner et al.
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1998; Lorig, Gonzalez et al. 1999; Barlow, Turner et al. 2000). One such
study (Lorig, Mazonson et al. 1993) reported improved SE despite worsening
in levels of disability. This is an important area that warrants further research.
Lay leaders are an integral component of the ASMP although there is little
evidence to support this model of SM in preference to utilizing health
professionals with more disease specific programs (Taylor and Bury 2007).
The argument for the use of lay leaders centres on the premise that lay
leaders are patient “experts”, and that the essential component of SM is to
promote SE rather than to educate or impart disease specific skills to the
participants (Newbould, Taylor et al. 2006). Taylor and Bury (2007) in their
review of chronic illness and SM suggest that not withstanding possible cost
advantages, lay-led SM interventions may have little effect on chronic illness
and they suggest that enhanced professional involvement in SM could be
beneficial (Taylor and Bury 2007). With this in mind, the comparison of a
generic lay led SM program (the ASMP) with a disease specific SM program
delivered by HP’s (the OAK Program) with a homogeneous cohort of
participants is of particular importance especially since it has not previously
been done.
Lay vs Health professionals
The OAK Program is designed to be disease specific and use the knowledge
and skills of health professionals to deliver a program that incorporates
detailed information and education on OA of the knee within SM constructs.
In this respect it is unique among SM programs for arthritis. As Newbould et
al (2006) in their review of lay led SM have reported, the development of
condition specific SM programs delivered by lay leaders has, to date, been
very limited (Newbould, Taylor et al. 2006). The specificity achieved by the
OAK Program would appear to meet this expectation of Newbould, Taylor et
al. (2006) and give the program weight.  The success of this endeavour is
further indicated by the improvement in participant assessment over the
period of interest to the studies reported here.
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With SM programs that are medication-orientated there appears to be
consensus regarding their effect by increasing adherence to medications
(Warsi, Wang et al. 2004; Chodosh, Morton et al. 2005). This is
demonstrated by the significant effects seen in asthma, hypertension and
diabetes SM programs (Chodosh, Morton et al. 2005) all of which are
medication orientated. As explained on page 125 in the Study 1 discussion,
in the OAK Program syllabus, pharmacological therapy and pain relief are a
central component.  This was reflected in the QA study as well as Study 1
and Study 2 by a dramatic reduction in pain at the third week of the program
that coincided with an increase in structured exercise expectation in the
program syllabus.
Pain was significantly reduced in the OAK group in outcomes in both studies.
Pain management is important because many people are hesitant to
undertake some activities for fear of pain, regardless of whether they have
previously experienced pain with that particular activity. Many people with OA
rely on medication for pain relief but are reluctant to take drugs that may
have side effects. Their inclination is to be aware of the pharmacologic and
treatment options available and then decide on their course of management
(Fraenkel, Bogardus et al. 2004). However, if their knowledge about the
available options is lacking, this may incorrectly influence their treatment of
choice and importantly, it may have an impact on their adherence to
treatment (Mitchell and Hurley 2008). Promoting understanding and
agreement between individuals and health professionals on medication
adherence reflects the growing awareness of the fact that health
professionals need to respect patients’ beliefs and decisions particularly with
regard to evidence-based practices (Taylor and Bury 2007).
Limitations of Studies 1 and 2
Study 1 compared a treatment program with a non-treatment control group
and was therefore unblinded; consequently there is a risk of reporting,
attrition, and other types of bias. In addition, self-reporting of pain may be
affected by bias, as patients are keen to “do well” and to please health care
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providers by reporting an improvement when there may not have been one.
Moreover, the perception of the efficacy of the treatment by the health care
providers may influence how the patients perceive their pain and result in
improved pain ratings (Hirsh, Atchison et al. 2005).
Participants within the control group attended three assessment visits prior to
commencing the OAK Program at the completion of the six-month control
(waiting) period. Positive expectations of attending the OAK Program may
also have contributed to the anticipated benefits of the OAK Program thereby
influencing the outcomes during the control period (Turner, Deyo et al. 1994).
Another limitation of Study 1 was the relatively short control period of six-
months. A longer control period would have been useful however, although a
longer control period was considered when planning the study design, the
Advisory Committee thought it would be difficult to recruit participants with a
control period longer than six months. In addition, as most participants were
self-referred through their GP, there were ethical issues involved in the
withholding of treatment for a longer period of time in order to obtain a
representative sample (Barlow, Wright et al. 2002; Bury, Newbould et al.
2005), particularly in light of the positive results demonstrated in the QA
study (Coleman, Briffa et al. 2008a).  Although follow-up assessments
continued for 12 months following the OAK Program, they were then
“uncontrolled” because of the absence of a comparison group and therefore
have not been reported in this thesis.
In both Studies 1 and 2, most enrolments were initiated by participants who
approached their own GPs to arrange referral into the study. This self-
initiated enrolment may have been responsible for potential bias as those
people who volunteered may already be predisposed to SM (Newbould,
Taylor et al. 2006; Taylor and Bury 2007)  and this behaviour may not be a
true reflection of health patterns in the community.
The participants enrolled in Studies 1 and 2 were over represented from
higher socio economic groups and therefore the results may not be a true
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reflection of the likely impact on the wider community as there is the potential
for people with higher education levels to show greater improvements.
In addition to the limitations noted above, Study 2 had a high attrition rate. In
the previous quality assurance study, the drop out rate was below 10% and
rose to 17% in Study 1. Assuming that this RCT would be similar, the power
calculations for Study 2 allowed for a drop out rate of 20%. Although both
groups had non-attendees at follow-up assessments it was especially
problematic in the ASMP group. The attrition rate was 26% in OAK and 44%
in ASMP at 12-months that was reduced to 15% and 25% respectively when
the data from posted questionnaires were utilized. However, the posted
responses consisted of self-reported questionnaires and did not capture
physical assessments such as balance and TUG tests.
Using an intention to treat study design, we employed last value carried
forward (LVCF) for other missing data. LVCF assumes that the participant’s
responses would have been constant from the beginning to the end of the
study and this can result in a false conclusion that a difference exists when in
fact there is none (Mallinckrodt, Sanger et al. 2003). Furthermore, OA is a
condition that generally deteriorates over time. Employing LVCF creates in
an impression that the participant is in a state of equilibrium- neither better
nor worse; an outcome that could be perceived as beneficial in terms of
disease progression in OA leading to bias of the estimates of treatment effect
(Baron, Boutron et al. 2005).
In keeping with an intention to treat study design, attempts were made in
both studies to retain the study population. This included telephone and
written notification of scheduled follow-up assessments; offers to reschedule
missed assessment appointments at the convenience of the participant with
telephone contact to encourage attendance of assessments missed.
Despite these endeavours there were some participants who did not attend
follow-up assessments.  All non-attending participants received posted self-
reported questionnaires with postage paid self-addressed envelopes
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enclosed. Some, though not all, returned the questionnaires and other
missing values were recorded with the last value carried forward, which is
consistent with an intention to treat analysis.
There was discordance between the number of participants attending
assessments post intervention and improvements demonstrated at the same
time-points. As attendance dropped (most dramatically between six and 12
months), the number of responders and MCIIs increased, especially in the
ASMP group. Considering the drop out rate in the ASMP group at 12 months
was 44%, with posted questionnaires this was reduced to 25%, it is difficult to
interpret the increase in the number of MCIIs as a treatment effect rather
than an overestimation. In addition if there are an unequal number of drop-
outs in both groups this can also result in bias in either under or over-
estimation of treatment effects (Liu-Seifert, Zhang et al. 2010).
The degree of attrition experienced in Study 2 has been reported in other SM
programs with attrition rates of 30 – 50% (Biller, Arnstein et al. 2000;
Newman, Steed et al. 2004; Bury, Newbould et al. 2005; Rooks, Gautam et
al. 2007).  Furthermore, despite the high attrition rate, non-completion may
not necessarily equate with lack of benefit (as in medication based trials)
especially if the attrition occurred during the follow-up period of the study,
which was generally the case in Study 2.
Similar sentiments have been described by Kerns and Rosenberg who report
a significant drop out rate associated with SM programs that are CBT
orientated (Kerns and Rosenberg 1999). This dissatisfaction was not
anticipated and was therefore not assessed as part of the study, however
this is an area that may benefit from further research. The ability to identify
those people who respond to different models of SM would have the potential
to be beneficial in terms of participant satisfaction, attrition, clinical
improvements and cost effectiveness.
Four different lay leaders all of whom were accredited ASMP leaders
facilitated the ASMP group. The senior lay leader was very experienced and
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was the dominant facilitator who participated in every ASMP group. A
possible limitation to Study 2 is that this lay leader had attended a previous
OAK Program and was therefore not OAK Program naïve and this may have
influenced her facilitation. Although instructed to adhere to the ASMP
facilitators manual there were occasions when this was not the case. There
were discrepancies with additional exercise instruction delivered to the
groups that were not scripted in the ASMP manual. Despite counselling to
adhere strictly to the ASMP script it was apparent that at times this did not
occur.
Future Research
In Study 2 both groups demonstrated improvements despite the
dissatisfaction of some of the ASMP group participants. The level of
dissatisfaction among some of the ASMP participants made follow-up
assessments difficult. It appears that any one particular type of SM model is
not going to be suitable for generalised application. There are those people
who want specific information including facts and skill based interventions
and those others who respond to support group or more, generic
interventions.   To be able to identify those people who benefit from support
group style SM would enable better distribution of health expenditure by
screening and allocating people to the type of SM style that suits them best –
either generic or disease specific. There is no literature available to suggest
that this concept has been investigated.
The central processes underlying successful SM are equivocal. As discussed
previously, SE is seen as the fundamental basis of most arthritis SM
programs, yet there is little evidence to support this sentiment (Taylor and
Bury 2007). It may be that focusing on improving SE as the pivot of the SM
intervention is misdirected. Research is needed to establish the mechanisms
behind successful SM and to structure SM programs accordingly.
Having established that the mechanisms of successful SM are not well
understood (Taylor and Bury 2007), trials that study SM may be relying on
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outcome measures that are inappropriate for these types of interventions and
are more suitable for medication based clinical trials. Currently accepted
outcome measures may not be capturing the underlying process that is
responsible for the SM treatment response.
Interventions that require long-term adherence and changes in behaviour
have notoriously high attrition rates (diet, exercise and SM interventions)
(Roddy, Zhang et al. 2005). With OA, a condition that is expected to
deteriorate over time, adherence to treatment interventions is essential and
strategies to encourage long-term compliance would be extremely beneficial.
Conclusion
SM may be regarded as an interface between the biomedical model and
health psychology by combining information and contributions from both
disciplines in an effort to improve the wellbeing of those people with chronic
illness (Taylor and Bury 2007).  SM may enable individuals with chronic
illness, whose main interests are access to treatment and support services,
to cope with the challenges of chronic illness.
The OAK Program, a disease specific self-management program delivered
by health professionals, demonstrated improvements in pain, function and
quality of life in an uncontrolled quality of life study (Coleman, Briffa et al.
2008a). Study 1 of this thesis, an RCT compared the OAK Program with a
control group and demonstrated similar results to those achieved in the
uncontrolled study. These improvements were maintained to six months
(Coleman, Conroy et al. 2002).
In Study 2, a second RCT that compared the OAK Program with Stanford
Universities ASMP, similar improvements were demonstrated in the OAK
group and to a lesser degree the ASMP group.  Most notable among these
improvements was the significant reduction in pain and improvement in
physical function reported.   It should be noted however, that the significance
of the differences between groups was relatively small with the exception of
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those outcomes that measured pain and the WOMAC Physical Function
measures. The reduction in pain experienced was a significant finding
throughout this series of studies and is one that has not been reported
previously in other studies. Although the OAK Program has demonstrated
significant benefits for people with OA of the knee in two separate studies,
the results of Study 2 raise questions with respect to the differences in SM
programs that require further investigation. In addition, Study 2 did not
definitively resolve the question of whether health professional or lay
leadership in SM is most effective.
The results of this doctoral work demonstrate that the OAK Program is an
effective SM program for people with OA of the knee.  Of major importance
was the fact that one of the studies provided an RCT with twelve-month
follow-up, showing that the improvements gained during the program could
be maintained (albeit to a lesser extent) over time.  The most consistent
finding was related to pain reduction and improvement in physical function
that was consistent for both studies and reproduced the finding of the initial
quality assurance study.
Based on this work is it possible to suggest that a targeted SM program for
people with OA of the knee is superior to routine treatment, particularly with
respect to pain reduction and function.  It has also been shown that
improvements gained during the targeted SM program are likely to be
maintained over a six-month period, although decline in these improvements
should be noted.
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APPENDIX 1
Study 1 Patient Information Sheet
A Randomised Controlled Trial of an Osteoarthritis Self-Management
Program.
Investigators: Dr. Kathy Briffa, Sophie Coleman, Jean McQuade, Dr Charles
Inderjeeth.
Introduction
The Arthritis Foundation of Western Australia is testing a new approach to
the management of osteoarthritis of the knee. Osteoarthritis is the most
common form of arthritis affecting about 10% of the Australian population.
People with osteoarthritis of the knee report pain, stiffness, and a decline in
quality of life as the disease progresses. Patient education, physical exercise
and behavioral modification have been shown to have a positive effect on
people with osteoarthritis and therefore we have formulated a program with
these three components. We now wish to see how effective this program is
for people with osteoarthritis of the knee and will compare it to a control
group.
What does the study involve?
In this study we will compare our osteoarthritis program with a no intervention
control group. This will involve recruiting people with osteoarthritis of the
knee and then allocating them into either the osteoarthritis program or a
control group. In order that we don’t influence the results of the trial we are
using special methods of allocating people to either group. This means that
you will not be able to choose which group you are allocated to and you will
be assigned to a group by a randomised draw.
The osteoarthritis program consist of 8 two-hour sessions over a period of 2
months. The sessions will be held at the Arthritis Foundation, 17 Lemnos
Street, Shenton Park. You will randomised and allocated to either Tuesday
morning program or Thursday morning program. The control group will have
no intervention and you will be able to continue with your usual medical care.
The control group will be expected to attend assessment sessions.
The Program
1. At the first, or baseline, session you will:
 Be asked to complete 4 physical tests:
• Functional Knee Assessment Test in order to assess your knee
function.
• A quadriceps muscle strength test
• A hamstrings muscle strength test
• A knee range of motion assessment
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 Be required to complete 3 questionnaires.
• The WOMAC questionnaire asks questions specific to arthritis of the
knee
• SF36 questionnaire is a general health survey.
• The VAS is a pain scale in which you rate the severity of your pain.
The information that you give in the questionnaires will not identify you
personally and it will be used to assess the effectiveness of the program.
You will also be required to:
 Be interviewed by a registered nurse who will record your current
medications, relevant past medical history, date of birth, and photocopy
your knee x-ray reports (if you have them). The information provided by
you will be kept confidential and not used for any other purpose other
than for the purpose of this study. If we are not sure that you have
osteoarthritis of the knee we will need you to provide us with your doctor’s
contact details so that we may ask him/her to confirm your diagnosis.
2. Sessions 2 –6 inclusive
    Consist of 6 group education sessions (one session per week). Each
session will run for 2.5 hours. These sessions cover the areas associated
with osteoarthritis. At the first session you will be given a course book
which you may use for the duration of the program, and throughout
sessions 2-6 you will be given information sheets, which you may keep or
return.
3. Session 8
Occurs in the week immediately following the 6 education sessions. At
this session the physical measurements and the questionnaires are
repeated.
These assessments will be repeated at 6 months
You should not enter this study if you plan to have knee surgery in the
immediate future, if you have rheumatoid arthritis or other joint disease, or if
you have physical impairments that preclude you from fulfilling the
requirements of the program.
Benefits and Risks
The Arthritis Foundation of Western Australia has completed a study of this
program and it will be compared to the US arthritis program. The results of
this study show that those people who participated had less pain, and
experienced improvements in their knee function and quality of life. There
were no apparent risks associated with participation in this program or with
the US program.
Withdrawal from the study
You may agree to participate in the study but change your mind later. You
may withdraw from the study at any time without explanation and in this case
your future treatment will not be affected.
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Confidentiality and Security of information
Any information about you will be stored in a safe and secure way to prevent
others from having access to it. The information provided by you will not be
used for any other purpose other than for the purpose of this study. Results
of the study may be published in a scientific journal without the use of your
name or any other identifying information. The data collected will be kept for
7 years after which time it will be destroyed.
For more information about this study contact:
Sophie Coleman
Arthritis Foundation of Western Australia
17 Lemnos Street
Shenton Park, 6008
Telephone: 9388 2199
Fax: 9388 4488
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APPENDIX 2
Study 1 Consent Form
CONSENT TO PARTICIPATION IN A TRIAL OF AN
OSTEOARTHRITIS SELF-MANAGEMENT PROGRAM
Investigators: Dr. Kathy Briffa, Sophie Coleman, Jean McQuade, Dr
Graeme Carroll, Dr Nicola Cook, Dr Charles Inderjeeth.
I have been given clear written information about this study. I
have read and understood it. I have been given time to consider
whether I want to take part.
I have been told about the possible advantages and risks of taking part
in the study and I understand what I am being asked to do.
I understand that I will be allocated to either a control group or an
intervention group using the method outlined in the information
brochure.
I understand that if I am allocated to the control group I will be
required to wait 6 months before commencing the program, and that if
I am allocated to the intervention group I will be required to start the
program straight away.
I know that I do not have to take part in the study and that I can
withdraw at any time during the study without affecting my future
medical care.
I agree to take part in this research study and for the data obtained to
be published provided my name or other identifying information is not
used.
Name of Participant Participant Signature
Date  
Name of Investigator Investigators Signature
Date
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Curtin University Human Research Ethics Committee has approved this
research study.
If you have any ethical concerns regarding the study you can contact the
secretary of the Curtin University Research Ethics Committee on Telephone No.
9266 2784
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APPENDIX 3
Study 1 Ethics Approval
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APPENDIX 4
Study 1 SF-36 Licence Agreement
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APPENDIX 5
Study 1 WOMAC Licence Agreement
-----Original Message-----
From: McGrath, Chesne [mailto:mcgrath@medicine.uq.edu.au]
Sent: Thu 2/20/2003 2:06 PM
To: Sophie Coleman
Subject: WOMAC(TM)
Email:  sophiec@arthritiswa.org.au <mailto:sophiec@arthritiswa.org.au>
Dear Sophie,
Many thanks for your email of February 4th, 2003.  Your project sounds very
interesting.  I would be pleased to provide the WOMACTM questionnaire for
your study.  I have attached  a copy of the Academic User Agreement  for
your signature.  I would be most grateful  if you could fax back the
completed document to me at 07 3851 1559.  There is a nominal charge of
AUD $110.00 (Inclusive of GST) to cover the costs of the WOMACTM User
Guide, a copy of WOMACTM LK 3.1 for Australia, and the airmail and
handling charge.
I trust that this nominal charge is acceptable.
Kind regards,
Nicholas Bellamy, MD, MSc, MBA, FRACP
Director of CONROD and
Chair of Rehabilitation Medicine
The University of Queensland
® WOMAC is a registered trade-mark
    (CDN No. TMA  545,986)
"Progress through understanding"
Chesne McGrath
CONROD, Department of Medicine
The University of Queensland
Level 3, Mayne Medical School
Herston Road
Herston   Qld  4006
* Telephone  +61 7 3346 4783
Fax        +61 7 3346 4603
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APPENDIX 6
Study 2 Patient Information Sheet
A Randomised Trial of Two Osteoarthritis Self-Management Programs.
Investigators: Dr. Kathy Briffa, Sophie Coleman, Jean McQuade, Dr Charles Inderjeeth.
Introduction
The Arthritis Foundation of Western Australia and Curtin University are
testing a new approach to the management of osteoarthritis. Osteoarthritis is
the most common form of arthritis affecting about 10% of the Australian
population. People with osteoarthritis report pain, stiffness, and a decline in
quality of life as the disease progresses. Patient education, physical exercise
and behavioral modification have been shown to have a positive effect on
people with osteoarthritis and therefore we have formulated a program with
these three components. We now wish to see how effective this program is
for people with osteoarthritis and will compare it to an internationally
recognized arthritis self-management program designed in the USA.
What does the study involve?
In this study we will compare our program with the arthritis program designed
in the USA. This will involve recruiting people with osteoarthritis and then
allocating them into either arthritis program. In order that we don’t influence
the results of the trial we are using special methods of allocating people to
either program. This means that you will not be able to choose which
program you are to attend and you will allocated to either program by a
randomised draw.
Both programs consist of 8 two-hour sessions over a period of 2 months. The
sessions will be held at the Arthritis Foundation, 17 Lemnos Street, Shenton
Park. You will randomised and allocated to either a Tuesday morning
program or a Thursday morning program. There will also be 2 follow up
assessments at 6 and 12 months.
The Program
4. At the first, or baseline, session you will:
 Be asked to complete 3 physical tests:
• Functional Knee Assessment Test in order to assess your knee
function.
• A balance test
• A step test
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 Be required to complete 4  questionnaires.
• The WOMAC questionnaire asks questions specific to arthritis of the
knee
• SF36 questionnaire is a general health survey.
• The VAS is a pain scale in which you rate the severity of your pain.
• Self-efficacy questionnaire
The information that you give in the questionnaires will not identify you
personally and it will be used to assess the effectiveness of the program.
You will also be required to:
 Be interviewed by a registered nurse who will record your current
medications, relevant past medical history, date of birth, and photocopy
your knee x-ray reports (if you have them). The information provided by
you will be kept confidential and not used for any other purpose other
than for the purpose of this study. If we are not sure that you have
osteoarthritis of the knee we will need you to provide us with your doctor’s
contact details so that we may ask him/her to confirm your diagnosis.
5. Sessions 2 –6 inclusive
    Consist of 6 group education sessions (one session per week). Each
session will run for 2.5 hours. These sessions cover the areas associated
with osteoarthritis. At the first session you will be given a course book
which you may use for the duration of the program, and throughout
sessions 2-6 you will be given information sheets, which you may keep or
return.
6. Session 8
Occurs in the week immediately following the 6 education sessions. At
this session the physical measurements and the questionnaires are
repeated.
You should not enter this study if you plan to have knee surgery in the
immediate future, if you have rheumatoid arthritis or other joint disease, or if
you have physical impairments that preclude you from fulfilling the
requirements of the program.
Benefits and Risks
The Arthritis Foundation of Western Australia has completed a study of this
program and it will be compared to the US arthritis program. The results of
this study show that those people who participated had less pain, and
experienced improvements in their knee function and quality of life. There
were no apparent risks associated with participation in this program or with
the US program.
Withdrawal from the study
You may agree to participate in the study but change your mind later. You
may withdraw from the study at any time without explanation and in this case
your future treatment will not be affected.
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Confidentiality and Security of information
Any information about you will be stored in a safe and secure way to prevent
others from having access to it. The information provided by you will not be
used for any other purpose other than for the purpose of this study. Results
of the study may be published in a scientific journal without the use of your
name or any other identifying information. The data collected will be kept for
7 years after which time it will be destroyed.
For more information about this study contact:
Sophie Coleman
Arthritis Foundation of Western Australia
17 Lemnos Street
Shenton Park, 6008
Telephone: 9388 2199
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APPENDIX 7
Study 2 Consent Form
CONSENT TO PARTICIPATION IN A TRIAL OF TWO
OSTEOARTHRITIS SELF-MANAGEMENT PROGRAMS
Investigators: Dr. Kathy Briffa, Sophie Coleman, Jean McQuade, Dr
Charles Inderjeeth.
I have been given clear written information about this study. I
have read and understood it. I have been given time to consider
whether I want to take part.
I have been told about the possible advantages and risks of taking part
in the study and I understand what I am being asked to do.
I understand that I will be allocated to either one of two arthritis self-
management groups using the method outlined in the information
brochure.
I understand that there will be follow-up assessments at 6 and 12
months.
I know that I do not have to take part in the study and that I can
withdraw at any time during the study without affecting my future
medical care.
I agree to take part in this research study and for the data obtained to
be published provided my name or other identifying information is not
used.
      Name of Participant Participant Signature
Date  
Investigator Invest igators  S ignature
Date
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Curtin University Human Research Ethics Committee has approved this
research study.
If you have any ethical concerns regarding the study you can contact the
secretary of the Curtin University Research Ethics Committee on Telephone No.
9266 2784
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APPENDIX 8
Study 2 Ethics Approval
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APPENDIX 9
Study 2 SF-36 Licence Agreement
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APPENDIX 10
Study 2 WOMAC Licence Agreement
Dear Sophie,
 
Thank you for your email of 4 September, 2008, and your completed
WOMACTM  Academic User Agreement dated 3 September, 2008, for your
study of up to 150 patients, in a study entitled “A randomised controlled study
to compare the effectiveness of the OAK and ASK self-management
programs for people with OA knee”.  From your email, I am not sure which
publications you are seeking.  By CII, do you mean Clinically Important
Improvement?
I will send to you this week, a copy of the WOMACTM LK 3.1 English for
Australia Index for use in your study of up to 150 patients in the
aforementioned protocol.    I will also send you 1 copy of WOMACTM  User
Guide IX.  These will be sent to your designated address in Nedlands, WA.  I
would be most grateful if you could please confirm receipt of materials in due
course. I am pleased to permit use of the WOMAC™ Index in the above
protocol without charge on this occasion, and without setting a precedent for
future use of the WOMAC™ Index.  
 
Please note that the WOMACTM LK 3.1 English for Australia Index is a
proprietary health status questionnaire, protected by copyright and
trademark, and the physical form of the Index should not be published or
placed in the public domain in paper, electronic or any other form, neither
should the instrument be modified or provided to unlicensed users.  
Please also note that this licensing Agreement relates to the study of up to
150 patients in the aforementioned protocol, and not to the study of
additional patients in this protocol, or to use of the WOMACTM Index in other
research protocols, clinical practice or other applications, without prior
completion of a relevant User Agreement appropriate for that additional
application, and remittance of applicable fees.  Thank you for your interest in
the WOMACTM Osteoarthritis Index.
Kind regards,
 
Nicholas Bellamy, MD, MSc, DSc, MBA, FRACP
 
® WOMAC is a registered trade-mark
    (CDN No. TMA 545,986)(EU No 004885235)
 
Prof. Nicholas Bellamy MD MSc DSc MBA FRCP (Glas, Edin, Canada),
FACP, FAFRM, FRACP.
Director
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Centre of National Research on Disability and Rehabilitation Medicine
(CONROD)
Faculty of Health Sciences
The University of Queensland
Queensland 4006
AUSTRALIA
 
Tel +61 7 3365 5560
Fax +61 7 3346 4603
Mobile +61 419 419 449
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APPENDIX 11
Quality Assurance Paper
Coleman, Briffa, et al. (2008b). “Effects of self-management, education and
specific exercises, delivered by health professionals, in patients with
osteoarthritis of the knee.” BMC Musculoskeletal Disorders 9:133.
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APPENDIX 12
Self-Efficacy Questionnaire
199
